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Abstract
The transparency of the lens is maintained throughout life, at least in part, by the chaperone
activity of the small heat shock protein (sHSP) αB-crystallin (αB). However, modified forms
of αB, including phosphorylated and deamidated isoforms, accumulate in insoluble protein
fractions from the lens with age. This has led to the suggestion that modification of αB is a
precursor to age-related nuclear cataract formation. This thesis investigated whether
phosphorylated αB could contribute to cataract formation by facilitating the formation of the
nucleocortical barrier, a physical barrier to the diffusion of small molecules into the nucleus
of the lens that forms at middle age. To determine how phosphorylation may modulate the
chaperone activity of αB, single (S19D; S45D; S59D), double (S19D and S45D) and triple
(S19D, S45D and S59D) mutants of αB which mimic phosphosphorylation at three key serine
residues (Ser19, Ser45 and Ser59) were used in an in vitro aggregation assay and their
activity compared to wild type (WT) αB. Whilst WTαB failed to inhibit the heat-induced
aggregation of creatine phosphokinase (CPK), the triple mutant (i.e. αB S19D, S45D and
S59D) inhibited the aggregation of CPK by 83.9±1.3%. Thus, it is concluded that the addition
of negative charges to αB, similar to those added by phosphorylation, increases its chaperone
activity.
Next, protein was isolated from adult human lenses via sucrose density centrifugation and
separated using 2-dimensional sodium dodecylsulphate polyacrylamide gel electrophoresis
(2D SDS PAGE) to identify changes in αB phosphorylation and the deamidation of
cytoskeletal proteins that occurs with age across different regions of the lens. The amount of
multiply phosphorylated αB (i.e. phosphorylated at multiple residues) was increased in highdensity protein fractions from the lens (representing membrane-bound protein) compared to
low density protein fractions. The amount of multiply phosphorylated αB increased towards
the nucleus in the aged lenses. In some high density protein fractions there was also evidence
of crosslinked high molecular weight complexes (HMWCs), involving αA-crystallin (αA),
αB and cytoskeletal proteins including filensin. This provides evidence for the involvement
of α-crystallin, via binding to intermediate filaments, in the formation of a network that
supports the fibre cell membrane.
To determine whether the association of αB with fibre cell membranes could also be
mediated by direct interactions with membrane pore proteins, a proximity assay was used to
v

identify interactions between isoforms of αB and the abundant membrane pore proteins
aquaporin 0 (AQP0) and connexin 46 (Cx46). Interactions between αB and both AQP0 and
Cx46 were restricted to the cortex of the lens in a region coinciding with the putative location
of the nucleocortical barrier, although total αB continued to associate with membranes in the
nucleus of the lens. This pattern was more prominent for the pSer59 isoform, with minimal
interactions between pSer19 αB and membrane pore proteins throughout the lens.
Finally, recombinant human αB was heat-treated under acidic (~pH 3.0), basic (~pH 8.0) and
unfolding buffer conditions in order to determine whether it was susceptible to nonenzymatic deamidation, a process known to occur with age in the lens. An additional site of
deamidation in αB was identified in the sample that was heat-treated under slightly alkaline
(~pH 8.0) buffer conditions (i.e. deamidation occurred at both N146 and N78) compared to
the sample heat-treated under acidic buffer conditions (i.e. deamidation occurred only at
N146). Although the amount of deamidation at each site was unaffected by protein unfolding,
a slight decrease in buffer pH (from ~pH 8.0 to ~pH 7.4) significantly increased the amount
of deamidation at N146 and Q151 of αB.
Based on the results of this work, a new model for age-related cataract formation is proposed,
whereby phosphorylation of αB induces its association with membrane pore proteins (such as
AQP0 and Cx46) and deamidated cytoskeletal components (particularly filensin) that coat the
membrane. It is proposed that if these interactions mediate the formation of the nucleocortical
barrier at middle age, the inhibition of the transport of glutathione (GSH) and water into the
lens nucleus would result in an oxidative environment in the nucleus of the lens. This
provides a pathway for protein cross-linking and aggregation of proteins that form the
insoluble deposits characteristic of age-related nuclear cataract.
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Chapter 1
Introduction

Sections of the work described in this chapter have been published:
1. Thornell, E. and Aquilina, A. (2015). Regulation of αA- and αB-crystallins via
phosphorylation in cellular homeostasis. Cellular and Molecular Life Sciences72:
4127-4137.
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Chapter 1
1.1 Introduction
The lens is a transparent structure located in the eye that is responsible for the transmission
and focusing of light onto the retina. During life, the lens has negligible protein turnover, and
thus lenticular proteins are vulnerable to the accumulation of post-translational modifications
and damage that can compromise the transparency of the lens, leading to cataract. The
transparency of the lens is therefore maintained, in most cases, throughout life by the
chaperone activity of α-crystallins (Sun et al., 1997), which act to ensure lenticular proteins
remain in a soluble state. However, α-crystallin is itself vulnerable to post-translational
modifications (PTMs), and these are believed to have the ability to alter its chaperone
activity. It has been shown that phosphorylated α-crystallin accumulates within lens fibre
cells with age (Takemoto and Boyle, 1998), but it is unclear if, and in what way, this may
contribute to cataract formation. It has also been proposed that the formation of the
nucleocortical barrier, a barrier to diffusion that is known to form in the lens at around middle
age, directly contributes to cataract formation (Sweeney and Truscott, 1998; Truscott, 2000;
Truscott, 2005) by leading to the formation of an oxidative environment in the centre of the
lens. The mechanism behind barrier formation also remains unclear, and any potential link
between α-crystallin phosphorylation and barrier formation is yet to be elucidated. This
chapter discusses these complimentary theories in the context of the ageing lens.

1.2 The Lens
The lens is located in the eye, anterior to the vitreous humour and posterior to the aqueous
humour and the iris. It is held in position by the suspensory ligaments which anchor it to the
ciliary body (Ross and Pawlina, 2006) (Figure 1.1). The role of the lens is to bend or refract
incoming light that has already passed through the cornea and the pupil at such an angle that
the rays focus directly onto the light-sensitive retina, the innermost layer of the wall of the
eyeball (Ross and Pawlina, 2006). The lens achieves this through the process of
‘accommodation’, whereby the curvature of the lens is adjusted by the ciliary muscle to allow
light reflected off objects at various distances from the eye to be bent at the correct angle for
precise focussing onto the retina (Ross and Pawlina, 2006) (Figure 1.1). Upon striking the
18
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retina, the sensory organ of the eye, light energy is transferred into action potentials, through
a process known as ‘transduction’ (Silverthorn, 2007).

Figure 1.1: Internal and external structures of the eye. The lens is attached to the ciliary
body via the suspensory ligaments (not labelled), which act to suspend it in a position anterior
to the vitreous humour and posterior to the aqueous humour and iris. Light passes through the
cornea and pupil and is transmitted through the lens which, through the process of
accommodation, acts to focus the rays directly onto the retina. Image obtained from National
Eye Institute (2015a).

Synthesis and growth of the lens commences in utero and continues until death (Phelps
Brown and Bron, 1996), with the average mature lens reaching 4 mm in width, and 9 mm in
diameter (Harper and Shock, 2004). The lens, which is asymmetric and biconvex in shape
(Figure 1.2), is entirely covered by a thick but permeable capsule which protects it from
bacterial infection whilst allowing the diffusion of materials such as water, ions and proteins
via the humours. This capsule, which is composed of connective tissue, notably Type IV
collagen, is secreted by the epithelial cells in utero (Phelps Brown and Bron, 1996).
Within the capsule, the bulk of the lens consists of a mass of fibre cells covered at the
anterior surface by a single layer of epithelial cells which extend as far as the equator
(Papaconstantinou, 1967; Grey and Schey, 2009) (Figure 1.2). These epithelial cells migrate
19
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to the equator of the lens as they differentiate into fibre cells, elongate and wrap around the
lens, meeting at their tips to form sutures (Papaconstantinou, 1967; Grey and Schey, 2009).
Differentiation of epithelial cells into fibre cells involves the degradation of the organelles
and nucleus in order to attain the state of transparency required for effective light
transmission (Han and Schey, 2006; Grey and Schey, 2009)
This pattern of growth, where the addition of new cells on top of older cells in the centre of
the lens, results in the formation of two indiscrete zones (Han and Schey, 2006): the nucleus,
defined as the lenticular material that was present at birth; and the cortex, concentric layers of
cells that are laid down postnatally (Phelps Brown and Bron, 1996). At around middle-age, a
barrier forms between these regions, known as the ‘nucleocortical barrier’ (Sweeney and
Truscott, 1998; Shestopalov and Bassnett, 2000; Cobb and Petrash, 2002b; Truscott, 2005).
The precise nature of this barrier is unknown, although it is believed to inhibit the diffusion
of water and other molecules between the two regions (Cobb and Petrash, 2002b; Truscott,
2005).

Figure 1.2: Structure of the optical lens along the meridial plane. The lens is composed of
concentrically layered fibre cells, covered at the anterior pole by a single layer of epithelial
cells, shaded in grey. The outer border of the lens on the equatorial plane is known as the
equator, indicated by the black broken line, and is the site of differentiation of the epithelial
cells into fibre cells. The purported location of the nucleocortical barrier is indicated by the
red broken line. The dimensions of the barrier are as indicated.
20
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The lens proteome
Due to the absence of a nucleus and organelles in lenticular fibre cells, protein synthesis is
not possible, thus the lens is particularly prone to degradation with age (Han and Schey,
2006). Most notably, there is a decrease in elasticity that is due, in part, to the loss of αcrystallin (Heys et al., 2007), the formation of protein crosslinks (Phelps Brown and Bron,
1996; Truscott, 2005), and the formation of insoluble high molecular weight (HMW) protein
complexes that also cause increased light scattering (Benedek, 1971; Horwitz, 1993; Carver
et al., 1996; Phelps Brown and Bron, 1996; Hejtmancik and Kantorow, 2004; Moreau and
King, 2012). Other changes in the lens that are associated with age include decreased
membrane permeability due to increased chain length and saturation of membrane
phospholipids (Merchant et al., 1991), decreased amount and activity of enzymes (Hockwin,
1965; Hockwin et al., 1965; Sethna et al., 1982; Phelps Brown and Bron, 1996; Cobb and
Petrash, 2002b), the formation of the nucleocortical barrier (Cobb and Petrash, 2002b;
Truscott, 2005) and a range of PTMs that occur to proteins (Lund et al., 1996; Lin et al.,
1997; Lampi et al., 1998; Lin et al., 1998; Ma et al., 1998; Hanson et al., 2000; Lapko et al.,
2001; MacCoss et al., 2002; Truscott, 2005; Han and Schey, 2006; Wang et al., 2013). These
events are highly significant as they contribute to the conditions of presbyopia and cataract
(reviewed in Spector, 1995; Phelps Brown and Bron, 1996; Truscott, 2005). Presbyopia, or
long-sightedness, occurs around middle-age as a result of the lens failing to accommodate
efficiently, whereas cataracts result from the diffusion and obstruction of light transmission
by insoluble HMW proteins (Benedek, 1971; Horwitz, 1993; Carver et al., 1996; Phelps
Brown and Bron, 1996; Hejtmancik and Kantorow, 2004; Truscott, 2005; Moreau and King,
2012; National Eye Institute, 2015b).
Despite the lack of protein turnover, lenticular cells retain cytoskeletal and membrane protein
components. Three cytoskeletal networks exist in the lens i.e. the actin, microtubule and
intermediate filament networks (Figure 1.3), each of which retain distinct roles and assemble
independently of each other (Quinlan et al., 1999). The actin and microtubule cytoskeletal
networks are involved in cellular differentiation and cell transport processes respectively
(Quinlan et al., 1999). The lenticular intermediate filament network comprises three filament
proteins specific to the lens; vimentin, phakinin and filensin, the latter two of which are lens
specific (Quinlan et al., 1999). Phakinin and filensin interact to form a filamentous network
(FitzGerald and Graham, 1991; Carter et al., 1995; Quinlan et al., 1999) that is believed to be
important in the maintenance of cell morphology and cell membrane architecture (Perng et
21
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al., 2007). Both filensin (Sandilands, Prescott, Hutcheson, et al., 1995) and phakinin
(Sandilands, Prescott, Carter, et al., 1995) are highly susceptible to cleavage in the lens. It has
been shown in vitro, that although only a 53 kDa fragment derived from the N-terminal head
of filensin is required for filament formation (Masaki and Quinlan, 1997), neither filensin nor
phakinin can form a filament without the presence of the other (Carter et al., 1995;
Goulielmos et al., 1996). In the lens, phakinin and filensin co-assemble at the fibre cell
membrane to form a beaded filament protein (FitzGerald and Graham, 1991; Carter et al.,
1995). This structure interacts with αA and αB, which are believed to produce the
characteristic beaded appearance of the beaded filament protein (Carter et al., 1995). It has
been suggested that the association of the α-crystallins with filensin and phakinin is essential
for intermediate filament formation (Ghosh et al., 2005). Additionally, an R120G point
mutation of αB has been implicated in the breakdown of the intermediate filament network
associated with desmin-related myopathy, being incorporated into the protein aggregates
characteristic of the disease (Vicart et al., 1998).

Figure 1.3: Cytoskeletal networks of the cell. Representation of a cell depicting the three
cytoskeletal networks; the actin (green), intermediate filament (red) and microtubule (blue)
network. Cytoskeletal networks anchor to the cell membrane (grey) and function in cell
transport and structural maintenance. The nucleus is indicated by purple sphere. Image
obtained from the National Institute of General Medical Sciences (2012).

The most abundant membrane pore proteins in the lens are the aquaporins (Bassnett et al.,
2009; Kumari et al., 2011), comprising AQP1, present only in epithelial cells, and AQP0,
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present in mature fibre cells (Varadaraj et al., 2007). Both are believed to act as water
channels in the lens (Varadaraj et al., 2007; Kumari et al., 2011) with AQP0, constituting
over 50% of membrane proteins (Varadaraj et al., 2007), also taking part in cell-to-cell
adhesions (Kumari et al., 2011). The second most abundant membrane protein in the lens is
membrane protein 20 (MP20), which is thought to be involved in fibre cell junction
formation and organisation (Tenbroek et al., 1992). The final family of membrane proteins in
the lens are the connexins; Cx43, Cx46 and Cx50. These proteins interact to form hexamer
hetero- or homotypic hemichannels (connexons), which align with hemichannels on the
surfaces of neighbouring cells to form gap junctions (Molina and Takemoto, 2012). Each of
the connexins have distinct distribution patterns within the lens; Cx43 is found exclusively in
epithelial cells while both Cx50 and Cx46 exist in mature fibre cells, where Cx50 decreases
in abundance towards the nucleus and Cx46 increases in abundance towards the nucleus
(Molina and Takemoto, 2012). Like all members of this family, lenticular connexins are
involved in ion and small solute transport in the lens (Beyer and Berthoud, 2014). However,
Cx46 has also been shown to transport glutathione (GSH) into the nucleus of the lens (Slavi
et al., 2014), as well as protect lenticular epithelial cells against hypoxic stress in vitro
(Banerjee et al., 2010). The remaining 90% of lenticular proteins are comprised of the
crystallins (Wistow and Piatigorsky, 1988; Groenen et al., 1994; Han and Schey, 2006).

1.3 Small Heat Shock Proteins and α-Crystallin

1.3.1 Small Heat Shock Proteins (sHsps)
The sHSPs are a ubiquitous family of proteins that typically have a monomeric mass less than
30 kDa (Perng et al., 1999) and reside in the cytosol of cells under physiological conditions
(Klemenz et al., 1991b), where they form multisubunit oligomers (Peschek et al., 2009). In
most cells, sHsps, (there are 10 isoforms in humans, denoted HSPB1-10), are induced under
stress conditions and operate as molecular chaperones by binding exposed hydrophobic
regions of partially unfolded proteins, thereby acting to prevent aggregation (de Jong et al.,
1998). They differ from other heat shock proteins (Hsps) in that they do not actively aid
protein refolding (Bloemendal et al., 2004) and as such their activity is adenosine
triphosphate (ATP)-independent (Nicholl and Quinlan, 1994). Members of the sHsp family
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are characterised by the presence of a region of conserved amino acid residues known as the
‘α-crystallin domain’ (ACD), located close to the C-terminus (de Jong et al., 1998). This
region is flanked by a hydrophobic N-terminal domain, and a hydrophilic C-terminal tail,
both of which are necessary for maintaining chaperone activity (de Jong et al., 1998). The Nterminal domain provides accessible binding sites for exposed hydrophobic regions of
partially unfolded proteins, whilst the flexible C-terminal tail interacts with the solvent to
maintain solubility (Farnsworth et al., 1998). Both of these domains are variable in sequence
and length in the different human sHsps, leading to variation between the activity of different
protein species (Peschek et al., 2009), for example in terms of substrate specificity.

1.3.2 α-Crystallin
The crystallins are water-soluble proteins (Sun et al., 1997) present in the cytoplasm of
lenticular fibre cells. The crystallin family constitutes 90% (by weight) of the total protein
content of the lens (Wistow and Piatigorsky, 1988; Groenen et al., 1994; Han and Schey,
2006), and encompasses three classes of proteins, the α-, β- and γ-crystallins. These proteins
are present in the cell at ratios that prevent crystallisation of proteins at high concentrations,
and ensure optimal conditions for the reduction of cytoplasmic viscosity, the control of cell
volume through the monitoring of osmotic pressure and the regulation of cytoplasmic
stability (Tardieu, 1998). In conjunction with this, all three crystallin classes play a structural
role in the lens (De Jong et al., 1994; Horwitz et al., 1999; Grey and Schey, 2009),
controlling protein-to-protein interactions in order to provide a light-refractive media that
optimises light transmission (Carver and Lindner, 1998).
In the human lens, α-crystallin is present at a concentration of 300-450 mg/mL (Fagerholm et
al., 1981; Veretout and Tardieu, 1989; Koretz et al., 1998) and consists of two closely related
subunits, αA (HSPB4) and αB (HSPB5) (Schoenmakers and Bloemendal, 1968; Van Der
Ouderaa et al., 1973; Van Der Ouderaa et al., 1974; Phelps Brown and Bron, 1996; Sun et
al., 1997). α-Crystallin is the most abundant of the crystallins, constituting 40% of the total
protein content of the lens (Peschek et al., 2009). It was originally thought that the sole
function of α-crystallin was to act as a structural protein, increasing the refractive index of the
lens above that of the humours (Koretz et al., 1998), a function that it shared with both β- and
γ-crystallin (Phelps Brown and Bron, 1996). In this way, it was considered to be a ‘required
protein’, that is, its function was enabled by the protein’s general characteristics such as its
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solubility and longevity, as opposed to a specific activity (Koretz et al., 1998). However,
Ingolia and Craig (1982) observed that a region of α-crystallin showed sequence similarity to
the regions of Drosophila proteins Hsp23, Hsp22, Hsp26 and Hsp27 (designated the ACD).
Further studies found that α-crystallin displayed chaperone activity (Horwitz, 1992), that αB
was also induced in NHN 3T3 cells by heat and chemical stress (Klemenz et al., 1991b), and
that αB trafficked into the nucleus under stress conditions (Klemenz et al., 1991b). These
characteristics, which are shared by all sHsps, confirmed α-crystallin as a member of the
sHsp family.
The structure of α-crystallins
The two subunits of α-crystallin, αA and αB, are homologs (Phelps Brown and Bron, 1996;
Sun et al., 1997) coded for by different genes on different chromosomes (de Jong et al.,
1998). The subunits are both approximately 20 kDa (Sun et al., 1997), share 60% sequence
similarity (Peschek et al., 2009) and, in the lens, exist in the cytoplasm at a ratio of three αA
subunits to one B subunit (Bloemendal, 1981; De Jong et al., 1994). Each subunit contains a
highly conserved ACD composed of seven β-strands that form a β sandwich fold
(Laganowsky et al., 2010) (Figure 1.5A), and this domain alone has chaperone activity
(Hochberg et al., 2014). The α-crystallin domain is flanked by two globular domains, formed
by the N- and C- terminal regions (de Jong et al., 1998), with a highly flexible C-terminal tail
at the C-terminus (Carver et al., 1992; Smulders et al., 1998) (Figure 1.4).
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Figure 1.4: Alignment of human αA- and αB-crystallin. Amino acid sequences for human
αA (CRYAA_HUMAN, accession number P02489) and αB (CRYAB_HUMAN, accession
number P02511) were submitted to the ExPASy SIM alignment tool for alignment. Nterminal domain is indicated with red text, ACD with blue text and the C-terminal domain in
purple text. β-Sheet regions of ACD are underlined.

Previous studies have shown that sequences within the α-crystallin domain of αB subunits
interact to form dimers that feature an anti-parallel β-sheet at the interface (Bagneris et al.,
2009; Laganowsky et al., 2010; Braun et al., 2011; Clark et al., 2011; Jehle et al., 2011)
(Figure 1.5A, B). The C-terminal tails of neighbouring dimers then bind to hydrophobic
grooves also formed within the α-crystallin domain (Bagneris et al., 2009; Jehle et al., 2010;
Laganowsky et al., 2010; Baldwin et al., 2011; Braun et al., 2011; Clark et al., 2011; Jehle et
al., 2011), forming a polydisperse population of hetero-oligomers with an average size of 800
kDa (Sun et al., 1997). α-Crystallin oligomers have been reported to exist in two
substructural formations: high affinity monomeric and low affinity dimeric substructures
(Benesch et al., 2008), the exchange between which is responsible for the moderation of
activity.
Due to difficulty in achieving protein crystallisation, the structure of larger oligomers is
based largely on conjecture with multiple models being proposed (Tardieu et al., 1986;
Augusteyn and Koretz, 1987; Wistow, 1993; Carver et al., 1994; Vanhoudt et al., 2000;
Bagneris et al., 2009; Baldwin et al., 2011; Braun et al., 2011; Jehle et al., 2011). More
recently, multiple groups have independently proposed a model where hexamers interact to
form larger structures that feature a roughly spherical shape with binding sites located either
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as pockets on the surface (Jehle et al., 2011), or within the hollow interior accessible through
openings in the shell (Haley et al., 1998; Peschek et al., 2009; Braun et al., 2011) (Figure
1.5C). Figure 1.5C depicts the quaternary structure of αB-crystallin based on electron
microscopy data obtained by Peschek et al.(2009).
It has been reported that αB shows a bias towards a 24meric structure (Braun et al., 2011),
which allows the formation of differently sized oligomers via either the association of extra
dimers to the external pockets (Jehle et al., 2011) or the addition and subtraction of subunits
to the shell itself (Baldwin et al., 2011; Braun et al., 2011). In the latter, the subtraction of
subunits would lead to the exposure of hydrophobic regions found on the inner walls (Braun
et al., 2011) and extensions (Bagneris et al., 2009), as well as the production of higheractivity smaller oligomers (Peschek et al., 2013) and, eventually, monomers (Aquilina et al.,
2004; Benesch et al., 2008). This may allow for the regulation of activity to be mediated by
the dissociation of subunits. The importance of the fluidity of the structure has been recently
highlighted by Mainz et al. (2015) who showed that upon exposure following subunit
dissociation, the N-terminal domain is able to undergo conformational changes in order to
mimic the properties of different disordered substrate proteins, allowing a wide range of
protein interactions essential in order to prevent the amorphous aggregation of substrate
proteins. Alternatively, hydrophobic β-sheet structured regions within the static α-crystallin
domain are also able to bind substrates with similar properties, enabling a separate pathway
for the prevention of amyloid aggregation (Mainz et al., 2015). It has been proposed that the
3:1 ratio of αA to αB subunits in the lens is important in maintaining oligomeric thermal
stability (Horwitz et al., 1999), while the dimeric substructure is key in regulating chaperone
activity (Aquilina et al., 2004).
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Figure 1.5: Model of recombinant human αB-crystallin structure. Model of the (A) ACD
(pdb entry 2KLR; Jehle et al.(2010)), (B) dimer fold (pdb entry 3J07; Jehle et al. (2011)) of
αB depicted as a ribbon representation (α-helices - red, β-sheets – blue, coils - grey), and the
(C) 24-mer depicted as (i) surface representation, (ii) density cross-section and with (iii)
dimeric α-crystallin domain of Hsp16.5 from M. jannaschii overlay (adapted from Peschek et
al., 2009).

αA is found almost exclusively in the lens (Peschek et al., 2009) with trace amounts being
detected in the thymus, the spleen and the retina (Kantorow and Piatigorsky, 1998). The
HSPB4 gene is located on chromosome 21 (de Jong et al., 1998), the protein has a molecular
mass of ~20 kDa and forms polydisperse homo-oligomers ranging in size from 440 to 720
kDa (i.e. containing 22-36 monomers) (Aquilina et al., 2005) . αB is found in relatively high
amounts in non-lenticular tissue compared to αA, being detected in the brain, heart, muscle
tissue (Peschek et al., 2009), nervous system, retina, iris, thyroid, colon, squamous epithelia,
placenta, spermatocytes and tissues subjected to high oxidative stress such as in the kidneys
(Kantorow and Piatigorsky, 1998). The HSPB5 gene is located on chromosome 11 (de Jong
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et al., 1998), and multi-angle light scattering data demonstrate that the protein forms homooligomers within the range of 400-800 kDa (i.e. containing 20-40 monomers), with an
average molecular mass of 540 kDa (Aquilina et al., 2004). The expression of αB in cells has
been found to be induced by oncogene expression (Klemenz et al., 1991), osmotic stress
(Dasgupta et al., 1992), heat shock (Klemenz et al., 1991b), dexamethasone, cadmium,
sodium arsenite (Klemenz et al., 1993) and muscle stretch (Atomi et al., 1990; Kantorow and
Piatigorsky, 1998).

1.4 α-Crystallin in Health and Disease
As αB is expressed ubiquitously throughout bodily tissues, the functions it serves are highly
diverse. These roles are summarised in Table 1.1.
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Table 1.1: Roles of αB-crystallin in non-lenticular tissue.
Function
Anti-apoptosis

Protection against oxidative damage
Maintenance of cytoskeletal integrity

Suppression of neurodegeneration

Formation of inclusion bodies in
protein conformation diseases

Acts as an oncoprotein

Anti-inflammation

Mechanism
Inhibits caspase-3

Reference
Morrison et al., 2003

Induces GSH expression in
response to tumour necrosis
factor α (TNFα)

Mehlen et al., 1996

Protects against damage cause by
inflammation following infection

Whiston et al., 2008

Inhibits caspase-3 activation
Increases expression of GSH
Prevents interactions between
intermediate filaments

Ousman et al., 2007
Mehlen et al., 1996
Perng et al., 1999
Launay et al., 2006

Binds to intermediate filaments
following stress to protect during
network remodelling

Djabali et al., 1997

Prevents aggregation of actin
filaments following pH stress
Prevents aggregation of glial
fibrillary acidic protein (GFAP)

Bennardini et al., 1992

Prevents aggregation of SOD1
and α-synuclein
Alexander’s disease

Wang et al., 2008

Alzheimer’s disease

Shinohara et al., 1993

Parkinson’s disease
Promotes neoplastic changes and
invasiveness of basal-like breast
carcinomas

Liu et al., 2015
Moyano et al., 2006

Marker for poor prognosis in
head and neck cancers

Chin et al., 2005

Overexpressed in laryngeal
sarcoma tissues

Yilmaz et al., 2015

Inhibits TNF-related apoptosisinducing ligand (TRAIL)induced apoptosis in various
cancer cell lines
Suppresses inflammatory role of
nuclear factor kappa-light-chainenhancer of activated B cells
(NF-κB)

Kamradt et al., 2005

Reduce inflammatory cytokine
levels following stroke

Arac et al., 2011

Hagemann et al., 2010

Head et al., 1993
Iwaki et al., 1989

Ousman et al., 2007
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Although the deposition or overexpression of αB in diseased tissues is generally interpreted
as a sign of pathogenicity, its beneficial role in healthy tissues may suggest that the increased
levels of αB are simply a by-product of the stress response in diseased cells, rather than the
cause of disease. This is yet to be fully elucidated and as such needs to be taken into
consideration when evaluating the pathogenic potential of αB.
Mutations in α-crystallin have also been associated with cataract and various myopathies.
These mutations are outlined in Table 1.2.

Table 1.2 Pathologically significant mutations of αA- and αB-crystallin in humans.
Disease

Species

Mutation

Reference

Autosomal dominant congenital cataract

αB

D140N

Liu, Zhang, et al., 2006

450delA

Berry et al., 2001

P20S

Liu, Ke, et al., 2006

R120G

Vicart et al.1998

R116C

Litt et al., 1998

αA

Vanita et al., 2006
R49C

Mackay et al., 2003

R116H

Richter et al., 2008

R54P

Su, Guyo, et al., 2012

Autosomal recessive congenital cataract

αA

W9X

Pras et al., 2000

Desmin-related myopathy

αB

R120G

Vicart et al., 1998

Dilated cardiomyopathy

αB

R157H

Inagaki et al., 2006

G157S

Pilotto et al., 2006

Q151X

Selcen and Engel, 2003

464delCT

Selcen and Engel, 2003

G154S

Reilich et al., 2010

Myofibrillar myopathy
Late-onset distal vacuolar myopathy

αB
αB

Central to all of these functions is the ability of αB to act as a molecular chaperone through
the binding of destabilised proteins which, in the lens, is also essential for the maintenance of
lens transparency.
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1.5

Chaperone Activity of α-Crystallin

In conjunction with crystalline-like short-range protein order (Delaye and Tardieu, 1983;
Bloemendal et al., 2004), the degeneration of vasculature and innervation in utero (Phelps
Brown and Bron, 1996) and the degradation of cellular organelles and the nucleus (Han and
Schey, 2006), α-crystallin plays a vital role in the maintenance of lens transparency with age
through its action as a molecular chaperone (Horwitz, 1992; Sun et al., 1997). Due to the loss
of the nucleus and other cellular organelles during the process of fibre cell differentiation, it
is often assumed that lenticular fibre cells do not experience protein turnover, meaning that
the proteins present in the lens have existed since birth and cannot be replaced (Bloemendal,
1977; Lynnerup et al., 2008; Truscott, 2010). However, more recently it has been suggested
that there are low but variable rates of carbon turnover ranging from 1-3% of soluble protein
annually throughout the human lifetime (Stewart et al., 2013). Due to this minimal turnover,
it is essential that lenticular proteins are long-lived to maintain the integrity of the lens
(Bloemendal et al., 2004). Longevity of a protein is determined by its thermodynamic
stability, that is, its ability to retain its tertiary or quaternary structure with time, and the
presence of an efficient chaperone system in the cell that is able to prevent protein
aggregation (Bloemendal et al., 2004). It is with the latter that α-crystallin plays an important
role.
The unfolding of cytoplasmic proteins in response to stresses such as heat or ultraviolet
radiation (Truscott, 2005) triggers the heat shock response, which acts to inhibit protein
synthesis and induce molecular chaperone production (Bloemendal et al., 2004). Molecular
chaperones exist as monomers or oligomers both intra- and extracellularly, where they act to
preserve the conformation of proteins in solution (Soti and Csermely, 2000). This is achieved
by either preventing aggregation, solubilising aggregates that have already formed, assisting
in the folding or refolding of misfolded or unfolded proteins, sequestering damaged proteins
in insoluble complexes or labelling damaged proteins for degradation (Soti and Csermely,
2000).
Proteins with compromised tertiary structure are partially unfolded and contain hydrophobic
regions that remain exposed to the solvent (Carver and Lindner, 1998). These exposed
hydrophobic regions can interact with each other eventually causing the protein to precipitate
from solution (Carver and Lindner, 1998). In the lens, this leads to the formation of insoluble
protein aggregates that cause opacification of the lens, and interfere with light transmission
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by scattering the incoming light (Phelps Brown and Bron, 1996). α-Crystallin prevents these
aggregates from forming by binding to the exposed hydrophobic regions of proteins that are
partially unfolded and on the path to irreversible aggregation (Carver and Lindner, 1998).
The complexes formed by α-crystallin and its substrates such β- and γ-crystallins remain
soluble until the chaperone is saturated and co-precipitates with the substrate (Lampi et al.,
2002; Evans et al., 2008; Acosta-Sampson and King, 2010). It has been reported that
mutations to αA (Koteiche and Mchaourab, 2006) and αB (Bova et al., 1999) can induce
aggregation by increasing substrate affinity leading to increased binding accelerated coprecipitation. Each α-crystallin assembly can bind multiple substrate molecules, with the
exact number being dependent on the substrate and the subunit makeup of α-crystallin
(Smulders et al., 1998). It has been proposed that in non-lenticular tissues, the bound
substrate may dissociate from the HMWC so it can be presented to the Hsp70 co-chaperone
system and be refolded (Horwitz, 1992; Carver and Lindner, 1998).
Intermediately folded states of proteins are inherently unstable (Carver and Lindner, 1998),
often differing from those that are on the protein folding pathway, that is, proteins that are in
the process of folding into their native state. α-Crystallin is selective, in that it binds
exclusively to partially folded or intermediate states of proteins that have left the folding
pathway and have entered an off-folding pathway, thereby allowing proteins that are on the
folding pathway to achieve their native state (Carver et al., 1993). The chaperone activity of
α-crystallin is also non-specific; it binds to hydrophobic regions on diverse proteins,
including non-lenticular proteins such as insulin (Smulders et al., 1998), and not to specific
amino acid sequences or motifs.
The major substrates of α-crystallin in the lens fibre cell are γ- and β-crystallin (Horwitz,
1992; Horwitz et al., 1999; Hanson et al., 2000; Horwitz, 2000; Acosta-Sampson and King,
2010; Michiel et al., 2010), although interactions with ‘house-keeping’ enzymes such as
enolase (Valasco et al., 1997), cytoskeletal elements (Quinlan, 2002) and membrane
associated proteins also occur (Cobb and Petrash, 2002b; Horwitz, 2003). In vitro, αcrystallin completely suppresses aggregation of β- and γ-crystallin (Horwitz, 1992; Boyle and
Takemoto, 1994; Wang and Spector, 1994; Evans et al., 2008; Acosta-Sampson and King,
2010; Andley et al., 2014) at molar ratios of 12:1 and 10:1 respectively (Horwitz, 1992). Like
all sHsps, both the N- and C-terminal regions are vital in maintaining the chaperone activity
of the protein with the C-terminal domain maintaining solubility (Carver et al., 1992; Merck
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et al., 1993; Carver and Lindner, 1998) and the N-terminal domain promoting
oligomerisation (Merck et al., 1992) and providing hydrophobic binding sites (Smulders et
al., 1998). Furthermore, it appears that the quaternary structure of the protein (with a
hydrophilic exterior and a hydrophobic interior) is vital to its chaperone activity, as it has
been observed that the structure is conserved (Farnsworth et al., 1998) and resistant to
changes in the amino acid sequence (Smulders et al., 1998). However, further studies have
shown that the chaperone activity of α-crystallin can be altered by buffer conditions or the
introduction of different surface charges. For example, the addition of calcium or magnesium
to buffers, or a decrease in pH has a detrimental effect on activity (Bindels et al., 1985),
while the addition of a negative charge to the protein surface, such as through citraconylation,
increases activity (Bindels et al., 1985). Significantly, as protein turnover in lenticular fibre
cells is negligible, various PTMs have also been found to affect the chaperone activity of αcrystallin, possibly correlating with an observed decrease in α-crystallin chaperone activity
with age (Horwitz, 1992; Cherian and Abraham, 1995; Derham and Harding, 1997; Soti and
Csermely, 2000).

1.6

Posttranslational Modification of α-Crystallin

Owing to the longevity of lenticular α-crystallins, they are vulnerable to the accumulation of
PTMs with age (Masters et al., 1977; Bloemendal et al., 2004; Wilmarth et al., 2006; Sharma
and Santhoshkumar, 2009; Truscott and Friedrich, 2016). PTMs have been detected in human
lenses using isoelectric focusing and SDS-PAGE (Kramps et al., 1978). Furthermore, it is
known that modifications occur from a very young age, with modifications being detectable
in foetal lenses (Phelps Brown and Bron, 1996). Perhaps surprisingly, it was noticed in a later
study that protein isolated from young lenses (i.e. 17 year old donor) show a similar levels of
modification to aged lenses (i.e. 54 to 55 year old donors) , implying the modifications occur
relatively early in life (Lampi et al., 1998). Grey and Schey (2009) reported that the amount
of intact α-crystallin (i.e. not proteolytically cleaved) decreases with age, with little remaining
after the age of 75 (Grey and Schey, 2009). It has also been shown that αB undergoes less
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truncation with age compared to αA, suggesting a higher level of stability (Grey and Schey,
2009).
The number of PTMs that can occur to α-crystallin is extensive and include carbamylation ,
acetylation , disulphide bond formation, oxidation, truncation, deamidation , glycation and
phosphorylation (Lund et al., 1996; Lin et al., 1997; Lampi et al., 1998; Lin et al., 1998; Ma
et al., 1998; Hanson et al., 2000; Lapko et al., 2001; MacCoss et al., 2002; Han and Schey,
2006; Wang et al., 2013). Phosphorylation of serine residues is the most common
modification αB (Kato et al., 1998), and is believed to alter the chaperone activity of the
protein (Ito et al., 2001; Koteiche and Mchaourab, 2003; Aquilina et al., 2004; Ecroyd et al.,
2007; Benesch et al., 2008). Likewise, deamidation is also common and believed to affect
chaperone activity (Gupta and Srivastava, 2004; Fujii et al., 2011). For these reasons, this
thesis focuses on the phosphorylation and deamidation of lenticular αB.

1.6.1 Phosphorylation of α-Crystallin
Phosphorylation rates of 33-50% have been reported for human lens αB (Carver and Lindner,
1998; Farnsworth et al., 1998), with phosphorylated products being present from birth
(Phelps Brown and Bron, 1996). The phosphorylation process occurs naturally in a state of
dynamic equilibrium under physiological conditions in dividing cells (Ito et al., 1997), for
example in epithelial cells for αB and in differentiating cells for αA (Phelps Brown and Bron,
1996). Phosphorylation can also be induced stress conditions such as ischemia (Ahmad et al.,
2008) and heat stress (Ito et al., 1997).
In vivo, the majority of α-crystallin is phosphorylated via the cyclic adenosine
monophosphate (cAMP)-dependent pathway in a reversible serine-specific manner
(Kantorow and Piatigorsky, 1998). It has been a long-held belief that the dominant sites of
phosphorylation in αB are Ser19, Ser45 and Ser59, and in αA Ser122. Western blots of
mitotic U373 human glioma cells revealed that the three phosphorylation sites of B are
regulated separately during mitosis (Kato et al., 1998). The elevated levels of pSer19
(phosphorylated Ser19) and pSer45 (phosphorylated Ser45) and the lower levels of pSer59
(phosphorylated Ser59) detected suggested that each site is phosphorylated by a different
kinase (Kato et al., 1998). Purification and activity assays of the different kinases revealed
that Ser45 and Ser59 are phosphorylated via p44/42 mitogen-activated protein (MAP) kinase
and MAP kinase-activated protein (MAPKAP) kinase-2 respectively (Kato et al., 1998). The
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kinase responsible for the phosphorylation of Ser19 has still not identified due to instability
of the enzyme, although it was found to be of a similar molecular weight to p44/42 MAP
kinase, approximately 60 kDa (Kato et al., 1998). The A Ser122 residue is also believed to
be phosphorylated by MAPKAP kinase-2 as it lies within a recognition site for the enzyme
((Arg/Lys)-X-Pro-Ser) (Kantorow and Piatigorsky, 1998). Despite the dominance of these
sites in the literature, a multitude of other sites of phosphorylation for both subunits have
been recently reported in the lens (Miesbauer et al., 1994; Kamei et al., 2000; MacCoss et al.,
2002; Searle et al., 2005; Wilmarth et al., 2006; Huang et al., 2011; Wang et al., 2013; Wang
et al., 2014). These are summarised in Appendix 1, and locations are indicated in Figure 1.7.
Although much less prominent in the literature, non-enzymatic phosphorylation has also been
observed in lenticular α-crystallin (Kantorow and Piatigorsky, 1998). Little is known about
the mechanism of non-enzymatic phosphorylation in the lens, but it has been shown in vitro
that both α-crystallin subunits are able to undergo non-enzymatic phosphorylation in the
presence of either Mn+ (Schieven and Martin, 1988) or Mg+ (Kantorow and Piatigorsky,
1994) and ATP. There is also evidence of a mechanism of non-enzymatic dephosphorylation
in the lens that involves the spontaneous β-elimination of phosphate groups from
phosphoserine and phosphothreonine residues and the subsequent glutathionylation of the
resultant dehydroalanine (DHA) intermediate, resulting in covalent crosslinking (Bessems et
al., 1987; Linetsky et al., 2004; Srivastava et al., 2004; Linetsky and LeGrand, 2005; Wang
et al., 2014). It is as yet unclear what proportion of the phosphorylation observed in the lens
is residual from early enzymatic phosphorylation events, and how much results from
subsequent non-enzymatic events. However, it is likely that α-crystallin enzymatically
phosphorylated in the metabolically active cells of the outer cortex are gradually
dephosphorylated non-enzymatically as they form part of the metabolically inactive nucleus.
Phosphorylation and α-crystallin chaperone activity
The effect that phosphorylation has on the chaperone activity of α-crystallin, if any, has met
with contention in the literature. Earlier studies by Ito et al. (2001) reported a decrease in
chaperone activity when thermal aggregation assays were performed utilising α-crystallin
S→D phosphomimics that mimic the negative charge introduced by a phosphate group. They
attributed this to an observed decrease in oligomeric size. These findings were supported by
Kamei et al. (2001) who reported a 30% decrease in the ability of phosphorylated bovine αcrystallin to prevent the heat-induced aggregation of βL-crystallin. A complimentary study by
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Augusteyn et al.(2002), however, reported no effect on chaperone activity. More recently,
studies utilising mutations that mimic phosphorylation have found that the addition of one or
more negative charges onto αB acts to increase target protein affinity (Koteiche and
Mchaourab, 2003; Ecroyd et al., 2007), increase oligomeric polydispersity (Ecroyd et al.,
2007) and decrease average oligomeric size (Ito et al., 2001; Ecroyd et al., 2007). It has been
proposed that such modifications to the N-terminal domain of α-crystallin induces flexibility
and structural changes that lead to increased exposure of substrate binding sites (Peschek et
al., 2013). Phosphorylation in this region may also interrupt intersubunit interactions,
resulting in dissociation of larger oligomers to form smaller oligomers with higher activity
(Ecroyd et al., 2007; Peschek et al., 2013).
It has been suggested that this hyperactivity can induce aggregation with the target, rather
than prevent it, as the αB reaches saturation and co-deposits with the target proteins (Ecroyd
et al., 2007). This is supported by a study by Aquilina et al. (2004) that reported both a
change in oligomeric substructure, i.e. a preference towards high affinity monomeric
substructure and away from low affinity dimeric substructure, coupled with an earlier onset
of aggregation with the target protein α-lactalbumin. Taken together, it appears that the
hyperactivity observed recently upon phosphorylation of αB may be a result of the increased
exposure of substrate binding sites brought about by the dissociation of dimeric subunits. As
the precise nature of the relationship between phosphorylation and chaperone activity of αB
is uncertain, an aim of the work described in this thesis was to attempt to elucidate whether
mimicking phosphorylation of αB, via S→D point mutations, increases or decreases the
ability of αB to suppress the heat-induced aggregation of a model substrate.

1.6.2 Deamidation of α-Crystallin
Another major age-related modification of lenticular α-crystallin is deamidation, involving
the chemically mediated conversion of asparagine and glutamine residues to aspartate and
glutamate residues respectively (Wilmarth et al., 2006). The reaction occurs nonenzymatically, taking one of two pathways depending on the environmental pH. At a neutral
or alkaline pH, the reaction follows two steps (Figure 1.6A); the peptide bond nitrogen of the
asparagine (or glutamine) residue attacks the carbonyl carbon of the sidechain and forms a
succinimide (for asparagine) or glutiminide (for glutamine) ring intermediate, which is then
hydrolysed at either the α or β carbon to form aspartate (or glutamate) or iso-aspartate (or iso37
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glutamate). Alternatively, at pH<5.0, the amide group on the asparagine (or glutamine)
sidechain undergoes direct hydrolysis to produce aspartate (or glutamate) as a sole product
(Figure 1.6B).
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A)

B)

Figure 1.6: Mechanism of deamidation of an asparagine residue. (A) At a neutral or
alkaline pH, the peptide bond nitrogen attacks the carbonyl carbon of the asparagine or
aspartate sidechain (both shown in red, connected by broken arrow) to form a succinimide
ring intermediate, which is then hydrolysed at either the α or β carbonyl group (bonds shown
in red), resulting in aspartate or iso-aspartate residues. (B) At an acidic pH (i.e. pH<5.0), the
amide group of the asparagine sidechain can undergo direct hydrolysis to form an aspartate
residue. Note that glutamine forms a 6-member ring (i.e. glutaminide) intermediate via a
similar mechanism that undergoes hydrolysis similar to the succinimide intermediate.
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Deamidation is restricted to amino acid residues that contain an amide side chain i.e.
asparagine and glutamine, and are influenced by the surface exposure of the residue (Lapko
et al., 2002) as well as the conformational flexibility of the surrounding residues (Kosky et
al., 1999; Hooi et al., 2012; Truscott and Friedrich, 2016). Multiple deamidation sites have
been identified in both lenticular αA and αB (Lund et al., 1996; Hanson et al., 2000;
Srivastava and Srivastava, 2003; Searle et al., 2005; Wilmarth et al., 2006; Asomugha et al.,
2010; Hains and Truscott, 2010), summarised in Appendix 1 with positions indicated in
Figure 1.7.
Deamidated α-crystallin is in high abundance in water-insoluble lens fractions, leading to the
suggestion that the deamidation of α-crystallin contributes to cataract formation (Srivastava
and Srivastava, 2003; Wilmarth et al., 2006). It has also been reported that, in conjunction
with other modifications, namely oxidation and C- and N-terminal truncation, deamidation
inhibits chaperone activity (Gupta and Srivastava, 2004; Chaves et al., 2008) and induces
insolubility of the protein (Lund et al., 1996; Hanson et al., 2000). Structural changes are
thought to be responsible for this loss of solubility, for example decreases in β-sheet content
(Gupta and Srivastava, 2004), exposure of hydrophobic regions (Hanson et al., 2000; Gupta
and Srivastava, 2004) and the formation of intramolecular disulphide bonds in αA (Lund et
al., 1996; Hanson et al., 2000). Furthermore, deamidation is known to induce both
racemisation (conversion of L- to D-) and isomerisation (conversion of α- to β-) to form L-βX, D-α-X and D-β-X isotypes that can in turn alter secondary structure (Fujii et al., 2010;
Fujii et al., 2016; Truscott and Friedrich, 2016) and cause a loss of function (Fujii et al.,
2007; Fujii et al., 2010). High rates of racemisation and isomerisation have been observed at
the residues N58, N76, N84 and N151 in lenticular αA, and N62 and N96 in αB (Fujii et al.,
2012). Notably, N96 is highly racemised in aged human lenses, where it is thought to
interrupt higher order oligomeric assembly (Sakaue et al., 2015; Takata and Fujii, 2015).
Locations of all reported deamidation sites are indicated in Figure 1.7.
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Figure 1.7: Location of reported phosphorylation and deamidation sites of human
lenticular αA (A) and αB (B). Depicts full length protein with N-terminal (N-orange), αcrystallin (α-blue) and C-terminal (C-purple) regions indicated. Red bars represent
phosphorylation sites and green bars represent deamidation sites; residue identities are
labelled with arrows. Phosphorylation sites investigated in this thesis are highlighted in red.

Similar to the α-crystallins, β- and γ-crystallins are heavily deamidated in the insoluble
fraction of aged and cataractous human lenses (Lapko et al., 2002; Wilmarth et al., 2006;
Hains and Truscott, 2010). Multiple studies have utilized deamidation mimics to investigate
the effect deamidation has on the structure and function of these proteins. Deamidation of
residues at the dimeric interface has been shown to not affect secondary structure or interfere
with dimer formation (Lampi et al., 2006; Takata et al., 2007; Takata et al., 2008). However,
the presence of deamidated residues at the oligomeric interface is suggested to alter tertiary
structure by interrupting hydrogen bond formation, thereby inhibiting interactions between
hetero- and homodimers (Takata et al., 2009). Deamidation has also been shown to
destabilise β- and γ-crystallins, inducing aggregation in urea and heat treatment (Kim et al.,
2002; Lampi et al., 2002; Flaugh et al., 2006; Lampi et al., 2006; Takata et al., 2007; Takata
et al., 2008; Michiel et al., 2010).

1.6.3 Protein crosslinking
Covalent crosslinking has been identified between crystallins, and between crystallins and
other proteins (Srivastava et al., 2004; Su, McArthur, Truscott, et al., 2011) in human lenses.
Crosslinks formed via DHA intermediates were first identified in human lenses by Linetsky
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et al. (2004). Wang et al. (2014) later identified such non-disulphide crosslinks between βand γ-crystallin proteins in lens extracts, and were able to induce formation under
physiological conditions in vitro. Crosslink formation via this mechanism is believed to occur
when phosphoric acid is cleaved from phosphorylated serine or threonine residues by βelimination, and the resulting DHA or dehydrobutyrine (DHB) intermediates are targeted for
nucleophilic attack by GSH (Wang et al., 2014). It has been suggested that this mechanism is
a predominant pathway of crosslink formation in lens proteins, thereby contributing to
protein aggregation and cataract (Wang et al., 2014).

1.7

Role of Phosphorylated α-Crystallin in Non-lenticular tissues

In non-lenticular tissues, phosphorylated αB-crystallin has been implicated in various cellular
responses ranging from cytoprotection in response to stress, the regulation of apoptosis and
actin dynamics, and protein quality control. These roles are summarised in Table 1.3.
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Table 1.3: Purported roles of phosphorylated αB-crystallin isotypes in non-lenticular
tissue.
Role
Cytoprotection
(inhibition of
apoptosis)

Regulation of
apoptosis (promotes
apoptosis)

Modulation of actin
dynamics

Protein quality
control

Mechanism
Localisation to Z-bands of
myocytes following ischemia

Ser45 and Ser59

Reference
Hoover et al., 2000
Golenhofen et al., 1999
Golenhofen et al., 1998
Eaton et al., 2001

Induces Bcl2 expression in
myoblasts in presence of TNF-α

Ser59

Adhikari et al., 2011

Inhibits caspase-3 activation in
myocytes following hyperosmotic
or hypoxic stress

Ser59

Morrison et al., 2003

Nuclear speckle formation
following heat shock

Ser45 and Ser59

Den Engelsman et al., 2013
Den Engelsman et al., 2005

Induced by PAR-2 in astrocytes in
presence of C2-ceramide and
staurosporine

Ser45 and Ser59

Li and Reiser, 2011

Prevents exosomal secretion of αB
in glioma cells
Reduces anti-apoptotic activity of
αB in differentiation induced cell
death of myoblasts

Ser19, Ser45
and Ser59
Ser19, Ser45
and Ser59

Kore and Abraham, 2014
Kore and Abraham, 2016
Kamradt et al., 2002

Binds to and inhibits anti-apoptotic
activity of Bcl2 in vinblastine
treated breast epithelial carcinoma
cells
Co-localises with and stabilises
cytoskeletal components at focal
adhesions in myoblasts treated with
vinblastine and cytochalasin D

Ser59

Launay et al., 2010

Ser59

Launay et al., 2006

Co-localises with proteins of the
actin nucleation complex involved
with membrane protrusion and cell
migration in migratory lenticular
epithelial cells

Ser59

Maddala and Rao, 2005

Negatively modulates actin
depolymerisation in vitro
Participates in the ubiquitinproteasome system to degrade
excess protein in disused rat soleus
muscle
Accumulates in and potentially
facilitates formation of aggresomes
in MG-132 treated glioma cells

Residue
Ser59

Wang and Spector, 1996
Ser59

Kato et al., 2002

Ser59

Ito et al., 2002
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1.8

Cataracts

The term cataract refers to any light-scattering opacity in the lens which significantly
obstructs vision. It is the leading cause of blindness worldwide, contributing to 48% of all
cases (World Health Organisation, 2010). The different classes of cataract can be divided into
those that are non-progressive, including congenital nuclear, sutural and coronary cataracts,
and those that are progressive, or age-related, with age-related cataract being defined as
cataracts that occur past the age of 50 years old, without an obvious cause (Phelps Brown and
Bron, 1996). Age-related cataract are thought to result from a combination of genetic, agerelated and environmental factors (Hammond et al., 2000). Age-related cataracts encompass
three different types: cortical, sub-capsular and nuclear (Phelps Brown and Bron, 1996).
Cortical and sub-capsular cataracts are caused by disorder in the cytoplasm or fibre cell
membranes (Phelps Brown and Bron, 1996).
Nuclear cataracts differ in that they result from the formation of insoluble protein aggregates
that directly obstruct light transmission (Phelps Brown and Bron, 1996). As these aggregates
remain insoluble, even in 8 M urea and 6 M guanidine hydrochloride (Truscott and
Augusteyn, 1977), it has traditionally been difficult to obtain molecular information
regarding the protein composition of the aggregate (Takemoto and Boyle, 1998). Truscott et
al. (1998), using tryptic digestion and high performance liquid chromatography (HPLC) to
purify peptides from the insoluble fraction of human cataractous lens tissue, found αB
subunits to be in overabundance when compared with αA and other lenticular proteins,
suggesting that αB is more directly involved in age-related cataract formation than αA (Chen
et al., 1997; Truscott et al., 1998).
This claim has been supported by work from a number of studies in recent years. The
identification of peptides derived from αB as well as αA, βB2-, γs- and βA3-crystallin in high
abundance in the insoluble protein fractions from aged human lenses suggests that truncation
of these proteins may be involved in protein insolubilisation (Hanson et al., 2000;
Santhoshkumar et al., 2008; Su et al., 2010). The addition of peptides αB1-18 and βA3/A159-74
decreases the chaperone activity of α-crystallin in vitro, while βA3/A159-74 increases the
oligomeric size and induces aggregation of αB homo-oligomers (Santhoshkumar et al.,
2008). In separate studies, αA66-80 was reported to bind to the C-terminal extension, the
chaperone site and the subunit interaction site of αB to form complexes with reduced
chaperone activity and solubility compared to αB homo-oligomers (Kannan et al.,
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2013),while αB1-18 was reported to increase the association of α-crystallin to purified
membranes in vitro (Su, McArthur, Friedrich, et al., 2011). Zhou et al. (2015), with the aid
of isobaric tag for relative and absolute quantitation (iTRAQ) technology, were able to report
that αB, but not αA, was downregulated in the nucleus of cataractous lenses compared to
healthy lenses. Datiles III et al. (2016), used dynamic light scattering to monitor free
lenticular α-crystallin levels in patients over 6-36 months and reported that low base levels of
free α-crystallin, as well as faster rates of free α-crystallin loss, positively correlate with
increased occurrence and faster progression of nuclear cataract. Finally, Makley et al. (2015)
were able to reverse R120G associated cataract opacity in mouse lenses in situ and in agedrelated opacities in human lenses ex situ by incubating lenses with 5-cholesten-3b, 25-diol. It
is reported that this compound binds to the hydrophobic groove of αB, thereby stabilising the
oligomer and preventing aggregation (Makley et al., 2015), suggesting that instability of αB
is a contributing factor to cataract formation.
The exact role that phosphorylated αB plays in cataract formation is unclear due to the
contention surrounding the effect that phosphorylation has on αB chaperone activity. If
activity is decreased upon phosphorylation, aggregates may form as a consequence of the
inability of αB to prevent interactions between other proteins (Phelps Brown and Bron, 1996;
Ito et al., 2001; Bloemendal et al., 2004; Grey and Schey, 2009). Alternatively, if activity is
increased, the affinity of αB to protein substrates may be increased to the point where it binds
excessively to substrate and co-deposits prematurely (Aquilina et al., 2004). Additionally,
previous studies have found that α-crystallin associates with fibre cell membranes
increasingly with both age (Boyle and Takemoto, 1996) and oxidation-induced
phosphorylation (Takemoto and Boyle, 1998). The mechanism behind this may be explained
by the theory proposed by Aquilina et al. (2004). If a change in αB substructure was in fact
responsible for the induction of hyperactivity due to the increased exposure of hydrophobic
regions, the protein may also have increased affinity with proteins that interact with fibre cell
membranes, which in turn could lead to greater localisation of αB with membranes (Aquilina
et al., 2004). This phenomenon is of particular interest when considering the formation of the
nucleocortical barrier and the role it is believed to play in cataract formation.
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1.8.1 Barrier Theory of Cataract Formation
The barrier theory was first proposed by Sweeney and Truscott (Sweeney and Truscott, 1998)
following the paradoxical observation that although levels of the reduced form of GSH were
observed to decrease in the nucleus of older lenses, concentrations in the cortex often remain
within the normal range. In a healthy lens, GSH is synthesised in the cortex and diffuses into
the nucleus via gap junctions that are present between fibre cells (Goodenough, 1992). To
determine the cause of this phenomenon, Sweeney and Truscott incubated lenses of varying
ages in artificial aqueous humor containing labelled [35S] cysteine, which is incorporated into
GSH metabolically. Following localisation experiments, the labelled cysteine was found to be
homogenously distributed in young lenses. However, only very low amounts of label were
detected in the nucleus of older lenses, indicating the presence of a barrier retarding the
diffusion of small molecules from the cortex into the nucleus, dubbed the nucleocortical
barrier (Sweeney and Truscott, 1998). As a minimum concentration of 2 mM GSH is required
to protect proteins from oxidation by reactive small molecules such as ascorbate (Truscott,
2005), it is believed that the decrease in the reduced form of GSH allows the oxidation of
proteins leading to the formation of disulphide bonds and thereby aggregate formation
(Truscott and Augusteyn, 1977; Truscott, 2005).
Evidence supporting a role for barrier formation in cataractogenesis includes the observation
that a sharp decrease in the concentration of reduced GSH always precedes the formation of
experimentally induced cataracts (Harding, 1991), the abundance of oxidised proteins in the
nucleus of aged lenses (Truscott, 2005) and the coinciding of the putative location of the
barrier and the sclerotic zone of cataractous lenses (Sweeney and Truscott, 1998). The
process of barrier formation itself is less well understood with multiple theories being
proposed, such as the uncoupling of gap junctions as a result of cellular damage or
modification of transport proteins (Sweeney and Truscott, 1998). It has also been postulated
that changes in lens membrane lipid composition and fibre cell compression may alter lens
membrane dynamics (Deeley et al., 2010). These models however have not been extensively
studied and little literature regarding them is available.
One well-documented phenomenon that has been proposed as a potential mechanism of
barrier formation is the binding of cytosolic proteins to fibre cell membranes with age
(Friedrich and Truscott, 2009; Friedrich and Truscott, 2010). Membrane association of fibre
cell membranes was first reported by Cenedella and Fleschner (1992), who observed that
crystallin and cytoskeletal proteins from bovine lens lysates codeposit with membrane
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components as high density bands on sucrose density gradients. Western blotting of these
bands indicated that 70% of membrane associated protein consisted of αA and its modified
forms, while 20% consisted of β- and γ-crystallins with the remaining components consisting
of cytoskeletal proteins (Cenedella and Fleschner, 1992). Later studies involved incubating
isolated bovine fibre cell membranes with either purified rat (Chandrasekher and Cenedella,
1997) or recombinant human α-crystallin (Cobb and Petrash, 2002b) to replicate membrane
binding in vitro. It was reported that α-crystallin was most likely to associate with membranes
as part of HMW aggregates (Chandrasekher and Cenedella, 1997; Cobb and Petrash, 2002b)
via hydrophobic interactions (Chandrasekher and Cenedella, 1997), and that once bound,
chaperone activity was diminished (Cobb and Petrash, 2002b) and the rate of disulphide
crosslinking was increased (Chandrasekher and Cenedella, 1997).
Localisation of α-crystallins with plasma membranes in aged and cataractous human lenses
was also confirmed using electron microscopy immunolocalisation (Boyle and Takemoto,
1996). Sucrose density centrifugation has been used to isolate high density membrane-bound
protein fractions from aged normal (Friedrich and Truscott, 2010) and cataractous
(Chandrasekher and Cenedella, 1995) human lenses. It has been shown that the proportion of
bound protein to total protein increases with both age (Friedrich and Truscott, 2010) and in
cataracts (Chandrasekher and Cenedella, 1995), and is coupled with a decrease in soluble
protein (Friedrich and Truscott, 2010). These high-density protein fractions are
predominantly composed of modified crystallins (Chandrasekher and Cenedella, 1995;
Friedrich and Truscott, 2010), that when separated via 2D SDS-PAGE, focus as a series of
negatively charged spots, suggesting the presence of deamidated and/or phosphorylated
species (Friedrich and Truscott, 2010).
How these associations with the membrane are mediated i.e. through direct binding to the
phospholipid membrane or interactions with cytoskeletal components and integral membrane
proteins, is yet to be fully elucidated. It has been proposed, however, that interactions
between α-crystallins and membrane pore proteins in the lens maybe be a contributing factor
to nucleocortical barrier formation (Cobb and Petrash, 2002b; Friedrich and Truscott, 2009;
Friedrich and Truscott, 2010). In short, the accumulation of HMW aggregates at fibre cell
membranes are thought to potentially occlude pore proteins, such as AQP0 and Cx46, which
are responsible for the transport of water (Gorin et al., 1984) and glutathione (GSH) (Slavi et
al., 2014) in the lens respectively. This would account for the fact that both the diffusion of
GSH and water is reduced markedly at middle age (Moffat et al., 1999). If obstruction of
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Cx46 were to occur, it is believed it may result in an oxidative environment in the nuclear
region of the older lens, leaving resident proteins vulnerable to oxidative damage (Truscott,
2005).
Phosphorylation and membrane association of αB-crystallin
This thesis expands upon this model, postulating that phosphorylation-induced hyperactivity
of αB is responsible for α-crystallin association with the pore proteins AQP0 and Cx46,
resulting in the formation of the nucleocortical barrier. This model is illustrated in Figure 1.8.
Although it is postulated that α-crystallin associates with fibre cell membrane components as
a HMW complex that includes αA, this thesis focuses mostly on αB. This is based on recent
reports that implicate αB, but not αA, in cataract formation (Makley et al., 2015; Datiles III et
al., 2016), as well as previous reports showing that αB has comparatively higher chaperone
activity (Sun et al., 1997) and lower thermostability (Sun and Liang, 1998; van Boekel et al.,
1999; Liang et al., 2000), which may predispose it to stress-induced aggregation.

Figure 1.8: Representation of obstructed fibre cell pores. In young lenses, membrane pore
proteins (AQP0 represented by pink ovals and Cx46 represented by purple ovals) facilitate
the transport of water and GSH into the nucleus of the lens (represented by blue circles where
intensity of colour represents concentration of metabolites). As αB becomes phosphorylated
with age (green oval, red spot represents phosphate group), hyperactivity causes its
association with fibre cell membranes in the barrier region (represented by dotted line),
inhibiting diffusion of water/GSH into the nucleus. A similar effect may occur with αA.
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Little is known regarding the relationship between protein modification and membrane
association of lenticular proteins. It is also important to note that as interactions between αcrystallins and Cx46 or AQP0 have not been detected in vivo, obstruction of pore proteins
due to membrane association of cytosolic proteins is still largely speculative. However, if
barrier formation is indeed instigated by the binding of proteins such as α-crystallins to
membrane or cytoskeletal proteins or the fibre cell membranes themselves, characterising the
modifications associated with age and protein deposition is likely to give a critical insight
into the molecular mechanisms behind barrier formation, and hence cataractogenesis. This
thesis attempts to elucidate how protein modification may be involved in barrier formation by
identifying what modifications are prevalent in membrane associated fractions, determining
how phosphorylation may affect the chaperone activity of αB, and by identifying interactions
between unmodified and phosphorylated αB, and the membrane pore proteins Cx46 and
AQP0 in human lenses.

1.9

Aims

Post-translational modification and membrane-binding of α-crystallin are two age-related
phenomena in lenticular fibre cells that have been implicated in cataractogenesis. However,
the relationship between these two events has not been extensively studied. This thesis
investigates phosphorylation and deamidation and how they may contribute to protein
deposition and membrane-binding in aged human lenses.
The specific aims of this thesis were to:
1. Determine the effect of phosphorylation on the chaperone activity of αB
Present knowledge regarding chaperone activity of phosphorylated αB is conflicting
and appears to be dependent on the substrate protein and buffer system. In chapter 3,
the chaperone of isoforms of αB containing mutations that mimic phosphorylation
were compared to WT αB using a biologically relevant substrate in order to elucidate
how the addition of a negative charge (like that added by phosphorylation) modulates
the chaperone activity of αB.
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2. Characterise the age-related phosphorylation of αB in aged human lenses
Lenticular proteins are susceptible to the accumulation of modifications with age, and
it is highly likely such modifications play a role in protein deposition and cataract
pathogenesis. In chapter 3, proteomic profiles of human lenses of varying ages were
compared, and used to establish patterns of αB phosphorylation across regions of the
lens in order to track the relationship between αB phosphorylation and age-related
protein insolubilisation and/or membrane association.

3. Elucidate αB localisation at fibre cell membranes
Association of αB with fibre cell membranes has been observed in aged human lenses
and may be the origin of nucleocortical barrier formation. In chapter 4, interactions
between αB and membrane pore proteins were visualised in order to elucidate how αB
localises with fibre cell membranes and to explain how these interactions may
obstruct transport GSH in vivo.
4. Identify and characterise sites of non-enzymatic αB deamidation in vitro
Non-enzymatic deamidation can induce structural changes within proteins that can
result in altered activity of the protein. This is relevant for all lens proteins including
αB as they exist in an essentially enzymatically inert environment in the lens. In
chapter 5, deamidated residues of αB were identified following various storage and
treatment conditions in order to determine the susceptibility of specific αB residues to
deamidation.
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2.1 Materials
2.1.1 Antibodies
Antibodies used and their sources are listed below in Table 2.1.

Table 2.1: Product details for the antibodies used in these experiments. Dilution values
are working dilution factors for immunblotting and immunofluorescence experiments.
Antibody

Catalogue

Source

Supplier

number

Western

Immunofluorescence

Blotting

Dilution

Dilution
Anti-αB

ab5597

Polyclonal rabbit

Crystallin

Abcam,

1:2000

1:200

1:2000

1:200

1:2000

1:125

1:1500

1:200

N/A

1:150

N/A

1:100

N/A

1:120

1:2500

N’A

N/A

1:200

USA

(phospho S19)
Anti-αB

ab5598

Polyclonal rabbit

Crystallin

Abcam,
USA

(phospho S45)
Anti-αB

ab5577

Polyclonal rabbit

Crystallin

Abcam,
USA

(phospho S59)
Anti-αB

ab13497

Polyclonal rabbit

Crystallin
Anti-AQP0 (T-

USA
sc-49364

Polyclonal goat

16)
Anti-connexin

sc-20859

Polyclonal goat

Santa Cruz,
USA

ab122476

Polyclonal rabbit

(phakinin)
Anti-rabbit IgG-

Santa Cruz,
USA

46
Anti-BFSP2

Abcam,

Abcam,
USA

A6154

Polyclonal goat

Peroxidase

SigmaAldrich,
USA

Anti-rabbit IgG
(H + L), Alexa

A11034

Polyclonal goat

Invitrogen,
USA

Fluor® 488
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2.1.2 Reagents and materials
Recombinantly expressed human αB was gifted by Dr Amie Morris (University of
Wollongong, Australia) or Dr Megan Kelly (University of Wollongong, Australia). All other
reagents were obtained from Sigma-Aldrich (USA) or Amresco (USA) unless otherwise
specified. Tris-base was obtained from PanReac AppliChem (Germany).
Ethylenediaminetetraacetic acid (EDTA) was obtained from Astral Scientific (Australia).
Dithiothreitol (DTT) was obtained from Pro-Lab (Canada). Biolyte® 3/10 Carrier Ampholyte
(100x), ReadyStripTM IPG Strips (17cm, pH 3-10 NL) and the RCDCTM Protein Assay Kit II
were obtained from BioRad (USA). Unichrom® methanol and Univar® phosphoric acid and
acetic acid were obtained from Ajax Finechem (Australia). SuperSignalTM West Pico
Chemiluminescent Substrate and Slide-A-Lyzer TM MINI Dialysis Devices were obtained
from ThermoFisher Scientific (USA). Sequencing Grade Modified Trypsin (porcine) was
obtained from Promega (USA). Duolink® products including the reagents Duolink® In Situ
PLA® Probe anti-rabbit MINUS, Duolink® In Situ PLA® Probe anti-goat PLUS, Duolink®
In Situ Detection Reagents Orange (including ligase and polymerase and dilution buffer
solutions) were obtained from Sigma-Aldrich (USA). Wheat germ agglutinin-Alexa 488 was
obtained from Invitrogen (USA). A list of buffers used in this work is included in Appendix
2.

2.2 Phosphorylation and membrane-binding events in aged human lenses
2.2.1 Chaperone assays
Recombinant WT αB (referred to as WTαB or 0P) and αB isoforms containing mutations that
mimic phosphorylation were expressed and purified by Dr Amie Morris (University of
Wollongong, Australia) according to the method previously described by Horwtiz et al.
(1998). Serine to aspartate (i.e. S→D) point mutations were made at all three dominant
phosphorylatable serines (Ito et al., 1997), i.e. S19 (referred to as S19D or 1P), S45 (referred
to as S45D), S59 (referred to as S59D), S19 and S45 (referred to as 2P), and S19, S45 and
S59 (referred to as 3P). Assays were performed in phosphate buffered saline (PBS; pH 7.4) at
40°C with creatine phosphokinase (CPK) concentrations of 0.125 µM and αB concentrations
of 0.5 or 0.25 µM, in 384 well plates (Greiner Bio-One, Austria) with a total volume of 20
µL. Samples were incubated in a POLARstar Omega microplate reader (BMG LABTECH,
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Germany) for 10 hours at 43°C with absorbance readings at 360 nm every 60 seconds, with
each reading preceded by a 10 second double orbital shake at 100 rpm. To assess the effect of
multiple phosphorylation sites, assays were performed for the 0P, 1P, 2P and 3P
phosphomutants using CPK concentrations of 0.125 µM and αB concentrations of 0.5 µM or
0.125 µM. To compare the effect of phosphorylation at each residue, single mutants were
used and assays were repeated using WTαB, S19D, S45D and S59D phosphomutants.
Samples using only CPK at 10 µM or only αBs at 10 µM or 5 µM acted as controls for each
set of assays. The ability to prevent aggregation was calculated as the percentage inhibition
using the formula: % protection = ((ACPK-AC)/ACPK) x 100 based on the final average
absorbance reading where AC denotes absorbance of sample containing chaperone and ACPK
denotes absorbance of CPK control, as previously described (Ecroyd et al., 2007). Assays
were performed in triplicate and results are expressed as means ± SD. Results were analysed
using analysis of variance (ANOVA) and Tukey’s statistical tests where P<0.05 was
considered statistically significant.

2.2.2 Tissue dissection
Donated human lenses aged 41-77 years of age were sourced from the Lions Eye Bank at the
Sydney Eye Hospital and stored at -80°C until use. Tissue was handled according to the
tenets of the Declaration of Helsinki. Trephines (6 mm and 4.5 mm) precooled with liquid
nitrogen were used to manually dissect lenses into cortical, barrier and nuclear regions
according to Figure 2.1.
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8mm

C
B
N
4.5mm

0.75
mm

1mm

Figure 2.1: Regions of the human lens. Schematic depicts cross section of human lens in
the equatorial plane. Cortical (C), barrier (B) and nuclear (N) regions are demarcated by
dotted lines and the approximate width of the regions is indicated in mm.

Briefly, decapsulated lenses were placed in precooled polytetrafluoroethylene moulds
(DuPont, USA) with a diameter of 8 mm, and a 6 mm trephine was used to excise cortical
tissue. From the cylindrical core that remained, approximately 0.5-1 mm of tissue was
removed from both ends using a precooled razor blade and was combined with previously
excised tissue to provide cortical samples. The remaining tissue was placed again into a
precooled 6 mm mould and a 4.5 mm trephine was used to isolate barrier and nuclear tissue
samples. Trephines and mould were precooled to -20°C and lenses were kept frozen
throughout process with regular submersion in liquid nitrogen.

2.2.3 Density sucrose gradient centrifugation
Sucrose solutions were prepared in sucrose buffer (Appendix 2) and layered into 9 mL
centrifuge tubes from bottom to top as follows: 1 mL 80% w/v sucrose, 2 mL 70%, 1.5 mL
60%, 1.5 mL 50%, 1.5 mL 45%, 1.5 mL 25%. Gradient tubes were kept cold on ice while
tissue was aspirated in 1 mL of 8% sucrose solution using a 21 g syringe. Homogenised
tissue was then layered on top of the gradient, before being overlayed by a further 1 mL of
8% sucrose solution. Tubes were then spun at 100, 000 g for 2 hours at 4°C using a swing55
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bucket rotor (Ti41; Beckman Coulter, USA) in an Optima-100 XP Ultracentrifuge (Beckman
Coulter, USA). Images were taken of the gradient tubes with a digital camera before protein
was extracted from bands (SG1-SG6, labelled with decreasing density) using glass pasture
pipettes. Sucrose was removed by diluting the sample twofold with sucrose buffer and
centrifuging at 4°C at 12281 g for 10 minutes in a MIKRO 20 microfuge (Hettich, Germany).
Protein was then delipidated by resuspension in 100% v/v ethanol and incubating overnight at
-20°C.

2.2.4 Protein quantitation
For 1D SDS-PAGE and western blotting, protein was solubilised in 8 M urea and absorbance
at 280 nm was measured using a NanoDrop 2000 system (ThermoFisher Scientific, USA)
using 8 M urea as a blank to compensate for absorption caused by urea in the buffer. The A280
readings were then used to calculate protein concentration assuming a molar extinction
coefficient of 19000 M-1 cm-1 (Horwitz et al., 1998). Samples were then made up to a final
concentration of 1 mg.mL-1 using 8 M urea. For 2D electrophoresis, protein was solubilised
in SSS buffer and protein concentration was calculated using a RC DCTM Protein Assay Kit
II, performed in microfuge tubes according to the manufacturer’s instructions. The RC DCTM
Protein Assay Kit was selected for quantitation of these samples as it is compatible with
buffers that contain high concentrations of reducing agents and detergents such as SSS buffer.
Briefly, 125 µL of RC Reagent I was added to 25 µL of sample, vortexed and incubated at
room temperature for 1 minute. Following this, 125µL of RC Reagent II was added, and
samples were vortexed and centrifuged at 15 000 g for 5 minutes using a Centrifuge 5415C
(Eppendorf, Germany). The supernatant was removed via aspiration and discarded following
centrifugation, before adding 127 µL of Reagent A’ (previously prepared by combining DC
Reagent S and DC Reagent A at a ratio of 1:5). Samples were then vortexed before being
incubated at room temperature for 5 minutes. Samples were again vortexed and 1 mL of DC
Reagent B was added, immediately vortexed, and incubated at room temperature for 15
minutes. Following incubation, 120 µL of each sample was transferred into a 98 well
microplate (Greiner Bio-One, Austria) and absorbance was read on a Spectramax Plus 384
(Molecular Devices, USA) at a wavelength of 750 nm. Samples were then made up to a final
concentration of 1 mg.mL-1 using SSS buffer.
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2.2.5 1-Dimensional (1D) electrophoresis and western blotting of protein bands
Protein isolated from SG2, SG3 and SG5, and Cortical SG6 bands was quantified and
prepared in 8 M urea as described in section 2.2.4. Samples were prepared in 2-times loading
buffer (Appendix 2), unfolded by incubation at 37°C for 30 minutes and subjected to SDS
PAGE on a 15% v/v gel for one hour at 110V. The gel was stained using Coomassie stain
(Appendix 2) for one hour, destained with coomassie destain (Appendix 2) overnight and
imaged using a Gel Logic 212 Pro imaging system (Carestream, USA). Relative protein load
was compared using ImageJ 1.49v densitometry software (Wayne Rasband, NIH, USA).
Duplicate gels (but for the exclusion of the cortical SG6 sample) were prepared and proteins
were transferred onto a polyvinylidene fluoride (PVDF) (MerckMillipore, USA) membrane
electrophoretically at 30 V overnight at 4°C for western blotting. Briefly, membranes were
blocked with 3% w/v bovine serum albumin (BSA) (Sigma, USA) in Tris buffered salinetween 20 (TBST) (Appendix 2) prior to incubation with individual anti-phosphoserine αB
antibodies specific to pSer19, pSer45 and pSer59, or an anti-αB antibody at concentrations
outlined in Table 2.1. Blots were washed 3 times for 5 minutes in TBST, prior to labelling
with goat anti-rabbit IgG/horse radish peroxidase (HRP). Blots were washed again 3 times for
5 minutes in TBST and developed using SuperSignalTM West Pico Chemiluminescent
Substrate and 3,3’ –Diaminobenzidine Tetrahydrochloride (DAB) substrate, before being
imaged using a Gel Logic 212 Pro imaging system (Carestream, USA). In-gel analysis of
scanned images was performed using ImageJ 1.49v densitometry software (Wayne Rasband,
NIH, USA). It should be noted that densitometric analysis was limited to the comparison of
the relative proportion of each band compared to the total signal for each lane within the
same gel as no one sample was run on all gels, therefore preventing comparison between
gels. Cross-reactivity of anti-phosphoserine antibodies with αA and unphoshporylated αB
was tested by repeating the blots with recombinant αA and αB alongside αB purified from
bovine lens lysate.

2.2.6 2-Dimensional (2D) electrophoresis and spot analysis
Protein extracted from SG2, SG3, SG5 and SG6 bands was quantified and prepared in SSS
buffer as previously described in section 2.2.4. For each protein extract, 300 µL of sample
(i.e. 300 µg protein) was loaded onto a ReadyStripTM IPG trip (17cm, pH 3-10 NL) via
overnight rehydration, and separated by charge using a Protean® IEF system (Biorad, USA)
with the following program: 100 V for 1 hour, 300 V for 1 hour, 600 V for 1 hours, 1000 V
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for 1 hour, 2000 V for 1 hour, 4000 V for 1 hour, 40000 V for 10 hours, then a 100 V hold.
For the second dimension, IEF strips were equilibrated for 20 minutes in equilibration buffer
(see Appendix 2) before being layered over 12.5% v/v polyacrylamide gels and subjected to
electrophoresis for 5 hours at 45 mA to separate the proteins by mass. Gels were stained with
colloidal Coomassie stain (Appendix 2), destained with colloidal destain (Appendix 2) and
imaged using a Gel Logic 212 Pro imaging system (Carestream, USA). Scanned images were
analysed using ImageJ 1.49v densitometry software (Wayne Rasband, NIH, USA). It should
be noted that no protein standards of a known amount were used, therefore densitometric
analysis is limited to the comparison of the relative proportion of each spot compared to spot
3 (as it was the most abundant spot on most gels). As such, comparison between gels of the
absolute amounts of protein present was not performed. To confirm spot identity, individual
protein spots were excised from gels of SG2 protein and were subjected to in-gel tryptic
digestion with 1 µg of trypsin at room temperature overnight. Resultant peptides were
detected using positive ion nano liquid chromatography quadrupole time-of-flight (NanoLC
QTOF) MS (SynaptTM HDMS; Waters, USA) and Masslynx V4.1 software (Waters, USA),
and parent proteins were identified by comparison with a peptide match database (UniProt).

2.2.7 Separation of crosslinked complexes
Western blot analysis was used to identify phosphorylated αB species present in the gels
present as discrete spots and as components of crosslinked complexes of ~45-90 kDa.
Briefly, a region of the gel of the SG3 fraction from the cortex incorporating non-complexed
αB spots (~20 kDa) was excised and labelled with anti-phosphoserine αB antibodies specific
to the residues pSer19, pSer45 and pSer59 as previously described in section 2.2.5. The blot
was then developed using SuperSignalTM West Pico Chemiluminescent Substrate. Blots were
scanned and imaged using a Gel Logic 212 Pro imaging system (Carestream, USA). To
characterise the protein composition of crosslinked protein complexes, spots (1-10) were
excised from the gel, and submitted for MS analysis.

2.2.8 Analysis of crosslinked complexes
The following work was undertaken at the Australian Proteome Analysis Facility (APAF),
the infrastructure provided by the Australian Government through the National Collaborative
Research Infrastructure Strategy (NCRIS). Briefly, excised spots were subjected to in-gel
overnight digestion with 50-150 µg trypsin with resultant peptides being extracted from the
58

Chapter 2
gel with acetonitrile:formic acid. Purported positively and negatively charged peptide bands
were excised from the dye front of the barrier and nuclear SG3 gels respectively. Peptides
were extracted from the gel spots using sonication and incubation with acetonitrile overnight
at 37°C without further digestion. All samples were then concentrated and desalted using a
peptide trap (Michrom peptide Captrap, USA). Peptides were separated using an Eksigent
Ultra NanoLC system (Eksigent, USA), and analysed using positive ion nanoflow
electrospray MS in an information dependent acquisition mode (IDA). The ten largest
multiply charged ions (counts>150) observed in the TOF-MS survey scan (m/z 350-1500, 0.5
seconds) were further analysed using MS/MS. MS/MS spectra were acquired over 100
milliseconds (m/z 100-1500) with rolling collision energy. Peptide identities and
modifications were determined by comparison with a human MASCOT database, and
deamidated residues were identified based on what potential sites were present on the
peptides (i.e. it is important to note that if more than a single potential deamidation site was
present on a single peptide, it was not possible to determine which residue was deamidated)
Percent deamidation of deamidated filensin sites was calculated by integrating ion
chromatograms of precursor peptides, and calculating the relative peak area of the
deamidated peptide compared to the total peptide (i.e. deamidated + non-deamidated
peptides).

2.3 Characterisation of αB membrane binding in aged human lenses
2.3.1 Tissue sectioning and treatment
Lenses were treated and mounted according to Lim et al. (2009). In short, intact lenses were
incubated for 24 hours in 0.75% w/v paraformaldehyde (PFA, see Appendix 2) in PBS at
4°C. Lenses were then encased in 6% w/v agarose in PBS prior to being cut in half along the
equatorial plane with a razor blade, and incubated again in 0.75% w/v PFA in PBS for a
further 24 hours at 4°C. Lens halves were equilibrated for 1 hour in 10% w/v sucrose in PBS,
1 hour in 20% w/v sucrose in PBS and overnight in 30% w/v sucrose in PBS at 4°C. Lens
halves were then sectioned at 15 µm at -20°C using a Leica CM1905 cryostat (Leica
Microsystems, Germany), and soft mounted onto glass slides. To ensure consistency of
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results and in the quality of tissue sections, all lenses used were of a similar age i.e. 62-63
years-old.

2.3.2 Labelling
For direct labelling of αB, sections were washed 3 times with PBS, permeabilised for 30
minutes with 0.25% v/v Triton X-100 in milliQ and blocked with 3% w/v BSA in TBST for a
minimum of 1 hour at room temperature. The sections were then labelled with antibodies
specific to WTαB, pS19αB, pS45αB or pS59αB using concentrations outlined in Table 2.1.
Labelled sections were then washed 3 times for 5 minutes in TBST before being incubated
with goat anti-rabbit IgG/Alexa 488 (Table 2.1) in blocking buffer (i.e. 3% w/v BSA in
TBST). Sections were washed 3 times for 10 minutes in TBST and mounted with CitifluorTM
CFPVOH and AF100 anti-fadent before being imaged on a Leica TCS SPS II confocal
microscope (Leica, Germany) and analysed using LAS AF Lite software (Leica, Germany).
To label fibre cell membranes, separate lens sections were washed 3 times for 5 minutes with
Hank’s balanced salt solution (HBSS) buffer (Appendix 2) and incubated with WGA/Alexa
633 diluted (1:200 in HBSS buffer) for 10 minutes at room temperature. Sections were
washed 2 times for 5 minutes with HBSS buffer before being mounted, imaged and analysed
as previously described.

2.3.3 Duolink® proximity assays
Mounted lens sections were permeabilised and blocked as previously described in section
2.3.2. Sections were then co-labelled with antibodies specific to either WTαB, pS19αB,
pS45αB or pS59αB and antibodies specific to either AQP0 or Cx46 in blocking buffer (i.e.
3% w/v BSA in TBST), at concentrations outlined in Table 2.1. Sections were incubated with
anti-rabbit and anti-goat PLA® probes for 1 hour at 37°C, and washed twice for 5 minutes
with wash buffer A (Appendix 2). Sections were then incubated with ligase according to the
manufacturer’s instructions for 30 minutes at 37°C and washed twice for 2 minutes in wash
buffer A. Sections were then incubated with polymerase according to company instructions
for 100 minutes at 37°C in the dark, before being washed twice for 10 minutes in wash buffer
B (Appendix 2) and for 1 minute in 0.01x wash buffer B (Appendix 2) in the dark. Sections
were allowed to air dry in the dark and mounted with CitifluorTM CFPVOH and AF100 antifadent before being imaged on a Leica TCS SPS II confocal microscope (Leica, Germany)
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and analysed using LAS AF Lite software (Leica, Germany). Two negative control sections
were prepared using no primary antibodies or co-labelling of rabbit polyclonal IgG with goat
anti-AQP0 IgG at concentrations outlined in Table 2.1. A positive control section was
prepared by co-labelling with polyclonal rabbit anti-BFSP2 antibody and AQP0 at
concentrations outlined in Table 1.2, as BFSP2 (also known as phakinin and CP49) is known
to associate with AQP0 in human lenses (Rose et al., 2006).

2.4 In vitro deamidation of αB
2.4.1 In vitro deamidation of αB under storage conditions
A batch of recombinant human αB expressed and purified by Dr Amie Morris (see section
2.2.1) was stored in 200 mM ammonium acetate (pH 7.0) at -20°C for a minimum of 5 years
(referred to as batch 1). To investigate deamidation events under low temperatures and pH
following long term storage, the method published by Liao et al. (2009) was modified and
adapted. Briefly, protein was transferred into 34 mM acetic acid (~pH 3.0) at a concentration
of 1 mg.mL-1, and incubated at 4°C for a total of 72 hours. Aliquots were taken at 0, 23, 48
and 72 hours, and were snap frozen in liquid nitrogen and stored at -20°C until analysis. To
compare deamidation events under varying pH conditions with the addition of heat following
long term storage, protein was transferred into either 34 mM acetic acid (~pH 3.0) or 200
mM ammonium acetate (pH 7.0) at a concentration of 1 mg.mL-1, and incubated at 50°C for
16 hours. Samples were digested with trypsin at a concentration of 0.5 µg.mL-1 for either 5
minutes or 2 hours, and resultant peptides were snap frozen in liquid nitrogen and stored at 20°C until analysis. For each experiment, protein samples that had not been subjected to heat
treatment were used as controls. Samples were analysed using positive ion NanoLC QTOF
MS (SynaptTM HDMS; Waters, USA) using a mass range m/z 1800-2000 for the 4°C treated
samples to allow detection of intact proteins, and m/z 300-1800 for the 50°C treated samples
to allow detection of peptides. Data was analysed using Masslynx V4.1 software (Waters,
USA). Mass changes were detected in 4°C treated samples by identifying mass shifts in
matching peaks between time point samples, and predicted masses were used to identify
peptides and potential modifications in the 50°C treated samples.
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2.4.2 In vitro deamidation of unfolded αB protein
A second batch of recombinant human αB was donated by Dr Megan Kelly (University of
Wollongong, Australia) and stored in 50 mM phosphate buffer (~pH 7.4) at -20°C until use,
but for a period of less than 12 months (referred to as batch 2). To determine the rate of
deamidation under unfolding conditions following short term storage, protein samples were
diluted into either 6 M urea (~pH 8.0) or 1 M ammonium bicarbonate (~pH 8.0) to a final
concentration of 2 mg.mL-1, and incubated at either 37°C for 4 hours or 50°C for 18 hours
respectively. Samples were then transferred back into PBS using Slide-A-Lyzer TM MINI
dialysis cups in order to allow for the slow refolding of the 6 M urea treated sample (Saha
and Das, 2007; Benesch et al., 2008). Samples were then snap frozen in liquid nitrogen and
stored at -20°C until submission for analysis at APAF. Protein samples in PBS with and
without heat treatment at 50°C for 18 hours were prepared and submitted as controls. To
compare isoelectric profiles of treated samples, 6 µg aliquots of the urea treated sample and
the PBS and PBS heat treated samples were retained prior to submission for MS analysis.

The following work was undertaken at APAF, the infrastructure provided by the Australian
Government through the National Collaborative Research Infrastructure Strategy (NCRIS).
Prior to MS analysis, 50 µg aliquots of each sample were made up to 0.5 mg.mL-1 with
ammonium bicarbonate and digested with 2 µg trypsin overnight. Samples were then
concentrated and subjected to MS analysis as previously described in section 2.2.7. For
further MS/MS analysis, MS/MS spectra were acquired over 200 milliseconds (m/z 1001500) with rolling collision energy for the ten largest multiply charged ions (counts>150)
observed in the TOF-MS survey scan (m/z 380-1500, 0.25 seconds). Peptide identities and
theoretical retention times were determined using a MASCOT database search, and a
computer simulation method was used to calculate deamidation percentages of peptides
containing asparagine (N) and glutamine (Q) residues. Briefly, this was performed using a
peak harvester program to develop a Poisson model for each isotopic distribution (Breen et
al., 2000), and then calculating the intensity of the peak corresponding to the deamidated
peptide as a proportion of the total intensity of the peaks corresponding to both the
deamidated and non-deamidated peptides. Samples were analysed three times, and results
were presented as mean ± SD. Results were analysed using ANOVA and Tukey’s statistical
tests and P<0.05 was considered statistically significant.
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Investigation of αB phosphorylation
in the human lens
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3.1 Introduction
Although αB is generally believed to play a protective role in the human lens, it has also been
reported to be the dominant protein in insoluble, membrane-bound protein fractions in aged
and cataractous human lenses (Cenedella and Fleschner, 1992; Fleschner and Cenedella,
1992; Chandrasekher and Cenedella, 1995; Friedrich and Truscott, 2010). This has led to
speculation that membrane association of the protein may be a pivotal step in
cataractogenesis (Sweeney and Truscott, 1998; Cobb and Petrash, 2002b; Friedrich and
Truscott, 2009). Membrane associated αB has also been shown to have a range of
modifications (Friedrich and Truscott, 2010; Wang et al., 2013), including phosphorylation.
To elucidate how phosphorylated αB may participate in pathogenic processes in the lens, it is
essential to determine how phosphorylation affects the chaperone activity of the protein. The
results from previous studies in this area are conflicting. For example, Ahmad et al. (2008)
reported that a triple αB phosphomimic (i.e. S19D/S45D/S59D αB) had increased chaperone
activity against insulin, citrate synthase and α-synuclein under either reducing conditions or
heat stress compared to wild type αB. In contrast, Aquilina et al. (2004) reported that a
double phosphomimic (i.e. S19D/S45D αB) co-aggregated with α-lactalbumin under
reducing conditions, while a single phosphomimic (i.e. S19D αB) retained activity similar to
WTαB. Ecroyd et al. (2007) later showed that the effect of phosphorylation on αB activity
was dependent on the substrate and buffer conditions. For example, αB phosphomimics were
more efficient than WTαB at preventing amyloid formation of RCMκ-casein (but not ccβTrp), the heat-induced aggregation of catalase, βL-crystallin and alcohol dehydrogenase, and
the DTT-induced aggregation of insulin and α-lactalbumin in phosphate buffer (Ecroyd et al.,
2007). However, incubation of αB phosphomimics with α-lactalbumin in ammonium acetate
buffer induced aggregation, suggesting that the stability of the chaperone in certain buffers
containing ammonium ions may be compromised, leading to hyperactivity and coprecipitation (Ecroyd et al., 2007). A number of phosphorylation-induced structural and
kinetic changes in αB oligomers have also been reported, including an increase in subunit
exchange (Ahmad et al., 2008), increased polydispersity, loss of dimeric substructure
(Aquilina et al., 2004) and an increase in flexibility and solvent accessibility of the Nterminal domain (Peschek et al., 2013).
An indication that protein modification may be involved in pathogenic processes in the lens is
the abundance of modifications (including phosphorylation) in protein associated with the
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insoluble, membrane associated lens fractions (Wang et al., 2013). Studies have shown an
age-related loss of soluble protein in the lens, coupled with an increase of membrane
associated protein (Friedrich and Truscott, 2009; Friedrich and Truscott, 2010). This pattern
becomes more pronounced towards the nuclear region of lenses (Truscott et al., 2011). It has
been shown that these membrane associated fractions are composed predominantly of αcrystallin (Friedrich and Truscott, 2009; Friedrich and Truscott, 2010; Truscott et al., 2011;
Wang et al., 2013), with lower levels of β- and γ-crystallins as well as cytoskeletal proteins
such as filensin, phakinin and spectrin (Wang et al., 2013). It is believed that α-crystallin
becomes tightly bound to membranes though hydrophobic interactions with either
phospholipids or integral membrane proteins (Chandrasekher and Cenedella, 1997; Cobb and
Petrash, 2000; Truscott et al., 2011). Soluble cytoplasmic HMWCs, consisting of α-crystallin
and its substrate proteins, then form low affinity associations with tightly-bound α-crystallin
at the membrane (Chandrasekher and Cenedella, 1997; Cobb and Petrash, 2002b; Friedrich
and Truscott, 2009). These soluble complexes show higher membrane affinity than native αcrystallin and, once bound, display decreased chaperone activity, although the ability to
participate in subunit exchange events is retained (Cobb and Petrash, 2002b). As such, these
complexes can recruit more cytoplasmic proteins, incorporating them into the complex
(Friedrich and Truscott, 2010).
However, protein modifications present in membrane associated fractions have not been
extensively studied. Friedrich and Truscott (2010) identified a pattern of multiple negatively
charged spots, corresponding to unmodified and modified αB, on 2D gels of high density
membrane associated fractions. However, this study did not differentiate between
phosphorylated or deamidated isoforms. More recently, a comprehensive phosphoproteomic
study was performed on human fibre cell membrane extracts (Wang et al., 2013). Although
this identified seventeen sites of αB and 22 sites of αA phosphorylation, some of which were
previously unreported, the study did not differentiate between lens age and region, and did
not compare levels with a soluble protein control. A full understanding of the mechanism of
membrane association and the role phosphorylation may play in this process is therefore
lacking and is the focus of the work presented in this chapter.
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3.2 Experimental Rationale
Creatine phosphokinase is found in the brain, myocardium and skeletal muscle (Baird et al.,
2012), and is overexpressed in diseases such as myocardial infarction (Vincent and Rapaport,
1965; Van der Veen and Willebrands, 1966; Goto, 1974) and muscular dystrophies (Van der
Veen and Willebrands, 1966; Goto, 1974; Somer et al., 1976). It is commonly used as a
substrate for chaperone assays (Dabbs and Wilson, 2014; Wyatt et al., 2015) due to its
tendency to reproducibly form amorphous aggregates following thermal stress, and it has
previously been shown that non-chaperone proteins have no effect on its aggregation (Dabbs
and Wilson, 2014). Both CPK and αB co-exist in skeletal muscle (section 2.2.1).
Furthermore, the comparatively low temperature used for these assays (i.e. 40°C) compared
to temperatures required to destabilise proteins native to the lens, such as β-crystallins
(Ecroyd et al., 2007; Takata et al., 2008), are closer to physiological temperatures
experienced by the lens. For these reasons, CPK was selected as a substrate for aggregation
assays rather than a native substrate to investigate the activity of αB.
Density sucrose centrifugation has become a well-established method to isolate membrane
associated and soluble protein fractions from lens homogenates. This method was previously
published by Lampi et al. (1992) and Cenedella and Fleschner (1992), and later modified by
Friedrich and Truscott (2009; 2010). This current work employed the modified protocol
published by Friedrich and Truscott (2009; 2010) to isolate membrane associated protein
fractions (section 2.2.3). Prior to this, human donor lenses from different ages were manually
dissected into cortical, barrier and nuclear regions to allow for comparison between different
lens regions (section 2.2.2). These fractions were then separated by 1D (section 2.2.5) and 2D
SDS PAGE (section 2.2.6). As 2D SDS PAGE separates proteins in two dimensions i.e. mass
and pI, modified proteins resolve as a series of discrete spots due to the variance in charge
bestowed on them by the modification. This method, used previously by Lampi et al. (1998)
to identify crystallin deamidation and truncation products in human lenses, was therefore
employed in order to separate modified forms of αB for more detailed analysis. To identify
phosphorylated species of αB, commercially available anti-phosphoserine antibodies specific
to pSer19, pSer45 and pSer59 αB were used for western blotting of 1D and 2D gels (section
2.2.5, section 2.2.6). These three residues were selected for study as they are the dominant
sites of phosphorylation (Miesbauer et al., 1994; MacCoss et al., 2002), the most extensively
studied and corresponding anti-phosphoserine antibodies were readily available. Another
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antibody specific to the C-terminal residues of αB was used as a control to detect both
phosphorylated and unphosphorylated αB, thereby reflecting the total αB pool. Densitometry
software was used on 1D blots to measure relative intensity of spots representing
phosphorylated αB in order to compare αB phosphorylation profiles between lens region and
density fractions, and with age (section 2.2.5).
Tandem mass spectrometry (MS/MS) is often used to determine peptide identity and to detect
modification sites. In-gel tryptic digests of discrete 2D spots were therefore subjected to
MS/MS to determine protein identities. This method was also applied to spots within the
mass range ~40-95 kDa to identify proteins and modification sites present in crosslinked
complexes (section 2.2.7).

3.3 Results
3.3.1 Mimicking phosphorylation activates chaperone activity of αB..
To determine how the addition of a negative charge can affect the chaperone activity of αB,
aggregation assays were performed to compare the ability of αB with single (S19D; hereafter
1P), double (S19D/S45D; hereafter 2P) and triple (S19D/S45D/S59D; hereafter 3P) point
mutations that mimic phosphorylation to inhibit the heat-induced aggregation of CPK. There
was minimal aggregation when WT or 1P αB were incubated alone under these experimental
conditions (Figure 3.1C). When present at a molar ratio of 1αB:1CPK, WTαB (no mutations)
increased the amount of aggregation of CPK by 2.8-fold (P=0.001) compared to when CPK
incubated alone (Figure 3.1A). In contrast, the amorphous aggregation of CPK was inhibited
by 72.3±2.9% (P=0.009) in the presence of 3P αB (Figure 3.1A). The amount of CPK
aggregation was also reduced (45.8±7.7%) by 2P αB, although these results did not reach
statistical significance (P=0.195) (Figure 3.1A). Incubation with 1P did not significantly
affect CPK aggregation (P=0.9) (Figure 3.1A). At a molar ratio of 1αB:2CPK, each subsequent
addition of a mutation that mimics phosphorylation led to a decrease in the amount of CPK
aggregation (Figure 3.1B). At this lower concentration of αB, incubation with WT (P=0.9) or
1P αB (P=0.134) did not significantly affect aggregation of CPK. However, 2P αB inhibited
aggregation by 41.9±7.5% (P=0.001) and 3P αB inhibited the aggregation of CPK by

67

Chapter 3
83.9±1.3% (P=0.001) (Figure 3.1B). WT, 1P, 2P and 3P αB incubated in the absence of
chaperone were used as negative controls (Appendix 3).

Figure 3.1: Effect of mutations that mimic phosphorylation on the ability of αB to
inhibit the heat-induced aggregation of CPK. CPK (0.125 µM) was incubated in PBS (pH
7.4) at 40°C in the presence of WT, 1P, 2P or 3P αB at a concentration of (A) 0.5 µM or (B)
0.25 µM. (i) The change in light scatter was measured at 360 nm over time. (ii) The amount
of aggregation at 600 minutes was calculated as a proportion of the control i.e. no αB. Data
are shown as means±1SD (N=3). Differences between group means were tested using a oneway ANOVA and Tukey’s post-hoc test (P≤0.01 is indicated by an asterisk). Note – scale of
y-axis is different in (A) compared to (B).
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To determine if the observed increase in chaperone activity of 2P and 3P αB was due to
mutation of a specific residue (e.g. Ser45), the CPK aggregation assays were repeated using
phosphomutants with single S→D point mutations at Ser19, Ser45 or Ser59 (i.e. S19D, S45D
and S59D αB). Again, there was minimal aggregation observed when CPK was not present in
the sample (Figure 3.2C). At a molar ratio of 1CPK:1αB, the addition of WTαB significantly
increased CPK aggregation by 2-fold (P=0.001) compared to when CPK was incubated alone
(Figure 3.2A). At a 1αB:1CPK ratio, the aggregation of CPK was not significantly affected by
incubation with the S19D, S45D or S59D αB phosphomutants (Figure 3.2A). At a molar ratio
of 1αB:4CPK, CPK aggregation was not significantly affected by incubation with any of the αB
isoforms (Figure 3.2B). WT, S19D, S45D and S59D incubated in the absence of chaperone
were used as negative controls (Appendix 3).

Figure 3.2: Effect of single-site αB phosphomimics on the heat-induced aggregation of
CPK. CPK (0.125 µM) was incubated in PBS (pH 7.4) at 40°C in the presence of WT, 1P,
2P or 3P αB at a concentration of (A) 0.5 µM or (B) 0.125 µM. (i) The change in light scatter
was measured at 360 nm over time. (ii) The amount of aggregation measured as light scatter
at 600 minutes was calculated as a proportion of the control i.e. no αB. Data are shown as
means±1SD (N=3). Differences between group means were tested using a one-way ANOVA
and Tukey’s post-hoc test (P≤0.01 is indicated by an asterisk).
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3.3.2 The amount of multiply phosphorylated αB is increased in the nucleus of aged human
lenses and coincides with the formation of high-density protein fractions.
Isolation of high density lens protein fractions
Density sucrose centrifugation was performed separately on two human lenses (aged 41 and
77 years old, representing a younger and an older lens respectively) to investigate how
density profiles from different regions of the lens change with age. Prior to centrifugation,
each lens was dissected into cortical, barrier and nuclear regions with a trephine (section
2.2.2, Figure 2.1). Protein deposited at density interfaces, was observed as cloudy white
bands (sucrose gradient 6-1, SG6-1, in order of increasing density). The amount of protein for
each band was measured as a percentage of the total protein in the tube.
The predominant band in the cortical sample from the younger lens was SG3 (Figure 3.3A,
B). As the amount of SG3 decreased in the younger lens towards the nucleus, SG5 increased
to become the predominant band in the nuclear sample (Figure 3.3A, B). The predominant
band in the older lens for all regions (i.e. cortical, barrier and nuclear samples) was SG2
(Figure 3.3A, B).
In the cortical samples, SG6, SG5 and SG3 decreased from 17%, 28% and 38% of the total
protein respectively in the younger lens to 14%, 19% and 24% in the older lens (Figure 3.3B,
C). The amount of SG4 remained constant (at 10% of the total protein) and SG2 increased
from 7% of the total protein in the younger lens to 32% in the older lens (Figure 3.3B, C).
In the barrier region, SG6, SG5, SG4 and SG3 decreased from 17%, 31%, 14% and 38% of
the total protein respectively in the younger lens to 14%, 20%, 7% and 16% in the older lens
(Figure 3.3B, C). While no SG2 band was evident in the younger lens, SG2 constituted 42%
of the total protein in the barrier region from the older lens (Figure 3.3B, C).
In the nuclear samples, SG5, SG4 and SG3 decreased from 44%, 16% and 23% of the total
protein respectively in the younger lens to 16%, 8% and 6% in the older lens (Figure 3.3B,
C). The amount of SG6 and SG2 increased from 12% and 4% of total protein respectively in
the younger lens to 16% and 41% in the older lens (Figure 3.3B, C). Although absent in the
nuclear region from the younger lens, and from cortical and barrier samples from both lenses,
SG1 constituted 11% of the total protein content in the nuclear sample from the older lens
(Figure 3.3B, C).
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Figure 3.3: Comparison of sucrose density gradient profiles from human lenses as a
function of age. (A) Human lenses from a 41 year-old and a 77 year-old were manually
dissected into cortical, barrier and nuclear regions and density fractions (SG6-SG1) were
separated via density sucrose centrifugation. Images were inverted using densitometry
software, and the amount of protein for each band was determined by measuring the area
under the corresponding peak on the densitometry profile. The relative amount of protein in
each band for the (B) 41 year-old and the (C) 77 year-old lens is expressed as a percentage of
the total protein in each tube.

71

Chapter 3
Comparison of protein composition of sucrose density bands
To compare proteins present in different density fractions, SG2, SG3, SG5 and SG6 were
isolated from each region of a 53 year-old human lens and separated using 1D SDS PAGE.
Fraction SG4 was not analysed as analysis was limited to high and low density fractions.
Additionally, SG4 was a relatively minor component for each lens. As a known amount of
standard was not loaded for each gel, densitometry analysis was limited to the comparison of
relative proportions compared to the total signal from each lane. A different lens of this age
was used in order to obtain sufficient protein yield for each fraction for analysis. Barrier and
nuclear SG6 were not analysed due to insufficient protein yields. In the cortical SG6 sample,
αB migrated a shorter distance than in the higher density fractions, potentially due to overall
lower rates of modification, notably truncation. Levels of protein (observed as discrete bands)
increased with decreasing density across all lens regions. Across all regions of the lens and all
density fractions, αA and αB were the predominant protein species in these samples (Figure
3.4A, B).
Additional protein bands at 100 kDa, 55 kDa and 40 kDa were also observed in some
samples (Figure 3.4A, B). The 100 kDa and 55 kDa bands were exclusively present in high
density fractions (i.e. SG2 and SG3) from cortical samples, albeit at low levels (1.1-2.0% and
0.8-1.7% of the total protein respectively) (Figure 3.4A, B). In comparison, the 40 kDa band
was observed in samples from all lens regions (Figure 3.4A, B). In cortical samples, levels of
the 40 kDa band decreased from 7.6% of the total protein in the SG5 fraction to 3.9% in the
SG2 fraction (Figure 3.4A, B). In barrier samples, the 40 kDa band was only observed in the
SG3 fraction, accounting for 6.1% of the total protein in the sample (Figure 3.4A, B). Levels
of a protein migrating with αA (‘αA’) decreased with increasing density across all lens
regions (Figure 3.4A, B). In the cortical samples, ‘αA’ decreased from 16% of the total
protein in SG6 to 6.7% in SG2 (Figure 3.4A, B). In barrier and nuclear samples, ‘αA’
decreased from 7.1% to 9.2% of total protein in the SG5 fraction to 6.1% and 5.9% in the
SG2 fraction respectively (Figure 3.4A, B). Although the levels of a protein migrating with
αB (‘αB’), as a proportion of the total protein, varied across density fractions, a trend towards
a decrease in ‘αB’ levels was observed when comparing cortical and nuclear samples across
all SG fractions (Figure 3.4A, B). In SG2 fractions, ‘αB’ accounted for 28.5% of the total
protein in cortical samples but only 11.5% in nuclear samples (Figure 3.4A, B). Levels of
‘αB’ as a proportion of the total protein in SG3 and SG5 fractions decreased from 24.3% and
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31.8% in cortical samples to 19.1% and 24.4% in nuclear samples respectively (Figure 3.4A,
B).

Figure 3.4: Protein components of SG fractions from different regions of a human lens.
(A) SG2, SG3 and SG5 fractions were isolated from the cortical, barrier and nuclear regions
of a 53 year-old female human lens via density sucrose centrifugation and separated using 1D
SDS PAGE. The position of dominant protein bands at 100 kDa, 55 kDa, 40 kDa, as well as
bands running at the distance of αA and αB are shown on the left. (B) The amount of each
protein band was measured using densitometry and calculated as a percentage of the total
protein in each lane to the closest whole number. Note - an empty lane was digitally excised
from the gel and the imaged was merged (indicated by broken line).
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Detection of phosphorylated αB in sucrose density bands
To compare levels of phosphorylated αB across density fractions from each region of this 53
year-old lens, protein from SG2-SG5 from each region was separated on 1D SDS gels,
transferred onto PVDF and labelled with antibodies specific to pSer19, pSer45 or pSer59 αB.
An identical blot was prepared and labelled with an anti-αB antibody for use as a control to
indicate levels of total αB for each sample. Densitometric data for each αB band was
standardized against the cortical SG5band for each blot (i.e. density of band was calculated as
a proportion of the signal for cortical SG5 band for each blot) as it was found to have the
highest level of total protein. Differences in the amount of protein in each sample were
accounted for by calculating the relative amount of phosphorylated αB as a proportion of the
relative amount of αB in the sample (i.e. density of pαB as a proportion of corresponding
band on blot labelled for total αB).
With regards to the pSer19 to total αB ratio between samples, the highest levels of pSer19 αB
were found in cortical samples for SG2 (0.9) and SG3 (0.8) (Figure 3.5). In comparison, SG5
had pSer19 αB levels equal to the amount of αB in the sample (Figure 3.5). The relative
levels of pSer19 αB were slightly lower in the barrier samples for SG2 (0.6), SG3 (0.8) and
SG5 (0.7) (Figure 3.5). The lowest relative levels of pSer19 αB were in nuclear samples for
SG2 (0.2), SG3 (0.3) and SG5 (0.6) (Figure 3.5).
With regards to the pSer45 to total αB ratio between samples, the highest levels of pSer45 αB
were also in the cortex, with the relative levels the same across all fractions and similar to the
amount of αB in the samples (Figure 3.5). The relative levels of pSer45 αB were lower in the
barrier samples for SG2 (0.5) and SG3 (0.6). However, relative levels of SG5 were elevated
in the barrier sample (1.2) compared to SG2 and SG3 (Figure 3.5). The lowest levels of
pSer45 αB were in nuclear samples for SG2 (0.1), SG3 (0.2) and SG5 (0.5) (Figure 3.5).
With regards to the pSer59 to total αB ratio between samples, the highest levels of pSer59 αB
were in the barrier for SG2 (0.9), SG3 (0.9) and SG5 (0.8) (Figure 3.5). The relative levels of
pSer59 in cortical and nuclear samples were comparable when levels across each of the
fractions were averaged (Figure 3.5). In the cortical samples, relative levels of pSer59 were
equal to the amount of αB in SG5 (Figure 3.5). However, relative levels of pSer59 were
lower for SG2 (0.5) and SG3 (0.8) compared to SG5 (Figure 3.5). In the nuclear samples, the
relative levels of pSer59 were equal to the amount of αB in SG2 (Figure 3.5). However,
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relative levels of pSer59 were lower in SG3 (0.9) and SG5 (0.4) compared to SG2 (Figure
3.5).

Figure 3.5: Identification of phosphorylated isoforms of αB and their relative amounts
in SG fractions from a human lens following 1D SDS-PAGE. SG2, SG3 and SG5
fractions were isolated from the cortical, barrier and nuclear regions of a 53 year-old human
lens, separated using 1D SDS PAGE and transferred onto PVDF membranes. Membranes
were incubated with anti-αB antibody (total αB) or antiphosphoserine specific antibodies to
pSer19, pSer45 or pSer59 αB, and developed with DAB. The intensity of each band was
measured using densitometry, standardised to the cortical SG5 band for each membrane, and
the relative amount of pαB in each band was calculated as a ratio of the relative amount of αB
in that sample.
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2D SDS PAGE separation of modified αB from SG fractions
To compare differences in αB phosphorylation patterns between density fractions and
between age groups, SG2, SG3 and SG5 fractions from each region were isolated from a
range of human lenses (aged 41-77 years), and separated using 2D SDS PAGE. As
corresponding controls for each region, another lens was dissected into cortical, barrier and
nuclear regions, and subjected to 2D SDS PAGE without sucrose density centrifugation i.e.
separated as a whole homogenate. Spots identified as αB (based on MS analysis and
migration patterns) were labelled 1-9 in order of increasing negative charge, and
phosphorylated isotypes were identified by immunoblotting with the pSer19, pSer45 and
pSer59 αB specific antibodies. The relative intensity for each gel spot was calculated as a
ratio of its density compared to that of spot 3 which, based on its pI, corresponds to the
unphosphorylated form of αB.
Gel spots 1-3 were not reactive with any of the αB phosphospecific antibodies (Figure 3.6),
suggesting these spots correspond to unphosphorylated forms of αB. The differences in
migration (i.e. the pI) between these αB isoforms is likely to be due to post-translational
modification (e.g. deamidation), other than phosphorylation, that act to change the pI of the
protein. The pSer19 antibody reacted with the fewest spots (spots 4-6) (Figure 3.6). The
pSer45 antibody reacted with five discrete spots, spots 4-7 and spot 9 (Figure 3.6). The
pSer59 antibody reacted with six discrete protein spots, spots 4-9 (Figure 3.6). The existence
of protein isoforms that reacted with the phosphospecific antibodies indicates the presence of
multiply phosphorylated isoforms of αB in some samples. It should be noted that on the
membrane probed with the pSer59 antibody (Figure 3.6), the negative banding of spot 4 is
consistent with substrate saturation due to high levels of this isoform in the sample.
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Figure 3.6: Identification of phosphorylated isoforms of αB in SG3 fraction from a 77
year-old human lens following 2D SDS-PAGE. SG3 was isolated from the cortical region
of a 77 year-old human lens and separated using 2D SDS PAGE. Sections of the gels were
excised and transferred onto PVDF membrane. Membranes were incubated with antiphosphoserine specific antibodies to pSer19, pSer45 or pSer59 αB, and developed using
chemiluminescence on X-ray film. X-ray films were superimposed onto a corresponding
Coomassie stained gel section to identify spots (labelled 1-9) corresponding to αB isoforms.
The spot previously identified as αA via MS analysis was used as a reference point.
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To compare phosphorylation profiles of different density fractions, SG2 and SG3 were
isolated from a 77 year-old lens. Due to insufficient protein yields from this lens, SG5 was
isolated from a 41 year-old lens. The fractions were then separated using 2D SDS PAGE.
Analysis of SG1, SG4, SG6 and cortical SG2 was not performed due to insufficient amounts
of proteins in these samples. Homogenised tissue from each region (i.e. cortex, barrier and
nucleus) was prepared and analysed for use as corresponding controls.
Control gels
The cortical region gel displayed only two phosphorylated spots, spot 4 and 6, both of which
had half the amount of protein (i.e. 0.5-fold) compared to spot 3 from the same gel (Figure
3.7A; Table 3.1). The relative amount of spot 4 remained constant in the barrier control (i.e.
0.5-fold) (Figure 3.7B; Table 3.1). The relative amount of spot 6 decreased slightly in the
barrier region compared to the cortical region (i.e. 0.3-fold the amount of protein compared to
spot 3 from the barrier region) (Figure 3.7B; Table 3.1). The nuclear region had only one
phosphorylated spot, spot 5 (i.e. 0.9-fold the amount of protein as spot 3 from the same gel)
(Figure 3.7C; Table 3.1). All control gels, i.e. the cortical, barrier and nuclear whole
homogenate gels, also displayed spot 2 (i.e. corresponding to an unphosphorylated isoform of
αB) at high levels (Figure 3.7A-C; Table 3.1) (i.e. 1.5-fold for the cortical region, 0.8-fold for
the barrier region and 1-fold for the nuclear region.
SG2 gels
Gels of the SG2 fractions demonstrated that there is an increase in phosphorylation levels
between the barrier and the nucleus, observed as an increase in the number of multiply
phosphorylated spots (i.e. spots 5-9) (Figure 3.7D-E; Table 3.1). The gel of the SG2 fraction
from the barrier displayed two phosphorylated spots; spot 5 (i.e. 0.3-fold) and spot 6 (i.e. 0.2fold the amount of protein compared to spot 3 from the same gel) (Figure 3.7D; Table 3.1).
The gel of the SG2 fraction from the nucleus displayed an increase in multiply
phosphorylated species compared to both the nuclear control gel (Figure 3.7C) and the SG2
gel from the barrier (Figure 3.7D) as evidenced by an increase in the number of negativelycharged spots (spots 5-9). These had 0.5-fold (spot 5), 0.4-fold (spot 6), 0.4-fold (spot 7), 0.2fold (spot 8) and 0.1-fold (spot 9) the amount of protein compared to spot 3 from the same
gel respectively (Figure 3.7E; Table 3.1). The amounts of spot 2 (i.e. an unphosphorylated
isoform of αB observed in the gels), decreased in the SG2 gel from the nucleus compared to
the SG2 gel from the barrier (Figure 3.7D-E; Table 3.1) (i.e. 0.8-fold for the barrier and 0.678
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fold the amount of protein compared to from spot 3 from the same gel for the nucleus)
(Figure 3.7D-E; Table 3.1). This relative decrease in this unphosphorylated αB could be
explained by either the presence of additional modifications that affect pI or an increase in
the relative amount of phosphorylated αB in the sample. Spots corresponding to truncated
forms of αA were present, predominantly on the nuclear gel. However, the spots were not
sufficiently resolved to allow for densitometric analysis.
SG3 gels
All gels of SG3 fractions (i.e. cortical, barrier and nucleus) displayed the maximum number
of spots observed amongst the gels (i.e. spots 4-9) (Figure 3.7F-H; Table 3.1) indicating
higher levels of αB phosphorylation compared to SG2 and SG5 fractions as well as whole
lens homogenates. The relative amounts for spots 4 and 6-8 decreased slightly from the
cortex towards the nucleus for the SG3 fraction (i.e. decreased from 0.6-fold, 0.6-fold, 0.3fold and 0.3-fold in the cortex to 0.5-fold, 0.3-fold, 0.2-fold and 0.2-fold in the nucleus
respectively) (Figure 3.7F-H; Table 3.1). The relative amounts of spots 5 and 9 remained
consistent in SG3 from the cortex and nucleus (0.3-fold and 0.2-fold the amount of protein
compared to spot 3 from the same gel) (Figure 3.7F-H; Table 3.1). Relative amounts of spot 2
decreased in SG3 between the cortex and the nucleus (i.e. 1.3-fold in the cortex to 0.4-fold in
the nucleus) (Figure 3.7F-H; Table 3.1). Spot 1 was only present in SG3 from the cortex
(Figure 3.7F) and the barrier (Figure 3.7G) (0.3-fold and 0.2-fold the amount of protein
compared to spot 3 from each gel). Spots corresponding to truncated forms of αA were
present on gels from each region (Figure 3.7F-H, indicated by boxed area). However, the
spots were not sufficiently resolved to allow for densitometric analysis.SG5 gels
Gels of SG5 fractions demonstrated a gradual decrease in αB phosphorylation levels towards
the nucleus, as evidenced by a decrease in the number and relative amounts of spots (Figure
3.7I-K; Table 3.1). The SG5 gel from the cortex displayed three spots corresponding to
phosphorylated αB isoforms i.e. spots 4-6, each having 0.5-fold the amount of protein
compared to spot 3 from the same gel (Figure 3.7I; Table 3.1). Relative amounts for spots 4
and 6 were similar to relative amounts of the corresponding spots on the cortical control
(Figure 3.7A; Table 3.1). Spot 5 however was not present on the cortical control gel,
indicating higher levels of αB phosphorylation in cortical SG5 compared to cortical
homogenate (Figure 3.7A, I; Table 3.1). The SG5 gel from the barrier displayed a single spot
corresponding to a phosphorylated αB isoform (i.e. spot 4, having 0.6-fold the amount of
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protein compared to spot 3 from the same gel) (Figure 3.7J; Table 3.1), indicating levels of
αB phosphorylation had decreased compared to the levels in the barrier control (Figure 3.7B).
The SG5 gel from the nucleus also only displayed spot 4, the relative amount of which had
decreased to 0.3-fold the amount of protein compared to spot 3 from the same gel (Figure
3.7K; Table 3.1). The relative amounts of spot 2 increased in SG5 between the cortex and the
nucleus (i.e. from 0.5-fold in the cortex to 0.7-fold in the nucleus) (Figure 3.7I-K; Table 3.1).
However, these amounts remained below those observed for spot 2 in the corresponding
control gels (Table 3.1).
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Figure 3.7: Comparison of phosphorylated isoforms of αB in SG fractions from
different regions of human lenses. SG2 (D-E) and SG3(F-H) isolated from each region (i.e.
cortex, barrier and nucleus) of a 77 year-old human lens, and SG5 (I-K) isolated from each
region of a 41 year-old human lens were separated using 2D SDS-PAGE. Tissue homogenate
from each region of a 53 year-old lens was separated using 2D SDS-PAGE without prior
sucrose density gradient centrifugation for use as a total protein control (A-C). Spot identities
for αA and αB were confirmed by MS, and spots corresponding to αB were labelled 1-9. The
regions of the gels corresponding to the acidic (+) and basic (-) region of the IEF strip used in
the first dimension separation are as indicated. Spots consistent with truncated αA are
indicated by boxed region. Samples which could not be analysed due to low yield are
indicated by “ND”.
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Table 3.1: Relative amounts of αB isoforms in SG fractions from different regions of human lenses. The intensity of αB spots (labelled 1-9;
see Figure 3.7) detected in SG2, SG3 (77 year-old lens), SG5 (41 year-old lens) fractions and the control sample (53 year-old lens) from each
region of the lens was measured using densitometry and the relative amount calculated as a proportion of spot 3 (corresponding to unmodified
αB) from each corresponding gel. Pink shading indicates spots corresponding to unphosphorylated αB isoforms and blue shading indicates spots
corresponding to phosphorylated αB isoforms. Samples which could not be analysed due to low yield are indicated by “ND”.

Control
SG2
SG3
SG5

Cortex
1
2
0
1.5
ND ND
.3
1.3
0
.5

3
1
ND
1
1

4
.5
ND
.6
.5

5
0
ND
.3
.5

6
.5
ND
.6
.5

7
0
ND
.3
0

8
0
ND
.3
0

9
0
ND
.2
0

Barrier
1 2
0 .8
0 .8
.2 .8
0 .5

3
1
1
1
1

4
.5
0
.5
.6

5
0
.3
.4
0

6
.3
.2
.5
0

7
0
0
.3
0

8
0
0
.3
0

9
0
0
.2
0

Nucleus
1 2 3
0 1 1
0 .6 1
0 .4 1
0 .7 1

4
0
0
.5
.3

5
.9
.5
.3
0

6
0
.4
.3
0

7
0
.4
.2
0

8
0
.2
.2
0

9
0
.1
.2
0
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Comparison of phosphorylated αB in SG2 as a function of age
To compare phosphorylation profiles of membrane associated αB across three lenses of
different ages, the same 2D gels of the SG2 fraction from the 77 year-old lens were compared
to gels of the SG2 fractions isolated from two younger human lenses (aged 41 and 62 years)
that had been separated using 2D SDS PAGE. Analysis of the 41 year-old barrier and 77
year-old cortical region was not performed due to insufficient amount of protein in these
samples.
The gels of the cortex and nucleus of the 41 year-old lens both displayed four spots
corresponding to phosphorylated αB isoforms; spots 4-8 (Figure 3.8A-B; Table 3.2). The
relative amounts of these spots varied between the nucleus and cortex of the 41 year-old lens.
Relative amounts of spots 6 and 8 were decreased in the nucleus compared to the cortex (0.4fold and 0.2-fold in the nucleus compared to 0.7-fold and 0.3-fold in the cortex respectively)
(Figure 3.8; Table 3.2). Spot 4 was only present in the cortical sample from the 41 year-old
lens, having 0.5-fold the amount of protein compared to spot 3 from the same gel (Figure
3.8A; Table 3.2). The relative amounts of spots 5 and 7 were increased in the nucleus
compared to the cortex for the 41 year-old lens (0.7-fold and 0.4-fold in the nucleus
compared to 0.5-fold and 0.2-fold in the cortex respectively) (Figure 3.8A-B; Table 3.2).
Relative amounts of spot 2 (i.e. corresponding to an unphosphorylated αB isoform) were
slightly decreased in the nucleus compared to the cortex for the 41 year-old lens (0.8-fold in
the nucleus compared to 0.9-fold in the cortex) (Figure 3.8A-B; Table 3.2).
62 year-old lens
The number and relative amounts of spots corresponding to phosphorylated αB isotypes
decreased towards the nucleus in the 62 year-old lens (Figure 3.8C-E; Table 3.2). The cortical
gel displayed three spots corresponding to phosphorylated αB isoforms i.e. spots 4-7 (Figure
3.8C). Spots 4-6 had 0.4-fold and spot 7 had 0.3-fold the amount of protein compared to spot
3 from the same gel (Figure 3.8C; Table 3.2). The barrier gel from the 62 year-old lens
displayed two spots corresponding to phosphorylated αB isoforms i.e. spots 5 and 6 (Figure
3.8D; Table 3.2). Spot 5 had 0.6-fold and spot 5 had 0.4-fold the amount of protein compared
to spot 3 from the same gel (Figure 3.8D; Table 3.2). The nuclear gel from the 62 year-old
lens displayed a single spot corresponding to a phosphorylated αB isoform, spot 5 which had
0.2-fold the amount of protein compared to spot 3 from the same gel (Figure 3.8E; Table 3.2).
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The relative amount of spot 2 decreased towards the nucleus in the 62 year-old lens (0.5-fold
in the nucleus compared to 0.8-fold in the cortex) (Figure 3.8C-E; Table 3.2).
77 year-old lens
The number and relative amounts of spots corresponding to phosphorylated αB isoforms
increased towards the nucleus in the 77 year-old lens (Figure 3.8F-G; Table 3.2). The barrier
gel from the 77 year-old lens displayed two spots corresponding to phosphorylated αB
isoforms, spots 5 and 6 having 0.3-fold and 0.2-fold the amount of protein compared to spot 3
from the same gel respectively (Figure 3.8F; Table 3.2). The nuclear gel from the 77 year-old
lens displayed five spots corresponding to phosphorylated αB isoforms, spots 5-9 having 0.5fold, 0.4-fold, 0.4-fold, 0.2-fold and 0.1-fold the amount of protein compared to spot 3 from
the same gel respectively (Figure 3.8G; Table 3.2). The relative amount of spot 2 decreased
between the barrier and the nucleus of the 77 year-old lens (0.8-fold in the cortex compared
to 0.6-fold in the nucleus) (Figure 3.8F-G; Table 3.2).
Spots corresponding to truncated forms of αA were present on gels for each lens (Figure 3.8).
However, the spots were not sufficiently resolved to allow for densitometric analysis.
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Figure 3.8: Comparison of phosphorylated isoforms of αB in SG2 from different regions
of human lenses with age. SG2 from each region of a 41 year-old (A-B), 62 year-old (C-E)
and 77 year-old (F-G) human lens was separated using 2D SDS-PAGE. Spots corresponding
to αB were identified and labelled 1-9. The regions of the gels corresponding to the acidic (+)
and basic (-) region of the IEF strip used in the first dimension separation are as indicated.
Spots consistent with truncated αA are indicated by boxed region. Analysis of SG2 from the
barrier of the 41 year-old lens and SG2 from the cortex of the 77 year-old lens was not
performed due to insufficient protein yields. Samples for which analysis could not be
performed due to low yield are indicated by “ND”. Note: panels D and E from Figure 3.7 are
shown here as panels F and G for comparison against other lenses.
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Table 3.2: Relative amounts of αB isoforms from SG2 as a function of age. The intensity of αB spots (labelled 1-9; see Figure 3.8) detected
in SG2 from each region of a 41 year-old, 62 year-old and 77 year-old lens was measured using densitometry and the relative amount calculated
as a proportion of spot 3 (corresponding to unmodified αB) from each corresponding gel. Pink shading indicates spots corresponding to
unphosphorylated αB isoforms and blue shading indicates spots corresponding to phosphorylated αB isoforms. Spots for which not enough
protein was isolated for analysis are indicated by “ND”.

41
62
77

Cortex
1
2
0
.9
0
.8
ND ND

3
1
1
ND

4
.5
.4
ND

5
.5
.4
ND

6
.7
.4
ND

7
.2
.3
ND

8
.3
0
ND

9
0
0
ND

Barrier
1
2
ND ND
0
.7
0
.8

3
ND
1
1

4
ND
0
0

5
ND
.6
.3

6
ND
.3
.2

7
ND
0
0

8
ND
0
0

9
ND
0
0

Nucleus
1 2 3
0 .8 1
0 .5 1
0 .6 1

4
0
0
0

5
.7
.2
.5

6
.4
0
.4

7
.4
0
.4

8
.2
0
.2

9
0
0
.1
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3.3.3 Modified filensin and crystallins form complexes
Protein from the SG3 fraction from the cortex of the 77 year-old lens was isolated and
separated by 2D-SDS-PAGE. A cluster of negatively charged proteins were observed in this
fraction, ranging in size from ~40-95 kDa (red boxed zone and expansion, Figure 3.9A).
Although most prominent in this gel, similar but fainter spots were also observed in the
barrier and nuclear gels from the same lens (Figure 3.7), and on cortical SG2 gels from a 41
and a 62 year-old lens (Figure 3.8). Discrete spots were excised and submitted for MS/MS
analysis to determine the composition and modification profile of each. A total of ten spots
were analysed and labelled complex 1-10 according to decreasing mass. The proportion of
filensin deamidated at each site (as a %) was calculated based on relative peak area for
complexes where filensin was the predominant protein (Table 3.3, Figure 3.10). A
comprehensive list of identified peptides and modified residues is available in Appendix 3.
With the exception of complex 3, based on the number of tryptic peptides, all spots were
predominately (>60%) composed of peptides derived from filensin (~75 kDa), with lower
amounts of peptides derived from αA (~20 kDa), αB (~20 kDa), βB1 (~28 kDa), phakinin
(~46 kDa), serum albumin (~ 69 kDa), retinol dehydrogenase (~55 kDa) and actin,
cytoplasmic 1 (~42 kDa) (Figure 3.9B). Complex 1 resolved as a discrete spot of ~95 kDa
with a pI of ~4.5 (Figure 3.9A), and was found to be composed of peptides derived from
filensin (83%), phakinin (7%) and αA (4%) (Figure 3.9B). From complex 1, four sites of
filensin deamidation (N383, N478, N145 and N304) and two of oxidation (M649 and M207)
were identified (Figure 3.9A). The proportion of filensin peptides deamidated at N478, N145
and N304 was calculated from the peak areas from the ion chromatograms (Figure 3.10) and
found to be 25.2%, 7% and 42.2% respectively (Table 3.3). For N383, only the deamidated
peptide was detected in complex 1 (Table 3.3).
Complex 2 resolved as a discrete spot of ~60 kDa with a pI of ~5 (Figure 3.9A), and was
shown to be composed of peptides derived from filensin (74%), phakinin (5%), αA (3%),
βB1 (6%), retinal dehydrogenase (4%) and αB (5%) (Figure 3.9B). From complex 2, a single
site of filensin oxidation (M207), and five of deamidation (N155, N145, N304, N383, N268)
were identified, as well as a single αB oxidation (M68) site (Figure 3.9A). The proportion of
filensin peptides deamidated at residues N155 and N304 was 3.8% and 34.7% respectively
(Table 3.3). The peptide containing both N145 and N155 had a percent deamidation of 12.4%
(Table 3.3). For N383, only the deamidated peptide was detected in complex 2 (Table 3.3).
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Complex 3 resolved as a discrete spot of ~55 kDa with a pI of ~4 (Figure 3.9A), and had a
unique protein profile predominantly composed of peptides derived from brain acidic soluble
protein 1 (BASP1, 54%), with lower amounts of filensin (22%), phakinin (9%), αA (4%),
serum albumin (6%) and αB (4%) (Figure 3.9B). From complex 3, a single site of filensin
oxidation (M649) was identified, as well as single site of BASP 1 deamidation (N218)
(Figure 3.9A).
Complexes 4-9 resolved as a cluster of spots with similar mass (~45 kDa) and pIs ranging
from 5.8 -6 (Figure 3.9A). Complex 4 had a pI of ~6.2 (Figure 3.3.9A) and was composed of
peptides derived from filensin (86%), αA (2%), βB1 (6%) and αB (2%) (Figure 3.9B). From
complex 4, a single αB deamidation site (N146) was identified, as well as four deamidation
(N268, N304, N145 and N155) and a single oxidation (M207) site from filensin (Figure
3.9A). The proportion of filensin peptides deamidated at N155 and N304 was 3.5% and
29.2% respectively (Table 3.3). The peptide containing both N145 and N155 was deamidated
2.5% (Table 3.3).
Complex 5 had a pI of ~6 (Figure 3.9A) and was shown to be composed of peptides derived
from filensin (85%), αA (3%), βB1 (5%) and αB (3%) (Figure 3.9B). From complex 5, three
sites of filensin deamidation (N304, N145 and N155) and a single site of oxidation (M207)
was identified (Figure 3.9A). The proportion of filensin peptides deamidated at N155 and
N304 was 3.8% and 56% respectively (Table 3.3). The peptide containing both N145 and
N155 was deamidated 2.8% (Table 3.3).
Complex 6 had a pI of 5.9 (Figure 3.9A) and was shown to be composed of peptides derived
from filensin (80%), αA (4%), serum albumin (4%), βB1 (5%) and αB (4%) (Figure 3.9B).
From complex 6, a single site of αB deamidation (N146) was identified, as well as four sites
of deamidation (N318, N304, N145 and N155) and a single site of oxidation (M207) from
filensin (Figure 3.9A). The proportion of filensin peptides deamidated at N155 and N304 was
3.5% and 59.4% respectively (Table 3.3). The peptide containing both N145 and N155 was
deamidated 2.7% (Table 3.3). For N318, only the deamidated peptide was detected (Table
3.3).
Complex 7 had a pI of ~5.8 (Figure 3.9A) and was shown to be composed of peptides
derived from filensin (78%), αA (3%), serum albumin (5%), βB1 (5%) and αB (5%) (Figure
3.9B). From complex 7, a single site of αB deamidation (N146) was identified, as well as
three sites of deamidation (N304, N145 and N155) and as a single site of oxidation (M207)
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from filensin (Figure 3.9A). The proportion of filensin peptides deamidated at N155 and
N304 was 3.5% and 56.7% respectively (Table 3.3). The peptide containing both N145 and
N155 was deamidated 2.9% (Table 3.3).
Complexes 8-9 were shown to have a slightly lower mass than complexes 4-7 (~42 kDa),
while having pIs similar to complex 6 and complex 7 respectively (~5.8 – 5.9) (Figure 3.9A).
Complex 8 was shown to be composed of peptides derived from filensin (83%), αA (4%),
βB2 (5%) and αB (5%) (Figure 3.9B). From complex 8, a single site of αB deamidation
(M146) was identified, as well as four sites of deamidation (N155, N145, N304 and N318)
and a single site of oxidation (M207) from filensin (Figure 3.9A). The proportion of filensin
peptides deamidated at N155 and N304 was 3.7% and 42.3% respectively (Table 3.3). The
peptide containing both N145 and N155 was deamidated 3.4% (Table 3.3). For N318, only
the deamidated peptide was detected (Table 3.3).
Complex 9 was shown to be composed of peptides derived from filensin (71%), phakinin
(2%), αA (5%), βB1 (9%) and αB (8%) (Figure 3.9B). From complex 9, five sites of filensin
deamidation (N145, N155, N478, N304 and N268) were identified, as well as two sites of
deamidation (N78 and N146) and single site of oxidation (M68) from αB (Figure 3.9A). The
proportion of filensin peptides deamidated at N155 and N304 was 5.3% and 44.2%
respectively (Table 3.3). The peptide containing both N145 and N155 was deamidated 3.3%
(Table 3.3). For N478, only the deamidated peptide was detected (Table 3.3).
Complex 10 resolved as a discrete spot of ~40 kDa with a pI of ~4 (Figure 3.9A), and was
shown to be composed of peptides derived from filensin (60%), phakinin (14%), αA (6%)
and actin, cytoplasmic 1 (10%) (Figure 3.9B). From complex 10, two sites of filensin
deamidation (N478 and N304) and two sites of phosphorylation (S488 and T450) were
identified (Figure 3.9A). The proportion of filensin peptides deamidated at N155, N304 and
N478 was calculated at 2%, 66.8% and 71.2% respectively (Table 3.3).
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Figure 3.9: Identification of proteins and modified residues from protein complexes in
the SG3 fraction from the cortex of the 77 year-old human lens. Discrete spots (labelled
1-10; inset) were excised from the gel of the SG3 fraction from the cortex of the 77 year-old
lens (Figure 3.3.7), digested with trypsin and characterised using MS/MS. (B) Proteins that
constituted ≥2% of the total peptide hits were identified for each spot by comparison with a
peptide database. (A) Modified residues within each spot were identified for filensin (in
black), αB (in red) and brain acid soluble protein 1 (BASP 1) (in green).
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Table 3.3: Deamidation of filensin in crosslinked complexes (see Figure 3.9). The
proportion of filensin deamidated in each 2D gel spot following tryptic digestion and analysis
of peptides. Values are expressed as the amount of deamidated peptide as a proportion of the
total amount of that peptide (i.e. deamidated + and non-deamidated peptide), calculated using
the relative peak areas from the ion chromatograms of the mass spectra. Residues located in
regions of the protein not included within the sequence coverage (i.e. cleaved regions) are
indicated by a dash. Peptides that were not detected are indicated with (ND). Residues
located within the same tryptic peptide are indicated with an asterisk.
Complex N145*
1
7%
2
4
5
6
7
8
9
10

N155
0%
3.8%
3.5%
3.8%
3.5%
3.5%
3.7%
5.3%
2%

N145/N155*
12.4%
2.5%
2.8%
2.7%
2.9%
3.4%
3.3%
0%

N304 N318
42.2% n.d.
34.7% 0%
29.2% 0%
56%
0%
59.4% 100%
56.7% ND
42.3% 100%
44.2% ND
66.8% ND

N383
100%
100%
ND
ND

N478
25.2%
100%
71.2%

Figure 3.10: Ion chromatogram of filensin tryptic peptide 294-308 of mass 1726.9 Da.
Ion chromatograms were integrated for each precursor peptide containing a deamidation site
to calculate peak area for the (A) non-deamidated and (B) deamidated peptide. Relative peak
area for each deamidated peptide was calculated as a proportion of total amount of peptide
(i.e.deamidated + non-deamidated peptide) to calculate the percent deamidation at each site.
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3.4 Discussion

3.4.1 Substitution of Asp at Ser19, Ser45 and S59 of αB increases chaperone activity in a
cumulative manner.
The results of this work demonstrate that at a 1αB:1CPK molar ratio, WT αB significantly
increased aggregation of CPK (Figure 3.1A; Figure 3.2A), however this isoform suppressed
aggregation when CPK was present in excess (i.e. 1αB:2CPK or 1αB:4CPK). Furthermore, the
activity of αB and its ability to suppress aggregation was increased by the mutations that
mimic phosphorylation (Figure 3.1). Although a trend of increased activity with an
increasing number of mutations that mimic phsophorylation was observed, the only
statistically significant results obtained were for the double and triple αB phosphomutants
(i.e. 2P and 3P) (Figure 3.1). While the presence of 2P at a 1αB:1CPK molar ratio was able to
inhibit aggregation of CPK by 41.9%, the addition of an extra negative charge (i.e. 3P) led to
an 83.9% inhibition of CPK aggregation (Figure 3.1B). Additionally, 3P was the only
phosphomutant to significantly suppress aggregation of CPK at a 1αB:1CPK molar ratio (Figure
3.1A). It has been postulated that multiple aspartate substitutions may induce hyperactivity of
αB and that this leads to co-aggregation of the substrate and the chaperone protein under
certain conditions (Aquilina et al., 2004). However, Ecroyd et al. (2007) demonstrated that
the use of buffer systems containing ammonium ions (e.g. ammonium acetate) has the ability
to destabilize 3P αB, leading to co-precipitation with the substrate (although this effect is
ameliorated by increases in pH). Furthermore, the addition of mutations that mimic
phosphorylation and destabilization of substrate proteins have both been shown to increase
αB substrate affinity (Koteiche and Mchaourab, 2003). Studies of an ∆41-58 αB mutant (a
mutant form of αB where residues 41-58 have been deleted) have shown that its ability to
prevent the heat-induced aggregation of fully unfolded citrate synthase is reduced compared
to WTαB, however, its activity is comparable to WTαB in regards to inhibiting the
aggregation of partially unfolded βL-crystallin and alcohol dehydrogenase (Ghosh et al.,
2006). This may explain why some studies, such as that by Aquilina et al. (2004), have
reported co-precipitation of αB phosphomimics with substrate proteins, i.e. destabilization of
the chaperone and/or substrate increased the affinity of the interaction to the point that both
proteins co-precipitate from solution.
The results of this study are consistent with previous reports that αB phosphomimics are
more efficient than WTαB at protecting against stress-induced protein aggregation (Ghosh et
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al., 2006; Ecroyd et al., 2007; Ahmad et al., 2008). As αB remains stable in the buffer system
used for this study (i.e. PBS, pH 7.4) (Ecroyd et al., 2007), it appears that the presence of
mutations that mimic phosphorylation increase the chaperone activity of αB without inducing
hyperactivity (Figure 3.1). These results do confirm however that αB can induce the
aggregation of substrate proteins when the chaperone activity is reduced, suggesting that
phosphorylation-induced increases in αB activity may be pivotal for maintaining cellular
homeostasis in the lens.
To confirm that an increase in chaperone activity was the cumulative effect of multiple
mutations that mimic phosphorylation and not the result of a particular single mutation, the
chaperone activity of αB with single serine-to-aspartate mutations at Ser19, Ser45 and Ser59
were compared (Figure 3.2). No αB isoform with a single mutation to mimic phosphorylation
was able to significantly reduce the aggregation of CPK compared to WTαB (Figure 3.2).
This is consistent with the previous finding that αB isoforms with a single mutation to mimic
phosphorylation have similar activity to WTαB (Aquilina et al., 2004). Moreover, these
results demonstrate that the significant increase in chaperone activity observed for 2P and 3P
(Figure 3.1) is due to the cumulative effect of multiple serine-to-aspartate substitutions,
suggesting that multiple phosphorylation events may be required in situ to enhance the
chaperone activity of αB.

3.4.2 Loss of soluble αA and αB may involve phosphorylation
It is important to note that it has previously been shown that lens proteins are already heavily
modified by early adulthood (Lampi et al., 1998), therefore feotal lenses would have
provided a more suitable control for this study. Unfortunately, feotal lenses were unavailable
for use, therefore lenses that covered the age when barrier and cataract formation occur (41–
77 years) were used.
Previous studies have reported that α-crystallin binds to fibre cell membranes with age,
forming high density fractions that can be isolated using density sucrose centrifugation
(Friedrich and Truscott, 2009; Friedrich and Truscott, 2010). The density profiles of this
work support these findings, i.e. there is a loss of low density soluble protein coupled with an
increase in high density membrane associated protein with age (Figure 3.3). This was further
validated by 1D SDS PAGE, where the relative amount of bands corresponding to
monomeric αA and αB (i.e. corresponding to a band of 20 kDa, labeled ‘αA’ and ‘αB’ as the
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bands were not definitively identified by MS analysis) decreased in the high density samples
(i.e. SG2 and SG3) from the cortex concomitant with the appearance of bands of ~40 kDa,
~55 kDa and ~100 kDa compared to the lowest density sample (i.e. SG6) (Figure 3.4). Spots
with similar masses were resolved following 2D SDS PAGE of the cortical SG3 fraction, and
were found to contain, among other proteins, αA and αB (Figure 3.9). This suggests that the
loss of αA and αB in the cortex is a consequence of their incorporation into soluble higher
molecular weight complexes. Furthermore, the relative amount of αA and αB (i.e. amount of
monomeric αA and αB compared to the total protein) was decreased in nuclear SG fractions
compared to cortical SG fractions (Figure 3.4). As this loss was concomitant with an increase
in protein smearing that was immunoreactive to αB (Figure 3.5), this suggests that loss of αA
and αB in the nucleus may be due to insolubilisation events. This is consistent with αA and
αB forming soluble complexes with substrate proteins in the cortex, which later become
insoluble in the nucleus. Similar to previous reports (Friedrich and Truscott, 2009; Friedrich
and Truscott, 2010), αA and αB were shown to be the predominant protein species in the high
density fractions i.e. SG2 and SG3 (Figure 3.4). The loss of αA or αB, whether via
incorporation into complexes (i.e. in the cortex) or insolubilisation (i.e. in the nucleus)
(Figure 3.4), could then potentially render the resident proteins susceptible to insolubilisation.
This is supported by a recent report that showed a negative correlation between free αcrystallin levels (i.e. α-crystallin not involved in HMWCs) and the prevalence and
progression of nuclear cataract (Datiles III et al., 2016), suggesting that free α-crystallin loss
is a phenomenon that precedes cataract in aged but otherwise healthy lenses.
When pSer19, pSer45 and pSer59 αB levels were compared across density fractions and lens
regions (Figure 3.5), it was shown that pSer19 and pSer45 were elevated in low density
fractions (i.e. SG5) compared to high density fractions. As this soluble state may allow higher
levels of activity and substrate accessibility, it is proposed that this reflects a physiological
role for these isoforms in vivo. A similar preference (i.e. increased levels in SG5) was shown
for pSer59 αB in cortical tissue. However, pSer59 αB was elevated in high density fractions
(i.e. SG2) compared to low density fractions in nuclear tissue, suggesting that
phosphorylation at this site may be associated with membrane association in the nucleus. As
single serine-to-aspartate substitutions were found to be insufficient to significantly affect the
chaperone activity of αB (Figure 3.2), it remains unclear how the charge provided by a single
phosphorylated residue could so significantly affect the behaviour of αB in vivo. It is
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therefore likely that pSer59 works in conjunction with other phosphorylatable residues to
induce hyperactivity that could lead to αB membrane association.
This is supported by data from the 2D western blots (Figure 3.6) that indicated that, although
αB was more likely to be phosphorylated at Ser19 when overall phosphorylation levels were
low (i.e. 1-3 phosphorylated residues), pSer59 (and to a lesser extent pSer45) were present in
multiply phosphorylated species (i.e. 4-6 phosphorylated residues). This suggests that the
increased ability of pSer59 to alter the membrane association of αB is a product of its
tendency to be present in more multiply phosphorylated species. The reason why pSer59 and
pSer45 are more often associated with highly phosphorylated species of αB while pSer19 is
associated with lower overall phosphorylation levels is unclear. It is possible that
phosphorylation at Ser59 or Ser45 induces structural changes that make neighbouring sites
more susceptible to phosphorylation. For example, Ser59 has been shown to directly contact
the β3 region of the α-crystallin domain (Jehle et al., 2010) and mutations within the
neighbouring region of Ser59 (Trp60-Ser66) were shown to alter oligomeric size and subunit
exchange rates between αA and αB (Sreelakshmi and Sharma, 2005). Likewise, Ser45 is
located within a substrate recognition and subunit interaction site (i.e. Ser41-Pro58) (Ghosh
et al., 2005; Ghosh et al., 2006). It is therefore plausible that phosphorylation at Ser59 or
Ser45 may induce subunit dissociation, resulting in exposure of otherwise occluded residues,
increasing the likelihood of further phosphorylation events. As the number of
phosphorylation events increases, increased exposure of binding sites caused by alterations in
subunit exchange dynamics, may in turn increase chaperone activity of the protein (Ahmad et
al., 2008). As Ser19 lies within a substrate recognition site (Trp9-Pro20), but not a subunit
interaction site (Ghosh et al., 2005), it would be expected that this process would not apply to
phosphorylation at this residue. Furthermore, the comparatively low number of spots
corresponding to phosphorylated αB that reacted with anti-pSer19 antibody suggests that
phosphorylation at Ser19 occurs early and inhibits phosphorylation of other residues,
preventing the formation of multiply phosphorylated isoforms.
It was observed that the amount of multiply phosphorylated αB increased in higher density
fractions such that the predominant isoforms in SG2 had 2-4 phosphate groups (i.e. spots 2-4)
while only the monophosphorylated isoform (i.e. spot 4) was present in SG5 from the barrier
and nucleus (Figure 3.7; Table 3.1). This further implicates multiply phosphorylated αB
isoforms with the formation of high density and membrane-bound fractions. Additionally,
while the amount of multiply phosphorylated isoforms was decreased in the nucleus
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compared to the cortex for SG3 and SG5, multiply phosphorylated isoforms were increased
in the nucleus for SG2 (Figure 3.7; Table 3.1). A similar pattern was observed for pSer59,
which was elevated in the nuclear and barrier samples compared to the cortical sample for
SG2 while pSer19 and pSer45 were decreased (Figure 3.5). These results again suggest a link
between phosphorylation at Ser59, αB hyperphosphorylation, and in turn membrane binding.
Furthermore, the fact that the increased amount of multiply phosphorylated isoforms was
only observed in the nucleus of the 77 year-old lens (Figure 3.5) suggests that the switch to
pathogenicity is gradual and occurs at later stages of life.

3.4.3 Deamidation and oxidation of filensin may contribute to HMWC formation
Clusters of spots between ~40-95 kDa were observed within the acidic region of SG3 and
cortical SG2 2D gels (Figure 3.7; Figure 3.8). As their masses were similar to the ~40-100
kDa bands observed following 1D separation (Figure 3.4), it was inferred they represent these
species. The dominant protein species for each complex (with the exception of complex 3)
was filensin. Intact filensin has a mass of ~75 kDa and is known to undergo extensive
truncation in the lens (Sandilands, Prescott, Hutcheson, et al., 1995; Su, McArthur, Truscott,
et al., 2011), producing largely N-terminal fragments. As the mass of each of the complexes
(with the exception of complex 1) was below 75 kDa, filensin must be present as truncated
forms. No spot consistent with intact non-crosslinked filensin was present (Figure 3.9).
Sequence coverage of filensin from each spot suggests that filensin undergoes truncation at
both N- and C-termini, with filensin from complex 1 remaining the most intact (24-652)
(Figure 3.11A). Notably, complex 1 exceeds the mass expected mass for intact filensin.
Sequence coverage for complexes 3 and 10 suggests that filensin from these complexes
underwent further N-terminal truncation (78-652 and 78-630 respectively), while complexes
2 and 4-9 underwent further C-terminal truncation (24-411 for complex 2, 24-362 for
complexes 4-8 and 24-483 for complex 9). Others have reported cleavage of filensin in
HMWCs (Srivastava et al., 2004; Su, McArthur, Truscott, et al., 2011). The cleavage of
filensin reported here is not as extensive as that previously reported from similar HMWCs by
Srivastava et al. (2004). For this study, peptides were detected that covered the residues 24652 (Figure 3.11A). Srivastava et al. (2004) detected peptides from residues 79-239 of
filensin, suggesting more extensive truncation than that observed for this study, particularly at
the C-terminus.
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Compared to the number of peptides detected derived from filensin, fewer peptides derived
from αA were detected in each complex, and fewer peptides derived from αB (complexes 29) and phakinin (complexes 1-3 and 9-10) were detected in some complexes (Figure 3. 9).
These proteins are well documented to interact with filensin in lens fibre cells (Carter et al.,
1995; Djabali et al., 1997), where they assemble to form beaded-chain filaments at fibre cell
membranes (Goulielmos et al., 1996). Additionally, filensin is also known to act as a
substrate for αB following stress (Muchowski et al., 1999). The co-migration of αA and αB
with filensin despite having a much smaller mass (~20 kDa) than what was observed (i.e. 40
kDa), suggests that these proteins exist together as soluble, covalently crosslinked complexes
in the lens. Notably, the peptides matching to αA and αB were derived solely from the N- and
α-crystallin domains of the proteins, covering the residues 12-99 for αA (Figure 3.11A) and
12-146 for αB (Figure 3.11B). This suggests that αA and αB involved in these complexes
may also be N- and C-terminally truncated. This is consistent with the presence of spots
corresponding to truncated αA on 2D gels from the SG2 and SG3 fractions (Figure 3.7,
Figure 3.8). Sequence coverage of αA and αB also indicates that the proteins are further
truncated in some complexes. Sequence coverage of αA from complexes 1, 3 and 7 indicated
further C-terminal truncation (13-78, 13-65 and 13-88 respectively). Sequence coverage of
αB indicated further C-terminal truncation (12-103) from complex 5 as well as N- and Cterminal truncation (75-103) from complex 3. This suggests that interaction sites and
crosslinking regions for intermediate filaments lie within residues 13-65 for αA and 75-103
for αB.
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Figure 3.11: Sequence coverage of filensin. Sequence coverage of (A) filensin, (B) αA and
(C) αB precursor peptides following tryptic digestion. Regions detected are indicated by the
presence of coloured lines corresponding to each 2D spots from which the peptides were
obtained: spot 1 (dark green), spot 2 (red), spot 3 (purple), spot 4 (light blue), spot 5 (light
green), spot 6 (dark blue), spot 7 (orange), spot 8 (pink), spot 9 (grey) and spot 10 (brown).
Modified residues are highlighted in red. Boundaries of the head (1-40), rod (41-320) and tail
(321-665) domains of filensin, and the N- (1-60 and 1-64 respectively), ACD (61-160 and 65156 respectively) and C-terminal (161-173 and 157-175 respectively) domains of αA and αB
are marked with arrows.
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Low levels of actin (complex 10), serum albumin (complex 3 and complexes 6-7), retinal
dehydrogenase (complex 2) and βB1-crystallin (complex 2 and complexes 4-9) were also
observed in some complexes (Figure 3.9B). To our knowledge, these proteins have not been
previously reported to associate with filensin. Complex 3 is unusual in that BASP 1, not
filensin, was the major component (Figure 3.9). BASP 1 is a membrane protein that has been
detected in the brain (Mosevitsky, 2005), axonal termini, testis, kidney, spleen, thymus
(Mosevitsky et al., 1997) and, more recently, in the lens (Bagchi et al., 2008; Truscott et al.,
2011). In the lens, BASP 1 is most abundant in the cortex, where it has been suggested to be
involved in membrane deformation and the formation ball and socket joints (Wenke et al.,
2016). Although it has a reported mass of ~23 kDa (Mosevitsky et al., 1997), in this study it
migrated to a distance corresponding to a protein of α55 kDa (Figure 3.9). Although this may
indicate crosslinking of the protein, BASP 1 has been reported to show retarded migration
patterns on SDS PAGE gels caused by interactions with non-ionic detergents (Mosevitsky et
al., 1997). The abnormal migration pattern of BASP 1 in this study is therefore unlikely to be
caused exclusively by protein crosslinking. The presence of these complexes in a high density
fraction (i.e. SG3), and the high levels of membrane associated proteins (i.e. filensin,
phakinin, actin and BASP1), suggests that the spots may be derived from soluble HMWCs
that had localised at fibre cell membranes (Chandrasekher and Cenedella, 1997; Cobb and
Petrash, 2002b; Friedrich and Truscott, 2009).
High molecular weight complexes have been reported in lens extracts previously, occurring
from a young age (Srivastava et al., 2004; Su, McArthur, Truscott, et al., 2011) and
increasing in abundance and complexity with age (Srivastava et al., 2004). Su et al.(2011)
reported complexes composed exclusively of crosslinked crystallin proteins in the watersoluble fraction of human lenses. Previously, Srivastava et al. (2004) reported complexes in
the urea-soluble fractions of human lenses formed by crystallin proteins, predominantly αA,
along with lower levels of intermediate filament proteins. As intermediate filaments were
only detected in complexes from lenses over 25 years of age, it was suggested that the
incorporation of intermediate filaments into such complexes is age-related (Srivastava et al.,
2004). In contrast, this study reports filensin as the predominant protein component of
crosslinked complexes, with lower levels of αA (Figure 3.9). However, as Srivastava et al.
(2004) were unable to resolve discrete HMW spots in lenses older than 41 years-old, it is
possible that the increased incorporation of filensin reported here is a continuation of this
age-related process. Srivastava et al. (2004) also identified modifications to αA, including C100
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terminal truncation, oxidation, conversion of serine to DHA and formylation, suggesting that
modified αA (particularly oxidised and DHA-containing αA) contributes to the formation of
HMWCs by mediating crosslink formation (Srivastava et al., 2004). In the current study, no
modifications to αA were identified (Appendix 3). However, filensin was observed to be
heavily deamidated (Figure 3.9), suggesting that modified filensin (particularly deamidated
filensin) may be more highly involved in complex formation. It is important to note that a
limitation of 2D SDS PAGE analysis is bias regarding which proteins are able to penetrate
the different dimensions of the gel. Although the effect of this is perhaps ameliorated by the
fact the complexes appear crosslinked, it is possible that proteins exist as part of these
complexes in situ that were not able to be detected.
There have been few reports of how filensin is modified in human lenses. Wilmarth et al.
(2006) reported extensive deamidation (i.e. 23 sites), as well as a single phosphorylation site
(S5), two sites of pyroglutamic acid formation (Q71 and Q294) and five sites of
carbamylation (V51, L144, E230, Q294 and S607). Su et al. (2011) observed truncation of
filensin, reporting products of 60 kDa, 53 kDa, 43 kDa and 24 kDa, predominantly in urea
soluble fractions. In the current study, seven previously identified sites of deamidation were
observed (N145, N155, N304, N318, N383, N478) as well as a previously unreported site,
N268 (Figure 3.9A). The most abundant site of deamidation was N304, with between 29.266.8% of this residue deamidated in the complexes studied in this work (Table 3.3). Whilst
the high degree of deamidation at this site suggests that deamidation at this residue is
involved in complex formation, the degree of deamidation did not directly correlate with the
size of the complex, i.e. the amount of deamidation did not increase correspondingly with the
mass of the complex (Figure 3.9, Table 3.3). Residue N304 lies within the rod domain of the
protein (Hess et al., 1998), a region of intermediate filament proteins are highly conserved
and predominantly composed of α-helices (Hess et al., 1998). As deamidation typically
requires a high level of conformational flexibility to occur (Paranandi et al., 1994; Kosky et
al., 1999; Hooi et al., 2012; Truscott and Friedrich, 2016), the high degree of deamidation in
this region may suggest that filensin is, at least partially, unfolded in the lens. Other filensin
residues with a high degree of deamidation were N383 (100%) and N478 (25.2-100%) (Table
3.3), both of which are positioned within the tail domain of the protein. Although having a
high proportion of these residues deamidated when present in complexes, including those
with a higher molecular mass (i.e. complexes 1 and 2), N383 and N478 were often not
detected in the complexes. This is most likely due to C-terminal truncation of filensin.
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Deamidation at N318 was only detected in filensin from complexes 6 and 8, although in these
complexes it was always deamidated (100%) (Table 3.3). Spots 6 and 8 co-migrated in the
first dimension on the 2D gel, but were separated in the second dimension, demonstrating that
they differ in mass (Figure 3.9A). This suggests they correspond to truncated forms of the
same isotype. However, as the sequence coverage was identical for both following tryptic
digestion, it cannot be determined where the truncation site is located. Additionally, as the
mass of these complexes does not vary substantially from the other complexes identified in
which N318 was not deamidated (i.e. complexes 4-5, 7 and 9), it is unclear how this residue
is involved in complex formation. With regards to residues N145 and N155, these were often
located on the same peptide, which made it difficult to determine the exact site of
deamidation. However, as the proportion of deamidation was consistently low for this peptide
in each complex (Figure 3.3), it is unlikely that deamidation at these two residues plays an
important role in complex formation.
Notably, in a previous study, 14 of the deamidation sites identified were found to be at
glutamine residues (Wilmarth et al., 2006). This is unusual as asparagine residues are known
to be deamidated much more readily than glutamine residues due to energetic stability of the
succinimide intermediate compared to the glutaminide intermediate (Wright, 1991; Robinson,
2002; Robinson and Robinson, 2004a; Hains and Truscott, 2010). This may suggest that
filensin has a tertiary structure that favours glutamine deamidation. However, in contrast, in
this work there was a strong preference towards deamidation of asparagine residues (Figure
3.9A). This is in accordance with previous research that indicated that asparagine residues of
αB undergo deamidation at 3-fold the rate of glutamine residues in aged human lenses (Hains
and Truscott, 2010). However, the possibility that deamidated asparagine residues were more
readily detected than glutamine by the selected treatment and analysis procedure cannot be
excluded. A slight preference was shown for deamidation of residues within the rod domain
of the protein, with 5 of the 8 potential deamidation sites being found to be deamidated in this
work compared to 2 of the 4 potential deamidation sites in the tail domain being observed.
Interestingly, no deamidation was detected in the head domain of filensin, although this is
likely to be due to the absence of asparagine residues in this region, in addition to N-terminal
truncation (Figure 3.11A).
The rod domain of filensin, together with phakinin form the beaded-chain filament, localising
at fibre cell membranes in the outer cortex before becoming distributed in the cytoplasm in
the inner cortex, while the tail domain remains localised at the membrane (Sandilands,
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Prescott, Carter, et al., 1995; Oka et al., 2008). As deamidation is able to induce structural
changes including partial protein unfolding (Kim et al., 2002; Flaugh et al., 2006; Hains and
Truscott, 2010; Lampi et al., 2014; Soulby et al., 2015; Takata and Fujii, 2015), it is possible
that the high degree of deamidation in these complexes, together with any previous unfolding
that contributes to deamidation in this domain, enables filensin to recruit proteins, including
αB, from the cytoplasm, forming HMWCs that localize at fibre cell membranes.
Alternatively, high levels of deamidation of cytoplasmic filensin may induce further
membrane association of the protein, which may account for the presence of the complexes in
the barrier and nuclear regions of the 77 year-old lens (Figure 3.7).
Although filensin from each complex had between 2-5 deamidated sites, no obvious pattern
was observed between migration rate and extent of either deamidation or phosphorylation.
Nor was there any observed pattern that was dependent on the protein composition, other
than a decrease in pI induced by the presence of phakinin (Figure 3.9A). Two sites of
phosphorylation of filensin previously reported by Wang et al. (2013) were also observed in
this study (i.e. S488 and T460). This work also identified two oxidation sites (M649 and
M207) in complexes 1-7 (Figure 3.9A). To our knowledge, this is the first report of oxidation
of filensin in lens tissue. Two oxidised residues in filensin were identified in complex 1,
which had a molecular mass of ~95 kDa, whereas only single oxidized residues were
identified in complexes 2-7 which had masses of ~45 kDa (Figure 3.9A). This 2-fold increase
in mass observed for complex 1 is probably explained by less truncation of the C-terminal
residues (as evidenced by increased sequence coverage). However, as the spots were digested
with trypsin, and there was no consistent pattern between sequence coverage and complex
size for the other complexes, and it is not possible to establish this definitively. Moreover, as
the increase in sequence coverage was not sufficient to account for a 2-fold increase in mass,
it is possible that increased oxidation contributes to a greater degree of crosslinking and
hence higher molecular weight complexes. However, it should be noted that oxidation of
methionine can take place artifactually.
A single oxidation site was observed for αB (M68) but did this not appear to correlate with
migration patterns of the proteins i.e. did not correlate with increased mass or pI of the
complexes (Figure 3.9A). Oxidation of lenticular proteins has repeatedly been found to be
increased in cataractous lenses and in insoluble lens fractions (Garner and Spector, 1980;
Lund et al., 1996; Boscia et al., 2000; Hanson et al., 2000). As oxidation can induce protein
crosslinking, the increase in mass observed for complex 1 (Figure 3.9A) could be due to
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increased levels of protein crosslinks between filensin and other proteins in the complex, or
an increased rate of protein recruitment from the cytoplasm. Despite the common assertion
that oxidation and oxidative damage is the direct factor leading to cataract formation
(Truscott, 2005), relatively little is known about the factors that contribute to the oxidative
environment of the lens. To more fully comprehend the exact mechanism behind cataract
formation, this needs to be further investigated.

3.5 Conclusion
It is apparent that phosphorylation may be necessary to maintain chaperone activity of αB.
However, increased levels of multiply phosphorylation αB in high density lens fractions and
in the nuclear region of aged lenses offers an insight into a potentially pathogenic role for the
phosphorylated protein. Although αB participates in complexes that localise at fibre cell
membranes, how this may be regulated by phosphorylation and how this may be involved in
cataract formation remains to be elucidated. However, as deamidation of several sites of
filensin was a consistent feature of the HMWCs analysed in this chapter, this suggests that
deamidation and potential partial unfolding of intermediate filaments, particularly filensin, is
an important factor in recruiting αB and phosphorylated αB to fibre cell membranes. This
would then result in an overall loss of non-complexed αB, reducing the ability of αB to
maintain the solubility of protein complexes in the lens, ultimately contributing to cataract
formation. In this chapter, we propose that the barrier region of the lens acts a transition zone
between the cortex and the barrier, characterised by an increase in αB phosphorylation,
complex formation and membrane binding, the onset of which is potentially an important step
in cataract formation.
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4.1 Introduction
It is generally accepted that the accumulation of oxidative damage of lenticular proteins is the
direct cause of nuclear cataract formation, resulting in protein crosslinking and aggregation
(Truscott, 2005). Early stage cataractous lenses have been shown to have higher levels of
oxidative stress compared to healthy lenses (Li et al., 2009). Higher rates of oxidation were
also observed in membrane fractions from cataractous (Garner and Spector, 1980) and
diabetic lenses (Boscia et al., 2000) compared to healthy lenses, and higher rates of αA
oxidation and protein crosslinking has been observed in insoluble protein fractions compared
to soluble fractions (Lund et al., 1996).
The burden of oxidative damage in the lens is generally minimised by high concentrations of
reduced GSH. However, the GSH concentration decreases in the nucleus of lenses prior to
cataract formation (Reddy and Giblin, 1984; Giblin, 2000; Truscott, 2005). Some contention
surrounds the mechanism of GSH loss. It has been proposed that the breakdown of the redox
cycle responsible for keeping GSH in its reduced form (Giblin, 2000), or the loss of activity
of enzymes involved in GSH production i.e. glutathione synthetase and γ-glutamylcysteine
synthetase (Rathbun et al., 1993), may be involved. As GSH is synthesised in the cortex and
is dependent on pore proteins for transport into the nucleus, an alternative hypothesis
stipulates that the presence of an impediment to GSH transport may be responsible (Sweeney
and Truscott, 1998).
This phenomenon was first observed by Sweeney and Truscott (1998), following the
incubation of human lenses in [35S] cysteine to mimic GSH transport. Although [35S] cysteine
diffused uniformly throughout the nucleus of the young lenses, diffusion was restricted to the
cortex of aged lenses (Sweeney and Truscott, 1998). Notably, this point of obstruction was
consistent between lenses, and coincided with the sclerotic zones as well as the point where
GSH levels decrease dramatically in cataractous lenses (Sweeney and Truscott, 1998). This
suggests that a physical barrier at the interface of the cortical and nuclear regions, known as
the nucleocortical barrier, is responsible for the loss of GSH in the nuclear region of aged
lenses (Sweeney and Truscott, 1998). This was later supported by Moffat and Pope (2002),
who reported a similar deficit in the transport of water into the nucleus of aged lenses. It is
not currently clear how or why this barrier forms, although explanations such as changes in
sphingolipid distribution have been proposed (Deeley et al., 2010). Alternatively, is has been
proposed that the age-related membrane-binding of proteins, largely α-crystallins, may be
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responsible for this impediment, obstructing pore proteins to prevent the transport of GSH as
well as water (Cobb and Petrash, 2002b; Friedrich and Truscott, 2009; Friedrich and Truscott,
2010). However, the mode of α-crystallin association with fibre cell membranes has not been
elucidated; it is unclear as to whether membrane association is mediated by αB interaction
with membrane phospholipids, or with membrane pore proteins (e.g. Cx46 and AQP0).
Although αA and αB have been shown to protect AQP0 against thermal stress in vitro
(Swamy-Mruthinti et al., 2013) and to interact with AQP0 following co-transfection into
HeLa cells (Liu and Liang, 2008), direct interactions between αB and AQP0 in situ are yet to
be reported. To our knowledge, αB has not been previously reported to interact with Cx46 in
human lenses. However, if interactions between αB and AQP0 and/or Cx46 in situ can be
confirmed, this would provide evidence that αB contributes to barrier formation by
mechanically blocking the transport of GSH from middle age onwards. This chapter
describes work aimed at mapping the membrane association of αB isoforms across aged
human lens sections, and to determine what, if any, effect phosphorylation has on its
membrane association. Additionally, interactions between αB isoforms and AQP0 and Cx46
were mapped across aged human lens sections in order to determine how αB membrane
association may contribute to barrier formation.

4.2 Experimental Rationale
Determination of the distribution and membrane association of αB in the lens has often
involved techniques that necessitate tissue homogenisation such as electrophoresis and MS,
inevitably leading to loss of spatial integrity of the tissue. To overcome this, immunoconfocal
microscopy was utilised to detect αB isoforms, and to visualise (with fine detail) its
subcellular distribution across intact human lens sections (sections 2.3.1 and 2.3.2). The
putative location of the nucleocortical barrier i.e. the point at which membrane association
would be expected to peak if involved in barrier formation, was determined based on the
previous study by Sweeney and Trucsott (1998) that reported that diffusion becomes
obstructed 0.5-1 mm in from the periphery of the lens.
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Potential interactions between two or more proteins have traditionally been identified through
methods such as co-immunoprecipitation or co-localisation experiments. These technologies
however have limitations. For example, co-immunoprecipitation involves tissue
homogenisation that results in a loss of spatial detail and can introduce artefactual protein
interactions. Additionally, conventional microscopy techniques used for co-localisation
experiments can only localise proteins to an accuracy of 200 nm. Information relating to
direct protein interactions is therefore limited. By utilising a commercially available
proximity ligation assay kit (Duolink®, Sigma, USA), this study was able to detect likely
direct interactions between αB isoforms (i.e. total, pSer19 and pSer59), and AQP0 or Cx46
(section 2.3.1 and 2.3.3). Proximity ligation assays involve labelling two proteins of interest
with antibodies with attached short oligonucleotides. These oligonucleotides anneal when in
close proximity (i.e. ≤40 nm), and with the addition of polymerase, ligase and fluorescentlylabelled nucleotides, produce a fluorescent product able to be detected using confocal
microscopy (Figure 4.1)

Figure 4.1: Summary of proximity ligation assay protocol. 1. Two proteins of interest are
labelled with primary antibodies derived from two different species. 2. PLA + and PLA –
probes with attached oligonucleotides bind the primary antibodies. 3. The addition of ligase
anneals oligonucleotides forming a circle. 3. The addition of polymerase causes rolling circle
amplification of annealed oligonucleotides. 4. Amplification results in fluorescent produced
able to be detected via fluorescent microscopy.
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As the reaction only proceeds when the proteins of interest are within 40 nm of each other, a
signal is only produced when the proteins are in close enough proximity for direct interaction
and therefore interaction is highly likely. Furthermore, as the fluorescent product is produced
through an amplification reaction, the assay is highly sensitive (i.e. able to detect relatively
low levels of interaction in situ), with each signal representing a single interaction. This
method was selected as it maintains spatial integrity of the tissue while indicating possible
interactions based on proximity of the proteins of interest with higher resolution than other
co-localisation techniques. As pSer19 and pSer59 of αB were previously found to be
associated with low and high levels of total phosphorylation respectively (section 3.3.2), they
were selected for use in this study in order to compare the effect of phosphorylation on
membrane association. AQP0 and Cx46 were selected due to their reported roles in water
(Gorin et al., 1984) and GSH transport (Slavi et al., 2014) respectively.

4.3 Results
4.3.1 Phosphorylated αB becomes predominantly membrane associated by 500 µm in from
the outside of the lens.
Human lens tissue sections were labelled for pSer19, pSer45 and pSer59 αB and imaged
using confocal microscopy in order to map phosphorylated αB (pαB) membrane association
throughout the lens. Each αB phosphoisoform was found to associate with fibre cell
membranes, with the extent of association increasing towards the nucleus of the lens (Figure
4.2Ai-iii, v-x, B). Zones of membrane interaction were identified based on degree of
membrane association of αB. In the outer ~150 µm of the sections (zone 1), each of the αB
phosphoisoforms were distributed in the cytoplasm (Figure 4.2B). In the region ~150-500 µm
in from the periphery of the lens (zone 2), each αB phosphoisoform was partially membrane
associated (Figure 4.2B). In the region starting from ~500 µm from the periphery and
continuing towards the centre (i.e. ~5 mm from the periphery, zone 3), each αB
phosphoisoform was completely membrane associated with minimal amounts being
distributed in the cytoplasm (Figure 4.2B). Non-specific binding of secondary antibodies was
tested for by labelling a tissue section with rabbit IgG. Minimal background staining was
detected (Figure 4.1 iv).
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Figure 4.2: Localisation of pαB at fibre cell membranes in human lenses. Sections were
obtained from a 63 year-old human lens using a cryostat and labelled with rabbit anti-pSer19,
pSer45 or pSer59 αB antibodies. A separate section was labelled with rabbit IgG for use as a
negative isotype control. Alexa-488 conjugated goat anti-rabbit antibody was used to
visualize sections by confocal microscopy. (A) Images were obtained from the periphery
(cortex), 1 mm inside the periphery (barrier) and the centre (nucleus) of each section. (B)
Tiled images were obtained of the outer 1.1 mm of each section (pSer59 shown). Zones of
cytosolic pαB distribution (zone 1), partial membrane association (zone 2), complete
membrane association (zone 3), and putative location of the nucleocortical barrier were
identified and marked.
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4.3.2 αB and phosphorylated αB associate directly with membrane pore proteins AQP0 and
Cx46.
It was previously shown that pαB becomes predominantly associated with cell membranes as
the cells are located closer to the lens nucleus (section 4.3.1). This association could involve
interactions with phospholipids or membrane pore proteins. To investigate this aspect further,
proximity ligation assays were performed on human lens sections from a 62 year-old lens
using a Duolink® labelling kit to visualise and map interactions between αB, pSer19 and
pSer59 αB, and AQP0 across the lens. Direct interactions between each αB isoform and
AQP0 were detected. The majority of interactions occurred in the outer 500 µm of the lens
with the incidence of interaction decreasing towards the nucleus (Figure 4.3Ai-iii, C).
Interactions between AQP0 and total αB (i.e. αB) were abundant in the outer cortex (Figure
4.3A, C). At a discrete point, ~500 µm from the lens periphery, the number of interactions
decreased dramatically compared to the outer cortex (Figure 4.3C). Interactions between
AQP0 and total αB continued to gradually decrease from this point towards the nucleus,
where interactions were sparse (Figure 4.3Ai-iii, C).
Interactions between AQP0 and pSer19 αB were minimal throughout the lens section (Figure
4.3iv-vi, C), with a slightly higher number of interactions occurring in the outer cortex (i.e.
the outer 500 µm) (Figure 4.3Aiv).
Interactions between AQP0 and pSer59 αB were abundant in the outer cortex (Figure
4.3Avii, C). At a discrete point, ~500 µm from the lens periphery, the number of interactions
decreased dramatically compared to the outer cortex, similar to that observed for total αB
(Figure 4.3C). From this point, interactions between AQP0 and pSer59 αB were sparse and
changed little in abundance towards the nucleus (Figure 4.3C).
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Figure 4.3: Direct association of αB with AQP0. Sections were obtained from a 62 year-old
human lens using a cryostat and co-labelled with rabbit anti-αB, pSer19 or pSer59 αB and
goat anti-AQP0 antibody. Separate sections were incubated with TBST (no antibodies) or
goat anti-AQP0 and rabbit IgG for use as negative controls, or goat anti-AQP0 and rabbit
anti-BFSP2 for use as a positive control. A Duolink® assay kit was used to detect
interactions, and sections were visualised by confocal microscopy. (A) Images were obtained
from the periphery (cortex), 1 mm inside the periphery (barrier) and the centre (nucleus) of
each section. (B) Control images were obtained from the periphery (cortex). (C) Tiled images
were obtained of the outer 4 mm of each section. The putative location of the nucleocortical
barrier is indicated, and a dashed line is used to indicate where signal decreases.
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Proximity assays were performed on human lens sections from a 62 year-old lens using a
Duolink® labelling kit to visualise and map interactions between αB, pSer19 and pSer59 αB,
and Cx46 across the lens. Direct interactions between each of the αB isoforms and Cx46 were
detected. The majority of interactions occurred in the outer 250 µm of the lens with the
incidence of interaction decreasing towards the nucleus (Figure 4.4B). Interactions between
Cx46 and total αB (i.e. αB) or pSer19 αB were minimal throughout the lens section, with a
slightly higher number of interactions occurring in the outer cortex (i.e. the outer 250 µm)
(Figure 4.4A, B). By contrast, interactions between Cx46 and pSer59 αB were abundant in
the outer cortex (Figure 4.4A, B). At a discrete point, ~250 µm from the lens periphery, the
number of interactions between Cx46 and pSer59 decreased dramatically compared to the
outer cortex (Figure 4.4B). From this point, interactions between Cx46 and pSer59 αB
decreased gradually in abundance towards the nucleus (Figure 4.4B).
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Figure 4.4: Direct association of αB with Cx46. Sections were obtained from a 62 year-old
human lens using a cryostat and co-labelled with rabbit anti-αB, pSer19 or pSer59αB and
goat anti-Cx46 antibody. Separate sections were incubated with TBST (no antibodies) or goat
anti-AQP0 and rabbit IgG for use as negative controls, or goat anti-AQP0 and rabbit antiBFSP2 for use as a positive control. A Duolink® assay kit was used to detect interactions,
and sections were visualised by confocal microscopy. (A) Images were obtained from the
periphery (cortex), from 1 mm inside the periphery (barrier) and the centre (nucleus) of each
section. (B) Tiled images were obtained of the outer 4 mm of each section. The putative
location of the nucleocortical barrier is indicated with an arrow, and a dashed line is used to
indicate where signal decreases. See Figure 5.3 for control images.
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4.4 Discussion

4.4.1 αB and phosphorylated αB membrane-binding coincides with location of barrier
To determine whether the association of phosphorylated or non-phosphorylated isoforms of
αB with fibre cell membranes may be involved in the formation of the nucleocortical barrier,
aged human lens sections were labelled for the pSer19, pSer45 and pSer59 αB isoforms, and
cellular distribution was visualised across lens sections. Each of the phosphorylated αB
isoforms tested were found to associate with fibre cell membranes (Figure 4.2A), and all
followed a similar pattern of distribution. The association patterns occurred in three zones
(zones 1-3) throughout the coronal cross section of the lens, with the extent of membrane
association increasing towards the nucleus (Figure 4.2). Complete membrane association of
αB occurred from a point ~500 µm interior to the periphery of the lens and continued towards
the centre (i.e. zone 3) (Figure 4.2B). Notably, Sweeney and Truscott (1998) observed that
the diffusion of [35S] in aged human lenses was abruptly disrupted at a point ~500 µm in from
the periphery of the lens. This point, which indicated the presence of a physical barrier to
diffusion (Sweeney and Truscott, 1998), approximately coincides with the location of zone 3
in this study (Figure 4.2B), suggesting that large-scale membrane association of
phosphorylated αB may be implicated in barrier formation. This is consistent with previous
results from 2D gels that indicated that α-crystallin was the predominant protein to associate
with fibre cell membranes, the majority of which was phosphorylated (Friedrich and Truscott,
2010).
As only lenses of a narrow age range were analysed, it cannot be confirmed whether the
location of these zones change with age. However, as it is likely that the distribution pattern
is the result of an age-related process that begins at the newly deposited cells at the lens
periphery, it is likely that the zones remain at a consistent distance from the periphery, similar
to the barrier region described by Sweeney and Truscott (1998).

4.4.2 αB and phosphorylated αB associates directly with membrane pore proteins AQP0 and
Cx46
To determine whether interactions with membrane proteins may be responsible for αB
membrane association, proximity ligase assays were performed on aged human lens sections
to visualize interactions between αB isoforms (total, pSer19 and pSer59 αB), and AQP0 and
Cx46 across the lens cross section. Each of the αB isoforms tested gave results consistent
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with interaction with AQP0 (Figure 4.3) and Cx46 (Figure 4.4) at fibre cell membranes.
These interactions occurred preferentially in the cortex; interactions involving AQP0 were
largely restricted to the outer 500 µm of the cortex (Figure 4.3C) and interactions with Cx46
predominantly occurred in the outer 250 µm of the cortex (Figure 4.4B). This distinct pattern
was more pronounced for interactions involving pSer59 αB than for pSer19 αB, for which
interactions were minimal throughout the lens section. As it was previously shown that
pSer59 is more common in multiply phosphorylated αB species compared to pSer19 (section
3.3.2), this may suggest that the presence of multiple phosphorylated residues in αB may
increase its interaction with AQP0 and Cx46. This may be due to structural changes induced
by phosphorylation, that act to increase substrate affinity (Aquilina et al., 2004).
Alternatively, as it was previously suggested that pSer19 may inhibit phosphorylation at other
residues in αB (section 3.4.2), it is also conceivable that pSer19 decreases αB membrane
binding capacity. Further membrane binding assays are required in the future to further
elucidate the mechanism by which αB associates with membrane proteins.
The lens regions where interactions were most abundant (i.e. outer 500 µm for AQP0 and
outer 250 µm for Cx46), coincide with zones 2 and 3 (Figure 4.2B). These are the same
regions in which the association of phosphorylated αB isoforms with membranes increases.
Together, this suggests that the αB membrane association observed in this region is mediated
by interactions with AQP0 and Cx46, or that αB co-localises with Cx46 and AQP0 due to
association with the fibre cell membrane such that it is in very close proximity to the
membrane proteins. As this region also coincides with the putative location of the
nucleocortical barrier (Sweeney and Truscott, 1998), it is likely that interactions between αB
isoforms and AQP0 and Cx46, whether direct or via fibre cell membranes, contribute to the
inhibition of diffusion in the barrier region of aged lenses.
As AQP0 and Cx46 are responsible for the transport of water (Gorin et al., 1984) and GSH
(Slavi et al., 2014) into the nucleus of the lens respectively, any event that decreases the
transport activity of these proteins would be detrimental to the lens. In fact, mutations of both
AQP0 (Francis et al., 2000; Ganesan et al., 2012; Hu et al., 2012; Kumari et al., 2013) and
Cx46 (Burdon et al., 2004; Wang and Zhu, 2012), which affect channel formation, have been
implicated in autosomal congenital cataract. With regards to mutations that lead to a loss of
Cx46 function, it has previously been proposed that the decrease in GSH transport into the
nucleus is responsible for nuclear cataract formation (Cobb and Petrash, 2002b; Friedrich and
Truscott, 2009; Friedrich and Truscott, 2010) as it leads to a highly oxidative environment
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conducive to protein cross-linking and proteolysis (Reddy and Giblin, 1984; Giblin, 2000;
Truscott, 2005). In support of this, Cx46 knockout mice develop nuclear cataract
characterised by proteolysis of crystallin proteins (Gong et al., 1997). Additionally, in this
study, crosslinked complexes were previously identified in high density lens fractions
(section 3.3.3). It is therefore likely that the obstruction of AQP0 and Cx46 channels by αB in
the cortex of the lens is a contributing factor in barrier formation, which leads to subsequent
damage and eventual cataract formation.
The association of αB with fibre cell membranes was found throughout the nucleus of the
lens (Figure 4.2), despite interactions between αB and AQP0 and Cx46 being localised in the
cortex (Figure 4.3, Figure 4.4). This suggests that αB membrane association in the nucleus
may be mediated via interactions with membrane lipids, cytoskeletal proteins or additional
membrane proteins other than AQP0 and Cx46. It is, however, difficult to exclude the
presence of interactions with AQP0 and Cx46 in the nucleus as a possibility. It is possible
that the accumulation of HMWCs at fibre cell membranes prevents the proteins of interest
from being accessed by antibodies and therefore being detected. However, as these lens
sections were washed with PBS prior to labelling, this is less likely to be a significant factor.
Alternatively, truncation of AQP0 and Cx46, which increases in the nucleus of the lens (Ball
et al., 2004; Grey et al., 2009; Wang and Schey, 2009), could conceivably affect either αB
interaction or antibody detection of AQP0 and Cx46. Truncation sites of AQP0 have been
identified at Asn246 (Ball et al., 2004; Grey et al., 2009), Pro249, Asn259, Thr260, Gln261
and Ala262 (Ball et al., 2004), resulting in the loss of the C-terminal residues. As the
antibody used for this study was specific to a sequence within the region Gly100 to Asp150
of AQP0 (Santa Cruz Biotechnology, Inc., personal correspondence), it is therefore more
likely that the decrease in interactions in the nucleus is due to αB dissociation from AQP0, as
opposed to a loss of antibody recognition sequences within AQP0. This may suggest that the
αB binding site for AQP0 lies within the C-terminus. Although it is not possible to exclude
C-terminal truncation of AQP0 itself as a factor in decreased function (Gonen et al., 2004;
Korlimbinis et al., 2009), another study suggests that AQP0 function is not strongly affected
by C-terminal truncation in vivo (Ball et al., 2003). This is likely due to the regulation of
AQP0 water permeability, whereby increased Ca+ and decreased pH increases the
permeability of AQP0 to compensate for the loss of non-truncated protein (Varadaraj et al.,
2005). Truncation sites for human Cx46 have been less extensively studied, although a
multitude of cleavage sites have been identified for bovine Cx46. These sites include Asn124,
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Leu255 (Shearer et al., 2008; Wang and Schey, 2009), Gly121, His122, Asp124, Gly251,
Asn259, Ile267, Phe269, Tyr273, Ala274, Ser278, Ser284, Ala285, Glu344, Gly347, Gln352
and Gly2 (Wang and Schey, 2009)). These residues lie within the C-terminus, cytoplasmic
loop and N-terminal regions of the protein, and within close proximity of the recognition site
for the antibody used in this study, i.e. residues 375-425 of human Cx46 (Santa Cruz
Biotechnology, Inc., personal correspondence). This makes it impossible to determine
whether the decrease in interaction between αB isoforms and Cx46 in the nucleus compared
to the cortex is due to truncation of the αB binding site or the antibody recognition site. The
narrower region of interaction for Cx46 with αB compared to AQP0 (i.e. 250 µm versus 500
µm) in the lens is consistent with a higher rate of truncation of Cx46, at an earlier age. As
Cx46 truncation occurs so extensively in all regions of the protein (Shearer et al., 2008;
Wang and Schey, 2009), the effect of truncation itself on Cx46 function in the lens is worthy
of further investigation.
Ultimately, as interactions between αB and Cx46 or AQP0 were not observed in the nucleus
of the lens, it remains unclear how αB associates with the membrane in this region and how
this may affect transport in the lens. However, as transport in the lens occurs from the cortex
into the nucleus, interactions that occur in the cortex, such as those identified in this thesis,
are more likely to be the primary cause to any obstruction to diffusion.

4.5 Conclusions
Isoforms, including phosphorylated isoforms, of αB interact with fibre cell membranes, in
part, through interactions with the membrane pore proteins AQP0 and Cx46. This provides a
mechanism for αB membrane association to be directly involved in the inhibition of small
metabolite transport, notably that of GSH. This impediment to GSH transport into the lens
nucleus and the loss of re-reduction of oxidized GSH in the cortex, is likely to result in the
oxidation of nuclear proteins leading to the formation of protein crosslinking and ultimately
cataract formation. Additionally, it appears that phosphorylation increases membrane binding
capacity of αB, potentially resulting in increased interactions between αB and AQP0 and
Cx46 in the cortex of the aged lens. Thus, this work provides some insight into the
interactions between αB and fibre cell membranes, particularly in the lens cortex. However, it
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is also important to note that some limitations to this research exist. As only a single lens was
investigated, further studies utilizing multiple lenses across a broader age range will need to
be undertaken in order to confirm and extend these findings. As the control antibody was the
same used for the AQP0 experiment for which very little non-specific binding was observed,
an IgG/Cx46 negative control was not performed, but should be incorporated into future
experiments to exclude the possibility of non-specific interactions . In addition, although the
results suggest it is highly likely that αB directly interacts with Cx46 and AQP0 in vivo in the
cortical and barrier region, these findings would be strengthened if direct interaction could be
confirmed through other methods such as immunoprecipitation assays, in order to exclude the
possibility of co-localisation of αB with Cx46 and AQP0 due to interactions with other
membrane components.
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Chapter 5
Investigation of non-enzymatic deamidation of
αB
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5.1 Introduction
Deamidation involves the conversion of asparagine and glutamine residues to aspartate and
glutamate residues respectively (Figure 1.5). In the lens, deamidation is believed to occur
primarily via non-enzymatic reactions (Hains and Truscott, 2010). The susceptibility of
residues to deamidation is affected primarily by the surrounding residues (Robinson et al.,
1970; Robinson et al., 1974; Robinson and Robinson, 1991; Wright, 1991; Robinson and
Robinson, 2001) which have both a steric and catalytic effect (Robinson and Robinson,
2004b), the secondary structure with deamidation being facilitated by more flexible α-helical
structures as opposed to β-sheets (Paranandi et al., 1994; Kosky et al., 1999; Hooi et al.,
2012; Truscott and Friedrich, 2016), and tertiary (Kossiakoff, 1988) and quaternary structure,
with surface exposed residues being more susceptible (Lapko et al., 2002). Deamidation of
αB at N146 reduces chaperone activity, decreases hydrophobic exposure and increases
oligomeric size compared to WTαB (Gupta and Srivastava, 2004; Asomugha et al., 2011).
Deamidation at either N146 or N78 has also been reported to increase association of αB with
βA3-crystallin in vitro (Tiwary et al., 2015). Deamidation is known to destabilise β- and γcrystallins triggering aggregation (Kim et al., 2002; Lampi et al., 2002; Flaugh et al., 2006;
Lampi et al., 2006; Takata et al., 2007; Takata et al., 2008; Michiel et al., 2010) as well as
interrupting H-bond formation at oligomeric interfaces causing predominantly tertiary
structural changes (Lampi et al., 2006; Takata et al., 2007; Takata et al., 2008; Takata et al.,
2009) and interfering with hetero-oligomeric interactions with other β-crystallins (Takata et
al., 2009). As such, it is speculated to be involved in cataract formation, also being elevated
in insoluble human lens fractions compared to soluble fractions (Hanson et al., 2000;
Srivastava and Srivastava, 2003). Isomerisation of αB at Asp96 resulting from deamidation,
is believed to partially unfold the protein, making it more susceptible to cleavage (Takata and
Fujii, 2015).
Outside of the lens, deamidation can be induced by acidic or basic conditions. The
mechanisms behind these reactions differ; acidic environments (pH<5.0) allow direct
hydrolysis of the amide group of asparagine and glutamine residues (Catak et al., 2009)
(Figure 1.5B). Under neutral to basic environments, cyclic intermediates are produced that
are then hydrolysed to form aspartate and glutamate (Geiger and Clarke, 1987; Capasso et al.,
1991; Wright, 1991; Catak et al., 2009) (Figure 1.5A). Deamidation at asparagine residues
forms a succinimide (i.e. 5-member ring) intermediate (Geiger and Clarke, 1987) while
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glutamine forms a glutaminide (6-member ring) intermediate (Capasso et al., 1991; Wright,
1991). As the reaction is non-enzymatic, spontaneous deamidation of proteins can occur. For
example, insulin has been reported to undergo non-enzymatic deamidation during storage at 15°C (Berson and Yalow, 1966). However, the susceptibility of αB to non-enzymatic
deamidation under storage conditions has not been previously studied. As deamidation can
alter the structure and function of proteins (Gupta and Srivastava, 2004; Asomugha et al.,
2011; Tiwary et al., 2015), the presence of deamidated residues can be problematic for
experimental interpretation (such as for functional studies of proteins). The susceptibility of
proteins to deamidation and the impact it can have on function therefore needs to be
considered when interpreting data. This chapter examines deamidation of αB when stored at 20°C and 4°C, as well as following heat-treatment under different buffer conditions, in order
to determine the susceptibility of αB to non-enzymatic deamidation in vitro.

5.2 Experimental Rationale
To determine which αB residues are susceptible to non-enzymatic deamidation under
different buffer conditions, a protocol was developed to induce deamidation using heat
treatment under different pH and unfolding buffer conditions. A protocol developed by Liao
et al. (2009) used low concentrations of acetic acid (0.03-0.14M) coupled with high
temperatures (121ºC), to induce deamidation in wheat gluten while avoiding other
modifications (i.e. hydrolysis and isomerisation) that can be introduced with other acids (e.g.
hydrochloric acid and phosphoric acid). An inherent obstacle in this procedure is the
instability of Hsps at such high temperatures. In an attempt to overcome this, the protocol
was modified to incorporate lower temperatures and increased incubation times. To
determine the effect of pH on deamidation, ammonium acetate (~pH 7.0), ammonium
bicarbonate (~pH 8.0) and acetic acid (~pH 3.0) were used as buffer systems in order to
compare which residues were susceptible to deamidation via the succinimide intermediate
(basic conditions) versus direct hydrolysis pathway (acidic conditions) (section 2.4.1).
Proteins were also heat-treated with urea in order determine the effect of protein unfolding on
αB deamidation. For this experiment, lower temperatures and shorter incubation times were
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used to prevent protein aggregation (section 2.4.2). Experimental conditions are described in
Table 5.1.
Table 5.1: Experimental conditions for each of the αB samples analysed in this section
of work.
Section
Batch
Storage
Buffer
Incubation
Digestion
Analysis
5.3.1
1
5 years at - 34 mM
0-72 hours
MS
20°C
acetic acid
at 4°C
5.3.2
1
5 years at - 34 mM
16 hours at
5 minutes or MS
20°C
acetic acid or 50 °C ± 5
2 hours
200 mM
minutes at
ammonium
100°C
acetate
5.3.3
1
1 year at - 6 M urea or
4 hours at 37 overnight
MS/MS
20°C
°C
(APAF)
5.3.3
2
1 year at - 1 M
18 hours at
overnight
MS/MS
20°C
ammonium
50°C
(APAF)
bicarbonate

5.3 Results
5.3.1 Modifications following incubation in acetic acid at 4°C
Recombinant human αB (i.e. batch 1) that had been stored at -20°C in 200 mM ammonium
acetate (for a minimum of 5 years) was incubated in 34 mM acetic acid (~pH 3.0) at 4°C for
0-72 hours before being analysed by MS to determine if modifications occurred to the protein
under these conditions. The dominant peak for each sample, peak A, had a mass of 20159.5
Da, consistent with unmodified αB (Figure 5.1, Table 5.2). The mass of peak A remained
consistent following incubation at 4°C (Figure 5.1, Table 5.2). In the sample that was not
incubated (i.e. control), another peak, peak B (20174.4 Da) showed a 15 Da increase in mass
compared to peak A, consistent with the addition of a methyl group (Figure 5.1, Table 5.2).
The mass of peak B increased by a further 3 Da after a 24 hour incubation at 4°C, and by
another 2 Da after a 72 hour incubation at 4°C (Table 5.2). This 5 Da increase of peak B over
72 hours of incubation is consistent with deamidation at 5 sites.
In the control sample (i.e. not incubated), a peak at 20200.8 Da (peak C) showed a mass
increase of 41.3 Da compared to peak A, consistent with acetylation of αB (Figure 5.1, Table
5.2). The mass of peak C increased by 1 Da after a 72 hour incubation at 4°C (Table 5.2),
123

Chapter 5
consistent with deamidation at a single site. The control sample also contained a peak
corresponding to a mass of 20257.4 Da (peak D) (Figure 5.1, Table 5.2). The increase in
mass of peak D over peak A, 39.9 is consistent with pyro-carbamidomethylation of the
protein (Figure 5.1, Table 5.2). The mass of peak D remained constant following incubation
at 4°C, but was increased in relative amount compared to peak A following a 24 hour
incubation before decreasing again following a 48 hour incubation, suggesting decomposition
of the compound upon further incubation. It is important to note that as the samples were not
subjected to tryptic digestion, the location and nature of modifications could not be
confirmed.
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Figure 5.1: Mass spectra of αB following incubation at 4°C for 0-72 hours. Recombinant
human αB was incubated at 4°C for 0-72 hours in 34 mM acetic acid (~pH 3.0) at a
concentration of 1 mg.mL-1. The protein was then analysed using MS. The position of 4
prominent peaks in the mass spectrum are labelled A-D and indicated on each spectra with a
dashed line.
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Table 5.2: Masses of αB isoforms calculated from the peaks identified by MS following
incubation at 4°C for 0-72 hours. Recombinant human αB was incubated at 4°C for 24-72
hours in 34 mM acetic acid (~pH 3.0) at a concentration of 1 mg.mL-1. The protein was
analysed using MS and masses of peaks were calculated using Masslynx software. Peak D
was not present (NP) in the sample incubated for 72 hours.

Length of
incubation
0 hours

A

B

C

D

20159.5

20174.4

20200.8

20257.4

24 hours

20159.5

20177.7

20201

20257.7

48 hours

20159.1

20177.9

20201.2

20257.6

72 hours

20159.4

20179.6

20201.5

NP

5.3.2 Deamidation under acidic or basic conditions
To determine which asparagine or glutamine residues in αB residues were susceptible to heatinduced deamidation under acidic or basic conditions, recombinant human αB (batch 1) was
incubated at 50°C for 2 hours in either 34 mM acetic acid (i.e. acidic sample; ~pH 3.0) or 200
mM ammonium acetate (i.e. basic sample; ~pH 7.0). The protein was then digested with
trypsin for 5 minutes and analysed by MS. Complete tryptic digestion of αB yielded 21
peptides, five of which contain an asparagine or glutamine residue. For the control sample, 11
αB tryptic peptides were identified (Table 5.3, Figure 5.2). A single deamidation site was
identified at N146 on peptide 124-149 (Table 5.3, Figure 5.2). Following incubation under
acidic conditions, 7 αB tryptic peptides were identified, 6 of which were the same peptides as
identified in the control sample (Table 5.3, Figure 5.2). No extra deamidation sites were
identified following incubation under acidic conditions (Table 5.3, Figure 5.2). Following
incubation under basic conditions, 8 αB tryptic peptides were identified, 7 of which were the
same peptide as identified in the control sample (Table 5.3, Figure 5.2). The same
deamidation site (N146) was identified on peptide 124-149 as observed in the control sample,
however, no additional deamidation sites were identified when the protein was incubated
under basic conditions (Table 5.2, Figure 5.2).
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Table 5.3: αB tryptic peptides identified following incubation at 50°C for 2 hours +
100°C for 5 minutes. Recombinant human αB was incubated at 50°C for 2 hours followed
by 5 minutes at 100°C in either 34 mM acetic acid (acidic; ~pH 3.0) or 200 mM ammonium
acetate (basic; ~pH 7.0) at a concentration of 1 mg.mL-1. Protein was digested with trypsin
for 5 minutes and analysed using MS, and peptide masses were calculated using Masslynx
software. Predicted masses were used to identify peptides and modification sites. Protein that
was not incubated was analysed as a control. Modified residues are highlighted in red.
m/z

Expected
Mass

588.2
656.9

588.3
1313.7

117-120
124-149

700.4
772.3
900.5
1088.5
1140.6
1268.7
1374.6
1388.7
1496.6

700.4
772.4
900.5
1088.5
1140.6
1268.7
1374.7
1388.7
1496.7

158-163
151-157
150-157
108-116
164-174
164-175
12-22
1-11
57-69

700.4
772.4

700.4
772.4

900.4
986.5
1088.5
1140.6
1268.7
588.3
700.4
772.4
900.5
1140.6
1165.6
1268.7
656.9

Residues Modification

Sequence

Observed
Mass

EFHR
IPADVDPLTITSSLSSDGVL
TVNGPR
TIPITR
QVSGPER
KQVSGPER
QDEHGFISR
EEKPAVTAAPK
EEKPAVTAAPKK
RPFFPFHSPSR
MDIAIHHPWIR
APSWFDTGLSEMR

588.2
1313.6

158-163
151-157

TIPITR
QVSGPER

700.4
772.4

900.5
986.5
1088.5
1140.6
1268.7

150-157
83-90
108-116
164-174
164-175

KQVSGPER
HFSPEELK
QDEHGFISR
EEKPAVTAAPK
EEKPAVTAAPKK

900.4
986.5
1088.5
1140.6
1268.7

588.3
700.4
772.4
900.5
1140.6
1165.7
1268.7
1313.7

117-120
158-163
151-157
150-157
164-174
93-103
164-175
124-149

EFHR
TIPITR
QVSGPER
KQVSGPER
EEKPAVTAAPK
VLGDVIEVHGK
EEKPAVTAAPKK
IPADVDPLTITSSLSSDGVL
TVNGPR

588.3
700.4
772.4
900.5
1140.6
1165.6
1268.7
1313.6

Control
N146

Acidic

Basic

N146

700.4
772.3
900.5
1088.5
1140.6
1268.7
1374.6
1388.7
1496.6
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Figure 5.2: Sequence coverage of αB following heat treatment and 5 minute tryptic
digestion. Regions of αB identified by tryptic digestion and subsequent MS analysis are
underlined. Potential deamidation sites are highlighted in red. The deamidated residue (i.e.
N146) is indicated by a green asterisk.

To determine whether additional deamidated residues could be detected by increasing the
incubation and digestion time, recombinant human αB was incubated for 16 hours at 50°C,
digested with trypsin for 2 hours and analysed by MS. For the control sample, 6 αB tryptic
peptides were identified (Table 5.4). No deamidation sites were identified (Table 5.4, Figure
5.3D). Following incubation under acidic conditions, 3 αB tryptic peptides were identified, 2
of which were the same peptide identified in the control sample (Table 5.4). A single
deamidation site was identified at N146 on peptide 124-149 (Figure 5.3B, D, Table 5.4).
Following incubation under basic conditions, 6 αB tryptic peptides were identified, 3 of
which were the same peptide identified in the control sample (Table 5.4). The same
deamidation site (N146) was identified on peptide 124-149 as observed following incubation
under acidic conditions (Figure 5.3C, D, Table 5.4). However, an additional deamidation at
N78 was identified on peptide 75-82 following incubation under basic conditions (Figure
5.3C, D, Table 5.4). Deamidation at this site was not observed following the shorter
incubation time (Figure 5.2, Table 5.3).
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Figure 5.3: Mass spectra of αB tryptic digests following incubation at 50°C for 16 hours.
Recombinant human αB was incubated at 50°C for 16 hours in either 34 mM acetic acid
(acidic; ~pH 3.0) or 200 mM ammonium acetate (basic; ~pH 7.0) at a concentration of 1
mg.mL-1. (A) Protein was digested with trypsin for 2 hours and analysed using MS. Predicted
masses were used to identify peptides (some of which are labelled in the spectra above, refer
to 5.3) and modification sites detected following treatment with (B) acidic or (C) basic
conditions. Peaks corresponding to a deamidated peptides are labelled with their m/z value
(B, C). Protein that was not incubated was analysed as a control. (D) Regions of αB identified
following heat treatment and 2 hour tryptic digestion and subsequent MS analysis were
mapped onto the protein sequence. Potential deamidation sites are highlighted in red.
Deamidated residues are indicated by a green asterisk.
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Table 5.4: αB tryptic peptides identified following incubation at 50°C for 16 hours.
Recombinant human αB was incubated at 50°C for 16 hours in either 34 mM acetic acid
(~pH 3.0) or 200 mM ammonium acetate (~pH 7.0) at a concentration of 1 mg.mL-1. Protein
was digested with trypsin for 2 hours and analysed using MS, and peptide masses were
calculated using Masslynx software. Predicted masses were used to identify peptides and
modification sites. Protein that was not incubated was analysed as a control. Modified
residues are highlighted in red.
m/z

588.3
700.5
772.4
900.5
1088.5
1140.6
656.9

Expected Residues Modification
Sequence
Observed
Mass
mass
Control
588.3
117-120
EFHR
588.3
700.4
158-163
TIPITR
700.5
772.4
151-157
QVSGPER
772.4
900.5
150-157
KQVSGPER
900.5
1088.5
108-116
QDEHGFISR
1088.5
1140.6
164-174
EEKPAVTAAPK
1140.6
ACIDIC
1313.7 124-149
N146
IPADVDPLTITSSLSSDGVL 1313.8
TVNGPR

700.5
772.4

700.4
772.4

158-163
151-157

656.9

1313.7

124-149

700.5 700.4
772.4 772.4
900.6 900.5
1268.8 1268.7
922.5 922.5

158-163
151-157
150-157
164-175
75-82

TIPITR
QVSGPER

N146

N78

BASIC
IPADVDPLTITSSLSSDGVL
TVNGPR
TIPITR
QVSGPER
KQVSGPER
EEKPAVTAAPKK
FSVNLDVK

700.5
772.4
1313.8
700.5
772.4
900.6
1268.8
922.5
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5.3.3 Deamidation under folding and unfolding conditions
To determine which αB residues were susceptible to deamidation under folding and
unfolding conditions, recombinant human αB (i.e. batch 2) that had been stored at -20°C for
<1 year was incubated in 1 M ammonium bicarbonate (~pH 8.0) for 18 hours at 50°C or in 6
M urea (~pH 8.0) for 4 hours at 37°C, digested with trypsin overnight and analysed using
MS. The sample treated with 6 M urea was incubated at a lower temperature for a shorter
time period to prevent insolubilisation of the unfolded protein. Protein in PBS (~pH 7.4) with
and without heating for 18 hours at 50°C were used as controls. From each of the samples, 8
deamidated αB tryptic peptides (denoted peptide 1-8) were identified (site of modification
given in parentheses); peptide 1 - 75-82 (N78); peptide 2 - 75-90 (N78); peptide 3 - 124-149
(N146); peptide 4 - 150-157 (Q151); peptide 5 - 23-46 (Q26); peptide 6 - 108-116 (Q108);
peptide 7 - 151-157 (Q151); peptide 8 - 122-149 (N146) (Figure 5.3). There was no
significant difference in amount of deamidation between each treatment for peptides 1-6
(Figure 5.4, Table 5.5).
One-way ANOVA analysis indicated that there was a significant effect of treatment on the
amount of deamidation of peptide 7 that contains Q151 [F (3, 8) = 11.8, p = 0.003]. The
amount of deamidation of peptide 7 was significantly increased in the heat-treated PBS
sample (i.e. PBS + heat, 26.8±4.6%) compared to the other samples (P≤0.05, Figure 5.4,
Table 5.5). All other samples had similar levels of deamidation for Q151 (Figure 5.4, Table
5.5).
One-way ANOVA analysis indicated that there was a significant effect of treatment on the
amount of deamidation of peptide 8 that contains N146 [F (3, 44) = 8.99, p = 0.0001]. The
amount of deamidation of peptide 8 was significantly increased in the PBS-treated sample
(64.5±6.2%) compared to the samples in ABC that were heat-treated (i.e. ABC ± heat,
49.7±6%) or urea-treated (i.e. urea + heat, 55.6±6.8, P≤0.05; Figure 5.4, Table 5.5). The
amount of deamidation of peptide 8 was also significantly increased in the heat-treated PBS
sample (i.e. PBS + heat, 59±9.2%) compared to the sample in ABC that was heat-treated (i.e.
ABC + heat, P≤0.05), but not the heat-treated urea sample (Figure 5.4, Table 5.5). There was
no significant difference in the amount of deamidation of peptide 8 between the PBS and
heat-treated PBS samples, or the heat-treated ABC (i.e. ABC + heat) and urea (i.e. urea +
heat) samples (Figure 5.4, Table 5.5).
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Table 5.5: Percentage of αB deamidation following heat treatment in urea or
ammonium bicarbonate buffer. Recombinant human αB was incubated at 37°C for 4 hours
in 6 M urea (~pH 8.0) or at 50°C for 18 hours in 1 M ammonium bicarbonate (ABC; ~pH
8.0), at a concentration of 2 mg.mL-1. Protein was digested with trypsin and analysed using
MS/MS. Peptides and modified residues were identified using a MASCOT database search,
and percentage deamidation for each peptide (1-8) was calculated using a computer
simulation method. Differences between treatments were tested using a one-way ANOVA
(P≤0.05 shaded grey) and post-hoc Tukey’s tests (P≤0.05 marked with asterisk). Values are
presented as means±1SD. Samples were anlaysed in triplicate, n = number of observations of
that peptide.
Peptide

Residues

ABC + heat

PBS

PBS + heat

Urea + heat

75-82

Deamidation
site
N78

1
(n=3)
2
(n=12)
3
(n=12)
4
(n=3)
5
(n=9)
6
(n=6)
7
(n=3)
8
(n=12)

19.4±5.8

16.2±5.4

21±5.1

24.4±5.1

75-90

N78

55.7±19.1

59.8±19.5

54.5±21.4

59.8±22.2

124-149

N146

44.9±9.7

58.2±8.9

52.4±9.8

50±13.6

150-157

Q151

14.7±10

15.2±8.4

15.5±1.4

5±2

23-46

Q26

50.7±7.3

52.9±9.1

51.2±13.3

55.9±4.1

108-116

Q108

23.9±6.6

25.1+12.2

18.5±3.3

17.4±7.8

151-157

Q151

11.4±2.7

17.3±2.4

26.8±4.6*

18.2±2.6

122-149

N146

49.7±6

64.5±6.2*

59±9.2*

55.6±6.8
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Figure 5.4: Sequence coverage of αB following heat treatment in folding or unfolding
conditions and overnight tryptic digestion. Regions of αB identified by tryptic digestion
and subsequent MS/MS analysis are underlined. Deamidated residues are highlighted in red.
Deamidated residues that show statistical significance between treatments (P≤0.05) as
calculated by one-way ANOVA are indicated by a green asterisk.

5.4 Discussion
Recombinant proteins are a convenient way to study protein structure and function in vitro.
However, recombinant proteins are prone to the accumulation of non-enzymatic
modifications, even under frozen storage conditions (Berson and Yalow, 1966). Modified
forms of αB (including methylated, deamidated and pyro-carbamidomethylation) were
present in protein that had been stored at -20°C in 200 mM ammonium acetate (~pH 7.0) for
5 years (Figure 5.1, Table 5.2). Unfortunately, the protein used as a control for these
experiments (i.e. not heat treated) had been stored under frozen conditions for a minimum of
one year. As such, it is impossible to determine whether the modifications present were
introduced during protein expression or during storage. The use of a recently expressed
protein batch as a control would help elucidate this in future experiments. It was possible
however, to determine whether further incubation in non-frozen conditions could contribute
to the introduction of further modifications.
When αB was incubated at 4°C, the majority of the additional modifications (the dominant
being deamidation) were introduced within the first 24 hours (Figure 5.1, Table 5.2). This
suggests that deamidation of αB occurs readily and spontaneously under common
experimental and storage conditions, as previously observed by Hao et al. (2011).
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An additional site of deamidation (i.e. N78) was identified when αB was heat-treated in a
basic buffer (200 mM ammonium acetate, ~pH 8.0) compared to an acidic buffer (34 mM
acetic acid, ~pH 3.0) (Table 5.3, Table 5.4). These treatments induce deamidation via two
different pathways i.e. via a succinimide ring intermediate (basic conditions), and via direct
hydrolysis (acidic conditions) (Geiger and Clarke, 1987; Catak et al., 2009). The sample
heat-treated in ammonium acetate (~pH 8.0) showed the highest number of deamidated
residues (N78 and N146) (Figure 5.3, Table 5.4), with the peak corresponding to deamidation
at N146 (m/z 656.9) being more prominent in this sample compared to the sample heattreated in acetic acid (~pH 3.0) (Figure 5.3 compare panels B, C). This is consistent with αB
being preferentially deamidated via the succinimide intermediate pathway rather than direct
hydrolysis in vitro. This is most likely due to higher thermodynamic favourability of the
succinimide forming pathway (Catak et al., 2009). Takemoto et al. (2001) reported that γcrystallin in human cataractous lenses undergoes deamidation via this same pathway, as
indicated by the formation of iso-aspartate, demonstrating that this pathway to deamidation
occurs in vivo.
It is important to note that deamidation at N78 was only detected when the samples were
subjected to the longer digestion time (i.e. 2 hours versus 5 minutes). Although overall
peptide coverage was higher for the samples subjected to the 5 minute digestion, the peptide
containing N78 was not detected (Figure 5.3). Therefore, repeat experiments incorporating
overnight digestion of samples may lead to the identification of deamidation at more residues.
Furthermore, a limitation for identifying PTMs of whole proteins is the accuracy and
sensitivity of the mass spectrometer used. Although the samples were run on the same day
and using the same setting to help ensure accuracy, only a single replicate was performed.
This is particularly pertinent regarding the identification of deamidation, as the modification
only introduces a mass change of 1 Da, a change too small for many mass spectrometres to
detect. The mass of peak B increased by 3 Da in the first 24 hours of incubation and by a
further 2 Da by 72 hours (Table 5.2). Although this is consistent with deamidation at five
sites, a possibility given that deamidation occurs relatively rapidly in acidic buffers, the
finding is tentative and would need to be confirmed with higher resolution mass
spectrometry.
Hydrolysis of the succinimide intermediate has been reported to be the rate-limiting step in
deamidation via this mechanism (Catak et al., 2009). A significant decrease in the amount of
αB deamidation at N146 and Q151 was observed in samples heat-treated in urea and ABC
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(~pH 8.0) compared to samples in PBS (pH 7.4) (Figure 5.4, Table 5.5). This suggests that
hydrolysis of the succinimide intermediate occurs faster at slightly acidic pH, and that even
slight increases in pH may therefore act to reduce heat-induced deamidation. The lens has a
pH gradient that decreases from ~pH 7.2 in the cortex (Bassnett et al., 1987; Eckert, 2002) to
~pH 6.7 in the nucleus (Bassnett et al., 1987). If this slight decrease in intracellular pH is
sufficient to affect αB deamidation, this may provide another explanation (in addition to
protein longevity) for the high levels of deamidation in the nucleus of aged lenses (Siebinga
et al., 1992; Hains and Truscott, 2007). As deamidation, particularly at N146, reduces the
chaperone activity of αB (Gupta and Srivastava, 2004; Asomugha et al., 2011), the higher
incidence of αB deamidation, associated with the decrease in pH in the nucleus, may
facilitate the formation of nuclear cataract in the lens.
Isomerisation resulting from deamidation following the succinimide intermediate pathway is
reported to increase the susceptibility of proteins to tryptic cleavage by inducing partial
unfolding (Takata and Fujii, 2015). However, following longer heat-treatment and digestion
times, the number of αB tryptic peptides identified decreased as the number of deamidated
residues increased (Table 5.3, Table 5.4). Additionally, when N78 was identified on two
separate peptides (i.e. peptide1 and peptide 2; Table 5.5), the presence of an additional 8
residues on peptide 2 led to an increase in the average amount of deamidation detected on
that peptide by 37% (Figure 5.4, Table 5.5). This was not observed for other residues. If
deamidation at N78 occurred during heat-treatment, this finding suggests that deamidation at
N78 protects surrounding residues from cleavage. Several studies have reported that peptides
derived from crystallin proteins form HMWCs during the onset of age-related cataract
formation (Ramalho et al., 1996; Santhoshkumar et al., 2008; Su et al., 2015). These peptides
are believed to form via autolytic cleavage at serine residues in the lens nucleus with age (Su
et al., 2012). Notably, there is a serine residue one residue away from N78 (Figure 5.3), and
thus this region may be susceptible to autolytic cleavage in the lens. However, if deamidation
of N78 inhibits cleavage of αB in vivo, this may act as a protective mechanism to prevent
protein cleavage that could lead to cataract. The possibility that N78 deamidation may not be
involved in cataract formation is supported by previous findings that deamidation at N78
does not affect the chaperone activity or oligomeric size of αB (Gupta and Srivastava, 2004).
Hains and Truscott (2010) previously reported that αB was deamidated at asparagine residues
at a ~3-fold higher rate than glutamine residues in the human lens. This can likely be
attributed to the lower thermodynamic stability of succinimide intermediates formed by
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asparagine residues (Wright, 1991; Robinson and Robinson, 2004a; Li et al., 2010). With the
exception of N78 in peptide 1 and Q26 in peptide 5, the current results support this finding of
a higher rate of deamidation at asparagine residues compared to glutamines (Figure 5.4,
Table 5.5). Deamidation of N78 (peptide 2) and N146 (peptide 3 and peptide 8) was, on
average, 3.3-fold higher than the amount of deamidation measured at Q151 (peptide 4 and
peptide 7) and Q108 (peptide 6). However, the average amount of deamidation for asparagine
and glutamine residues reported here (46.5% and 26.2%, respectively) were higher than the
amount reported by Hains and Truscott (2010) in vivo (22.6% and 6.6%, respectively). This
difference can be attributed to different experimental conditions (i.e. in vivo versus in vitro
conditions) as well high levels of deamidated Q26 (peptide 5) in this work. When Q26 is
excluded from the analysis, asparagine and glutamine were deamidated to the same extent as
reported by Hains and Truscott (i.e. 3:1) (2010), thus suggesting a similar preference for
asparagine residue deamidation in vitro. As Q26 is located within an α-helical region it may
be expected to be deamidated to a lesser extent than Q151 which lies within an unstructured
coil region (Figure 5.5A). Additionally, as all three glutamine residues (i.e. Q26, Q108 and
Q151) are surface exposed (Figure 5.5B), the mechanism of the higher amount of
deamidation at Q26 (peptide 5) compared to Q151 (peptide 4 and peptide 7) and Q108
(peptide 6) (Figure 5.4, Table 5.5) is currently unclear.

Figure 5.5: Model of αB indicating location of Q26, Q108 and Q151. Model of the (A)
monomer depicted as a ribbon representation (β-sheets – orange, α-helices – blue, coil – grey)
and the (B) 24mer depicted as a surface representation of human αB (pdb entry 3J07; Jehle et
al. (2011)). The deamidated residues Q26 (red), Q108 (magenta) and Q151 (green) are
solvent exposed. The red box indicates the area presented as inset.
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The only residues for which the amount of deamidation was significantly affected by
treatment were N146 (peptide 8) and Q151 (peptide 7), whereby changes in buffer pH, but
not protein unfolding, increased the amount of deamidation of these sites (Figure 5.4, Table
5.5). These residues lie within five residues of each other (Figure 5.4); N146 lies within the
β9-strand of the ACD and Q151 lies within the hinge loop region (Laganowsky et al., 2010).
As deamidation of these sites was not affected by unfolding (Table 5.5), this suggests that
surface exposure was not a limiting factor. This was confirmed by mapping the location of
N146 and Q151 in a structural model of oligomeric αB (Figure 5.4). Both residues are highly
solvent exposed in the αB oligomer (Figure 5.5A), making them susceptible to nonenzymatic deamidation. Deamidation is also facilitated by the conformational flexibility of
the surrounding region (Truscott and Friedrich, 2016), as well as the presence of
neighbouring glycine and basic residues (Hains and Truscott, 2010). As such, the flexibility
of the surrounding hinge loop region may facilitate deamidation of N146 and Q151.
Deamidation of N146 and Q151 may also be further facilitated by the presence of
neighbouring glycine (G147) and arginine residues (R149) respectively, accounting for the
high amount of deamidation at these residues in this study. As the amount of deamidation of
N146 and Q151 was affected by pH, this suggests that the surrounding region may also
undergo conformational changes at lower pHs that make these residues more susceptible to
deamidation, such as a further increase in conformational flexibility. Moreover, since the
amount of deamidation was significantly increased in the heat-treated PBS sample compared
to the untreated PBS sample for N146 but not Q151 (Figure 5.4, Table 5.5), this suggests that
Q151 is more susceptible to deamidation under conditions that promote changes in
conformation than N146.
In addition to being highly solvent exposed, N146 is positioned in close proximity to the
subunit interaction site of αB (Figure 5.6). As deamidation induces a structural change in the
protein, it is likely that deamidation of N146 may interfere with subunit interactions, causing
the dissociation of dimers from the αB oligomer. It has previously been shown that αB
deamidation mutants (N146D and N78D αB) have increased binding affinity for βA3crystallin compared to WTαB (Tiwary et al., 2015). It is therefore plausible that dimer
dissociation induced by deamidation at N146 may result in the exposure of substrate binding
sites, thereby increasing the substrate affinity of αB. This can be tested experimentally by
measuring structural changes in N146D and N78D mutants using techniques such as circular
dichroism. Changes in hydrophobic exposure can be examined using intrinsic tryptophan
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fluorescence, and resulting changes in oligomeric size can then be observed using methods
such as size exclusion chromatography or native mass spectrometry. If this results in
irreversible substrate binding, this may account for the high levels of deamidation observed in
insoluble protein fractions from human lenses (Hanson et al., 2000; Srivastava and
Srivastava, 2003).
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Figure 5.6: A model of the structure of oligomeric αB highlighting the position of
deamidation sites N146 and Q151 identified in this work. Model of the 24-mer (i) and
dimer forms (ii) of αB (pdb entry 3J07; Jehle et al. (2011)) depicted as a (A) ribbon
representation and as a (B) surface representation highlighting the secondary structure
elements (β-sheets – orange, α-helices – blue). The deamidated residues N146 (green) and
Q151 (magenta) are highly solvent exposed at the surface of the oligomer, and are located in
close proximity to sites of subunit interaction. Red boxes indicate area presented as inset.
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5.5 Conclusion
Non-enzymatic deamidation of αB has been implicated in protein insolubilisation in the lens
and cataract formation. To study this, in vitro studies often use recombinant protein as an
experimental model. However, non-enzymatic deamidation of αB resulting from expression,
storage or treatment conditions can affect the structure and therefore function of the protein.
The results in this chapter indicate that deamidation of αB at Q151 and N146 can be induced
by common buffer and treatment conditions i.e. neutral pH and high temperatures. It is
therefore important to consider the presence of deamidated residues in recombinant proteins,
and how this may affect protein function and chaperone assays. Such modifications need to
be taken into account to interpret experimental results appropriately. As similar conditions to
those that were shown to induce deamidation in vitro exist in the nucleus of the aging lens,
these results also provide an insight into the susceptibility and potential consequences of nonenzymatic deamidation in vivo.
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6.1 Conclusions
Despite its pivotal role in maintaining the health and transparency of the lens, αB has also
been implicated in various pathological states (Shinohara et al., 1993; Chin et al., 2005;
Kamradt et al., 2005; Moyano et al., 2006; Liu et al., 2015; Yilmaz et al., 2015). This thesis
investigated the possible role that phosphorylated αB plays in age-related cataract formation
by addressing four separate aims. The first aim was to determine how the addition of a
negative charge, similar to that added by phosphorylation, modulates the chaperone activity
of αB. To achieve this, the ability of αB isoforms with mutations that mimic phosphorylation
to inhibit the heat-induced aggregation of CPK was assessed using aggregation assays. The
second aim was to compare αB phosphorylation profiles across different regions, sucrose
density gradient fractions and ages of human lenses in order to determine whether αB
phosphorylation could be involved in protein insolubilisation. This was achieved by isolating
fractions from lenses using sucrose density gradient centrifugation, and assessing the
phosphorylated status of αB in the fractions by 2D SDS-PAGE. The constituents of HMWCs
were determined, and modification sites identified, by MS/MS analysis of 2D spots with
masses of 40-100 kDa. The third aim was to identify interactions between αB and abundant
membrane proteins (AQP0 and Cx46) at fibre cell membranes to determine how association
of αB with membranes may contribute to barrier formation. This was achieved by colabelling lens sections for αB and membrane proteins using a Duolink® proximity assay kit,
and visualising interactions across the section using confocal microscopy. The final aim was
to determine which αB residues are susceptible to non-enzymatic deamidation. To do this,
recombinant human αB was heat-treated under acidic (~pH 3.0), alkaline (~pH 8.0) and
unfolding buffer conditions, and deamidation sites were identified using MS. Taken together,
the results of the current thesis suggest that αB participates in multiple pathways that
ultimately can facilitate cataract formation in the lens.

6.2 A potential role of phosphorylation and deamidation
Previous studies have provided conflicting results into how the addition of a negative charge,
designed to mimic phosphorylation, affects the chaperone activity of αB (Ito et al., 2001;
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Kamei et al., 2001; Augusteyn et al., 2002; Aquilina et al., 2004; Ecroyd et al., 2007). The
results of this study indicate that WTαB, at concentrations equal to the substrate, induces
protein aggregation following heat treatment (section 3.3.1). Although it is likely that this
occurs via co-deposition of αB with the substrate protein (Aquilina et al., 2004; Ecroyd et al.,
2007), this was not confirmed in the present study. The ability of αB to inhibit the
aggregation of substrate (i.e. CPK) was, however, significantly increased with the addition of
multiple negative charges, such that the introduction of 3 negative charges (via aspartate
substitution at Ser19, Ser45 and Ser59) inhibited CPK aggregation by 83.9±1.3% (section
3.3.1). These results are consistent with previous findings that mutations that mimic
phosphorylation of αB act to increase its capacity to inhibit stress-induced protein
aggregation compared to the WT chaperone (Ghosh et al., 2006; Ecroyd et al., 2007; Ahmad
et al., 2008). It has been proposed that this increase in chaperone activity is a result of the
dissociation of αB oligomers into higher activity monomers (Ecroyd et al., 2007; Peschek et
al., 2013) which have higher substrate affinity (Koteiche and Mchaourab, 2003; Ecroyd et al.,
2007). If a similar mechanism occurs in the lens acts to maintain sufficient αB activity to
maintain protein solubility. It is possible, however, that if substrate affinity is increased to the
point of irreversible substrate binding, co-deposition of αB with the substrate protein may
occur (Aquilina et al., 2004; Ecroyd et al., 2007).
Although mutations of cytoskeletal proteins in the lens have been implicated in cataract
formation (Conley et al., 2000; Jakobs et al., 2000; Alizadeh et al., 2002; Alizadeh et al.,
2003; Ramachandran et al., 2007; Muller et al., 2009), modification of these proteins have
been largely overlooked. This study reported evidence of the formation of crosslinked protein
complexes involving αA, αB and filensin, suggesting that the association of αB with fibre cell
membranes may be mediated by interactions with cytoskeletal components. Such complexes
have been reported previously, but have not been well characterised in lenses over the age of
45 (Srivastava et al., 2004). The predominance of αA, particularly C-terminally truncated αA,
in these complexes led to the suggestion that they were first formed via crosslinking between
crystallin proteins (Srivastava et al., 2004). Furthermore, it was suggested that these
crosslinks were mediated by αA oxidation and serine to DHA conversion, with the agerelated addition of intermediate filaments, including filensin, in older lenses (Srivastava et al.,
2004). This study characterised HMWCs isolated from a 77 year-old lens; filensin was found
to be the predominant protein in these complexes, followed by αA (Figure 3.9). Without
further comparisons with lenses from different age ranges, it remains to be established
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whether the predominance of filensin in the complexes isolated from this older lens is a result
of the age-related incorporation of intermediate filaments into crosslinked crystallin
complexes, or the result of age-related binding of crystallins to the intermediate network.
While filensin, αA and αB in the HMWCs were all N- and C-terminally truncated, αA was
more extensively truncated than previously reported (Srivastava et al., 2004), suggesting that
proteolytic cleavage, particularly of αA, may contribute to complex formation. Additionally,
a high degree of deamidation of filensin was also detected, particularly at N303 (29.2-66.8%
for each complex), which resides in the rod domain of the protein (Table 3.3). High levels of
deamidation were also detected at N383 and N478 in the tail domain (Table 3.3). However,
as peptides containing N383 and N478 were not detected for most complexes (likely due to
C-terminal truncation), this suggests that N303 plays a larger role in complex formation. It
remains to be determined how deamidation at N383 contributes to complex formation.
However, as deamidation-induced isomerisation can cause partial unfolding of proteins
(Takata and Fujii, 2015), it is conceivable that structural changes in filensin caused by
deamidation at N303, in conjunction with increased substrate affinity of phosphorylated αB,
may trigger αB to associate with the intermediate network at fibre cell membranes.
Together these results suggest that, whether through direct interaction or by accumulation of
proteins at fibre cell membranes, the association of αB at fibre cell membranes may obstruct
membrane pores, contributing to the formation of the nucleocortical barrier at middle age.
Based on the results of the work presented here, a new model of how αB contributes to agerelated nuclear cataract formation in proposed (Figure 6.1).
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Figure 6.1: Possible roles of αB in age-related nuclear cataractogenesis. In aged lenses,
(1) phosphorylation (red circles) of multiple serine residues in cortical αB (green oval) results
in an increase in the chaperone activity of αB. (2) Deamidation (orange circles) of
cytoskeletal proteins, including filensin (red lines), induces protein unfolding, increasing
substrate affinity of cytoskeletal proteins and, together with the increase in the chaperone
activity of αB, induces association of αB at fibre cell membranes. Association of αB with
fibre cell membranes occludes (3A) Cx46 pores (purple ovals) inhibiting GSH transport, and
(3B) AQP0 pores (pink ovals) inhibiting water transport from the cortex (dark blue) into the
nucleus (light blue), leading to the formation of the nucleocortical barrier (dashed line) at
middle age. (4) An increased level of oxidation in the nucleus, as a result of decreased GSH
transport from the cortex, results in the formation of crosslinked HMW protein complexes
involving filensin, αA (blue oval) and αB. (5A) Age-related, non-enzymatic deamidation of
αB (e.g. at N146 and Q151) decreases the chaperone activity of the remaining noncomplexed αBand (5B) deamidation of nuclear proteins, such as filensin, increases the
recruitment of proteins into HMWCs. (6) Reduced activity of non-complexed αB, and the
loss of soluble, chaperone-active αB into HMWCs in the nucleus results in these protein
complexes becoming insoluble. Together with protein oxidation, this leads to nuclear cataract
formation.
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6.2.1 Barrier to GSH transport
To investigate how the association of αB at fibre cell membranes may be involved in barrier
formation, 2D profiles of membrane proteins fractions were compared (section 3.3.2), and the
distribution of interactions between αB and abundant membrane pore proteins (i.e. Cx46 and
AQP0) was mapped across human lens sections (section 4.3.2).
Two dimensional electrophoretic profiles of high density protein fractions of aged human
lenses showed increased amounts of highly phosphorylated αB isotypes compared to low
density fractions (section 3.3.2). As these high density fractions have previously been shown
to represent membrane associated protein (Friedrich and Truscott, 2009; Friedrich and
Truscott, 2010), this suggests that increased αB phosphorylation leads to increased membrane
association.
The association of αB with Cx46 and AQP0 was restricted to the cortical region of the lens
(outer 500 µm for AQP0 and outer 250 µm for Cx46) (section 4.3, section 4.4.2) (section
3.4.2). This region coincides with the onset of the association of αB with fibre cell
membranes (i.e. zone 3) (section 4.3.1) and the putative location of the nucleocortical barrier
(section 4.4.2). It has been previously postulated that the presence of this barrier may cause
the decrease in nuclear GSH that is believed to be a precursor to cataract formation (Cobb
and Petrash, 2002b; Friedrich and Truscott, 2009; Friedrich and Truscott, 2010). The
association of αB with membrane proteins, particularly Cx46, reported in this study supports
this hypothesis. If, as a result of this association between αB and Cx46, these gap junctions
become obstructed, GSH transport into the nucleus may be hindered leading to a decrease in
nuclear GSH concentrations and the accumulation of oxidative protein damage (Figure 6.1).
This would potentially result in the formation of HMWCs, such as those observed during this
study (section 3.4.3). Furthermore, the presence of an additional oxidation site at M649 on
filensin corresponded with a ~2-fold increase in the size of the complexes reported in this
study (section 3.4.3). It has been proposed that the insolubility of such complexes is the
dominant pathway leading to insoluble protein associated with cataract formation (Smulders
et al., 1998). Additionally, the increased susceptibility of proteins to non-enzymatic
deamidation in the nucleus could also contribute to the recruitment of proteins into HMWCs,
while reducing the chaperone activity of αB (Gupta and Srivastava, 2004; Asomugha et al.,
2011). The loss of soluble and chaperone-active αB, due to its incorporation into crosslinked
complexes, could then be a mitigating factor in cataract formation (Figure 6.1).
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6.3 Future directions
This study utilised αB phosphomimics to determine how phosphorylation may affect the
chaperone activity of αB (section 3.3.1). Phosphomimics are often used as they impart a
negative charge to proteins similar to phosphorylation, while allowing the targeting of
specific residues to give a homogeneous product. However, as phosphomimics are nonphysiological and impart a single charge compared to the double negative charge introduced
by phosphorylation, their relevance as models of the effect of phosphorylation is limited.
Although some residue specificity is lost, protein kinases are commercially available, and can
be used to induce phosphorylation of recombinant protein in vitro. For example,
commercially available MAPKAP2, the kinase responsible for phosphorylation of Ser59
(Kato et al., 1998), could be used to phosphorylate Ser59 of αB in vitro. This would provide a
more physiologically relevant model of phosphorylated αB, and may provide further insight
into how the chaperone activity of αB is regulated by phosphorylation.
Although interactions between αB and membrane proteins (i.e. Cx46 and AQP0) were
observed in this work (section 4.3.2), it is possible that membrane association could also be
mediated by association of αB with cytoskeletal components or membrane phospholipids.
Previous reports regarding this have been conflicting. For example, Mulders et al. (1985)
reported that α-crystallin associated only with fibre cell membrane extracts that retained some
native proteins, while association with artificial phospholipid vesicles only occurred when the
vesicles had been reconstituted with MP26 (Mulders et al., 1985). However, Cobb and
Petrash (2002a) later reported that α-crystallin was able to bind artificial phospholipid
bilayers in the absence of all proteins. Performing further substrate binding and membrane
affinity assays may elucidate the precise nature by which αB associates with membranes cells
from the lens. Furthermore, the use of αB phosphomimics for such assays would provide
further insight into how phosphorylation affects this process.
Deamidation of αB at both N146 and Q151 was increased by heat-treatment under neutral
conditions (Table 5.5, section 5.4). While deamidation at N146 is well characterised and
known to reduce chaperone activity of αB (Gupta and Srivastava, 2004; Asomugha et al.,
2011), deamidation at Q151 has not been investigated due to its relatively low abundance in
vivo. Mutants that mimic deamidation at asparagine residues of αB (i.e. N→D substitutions)
have been extensively used to study the functional impact of deamidation of proteins (Gupta
and Srivastava, 2004; Asomugha et al., 2011; Tiwary et al., 2015). Additionally, Q85E and
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Q180E mutants have been used previously for structural studies of βA3-crystallin (Takata et
al., 2008). However, to our knowledge, studies utilising Q→E mutants to mimic deamidation
at glutamine residues of αB have not been previously attempted. Performing aggregation
assays utilising αB Q→E deamidation mimics may help elucidate whether deamidation at
Q151 has a similar detrimental effect on αB function.

6.4 Conclusion
The results of this work provide evidence of a role for αB in multiple pathways that
culminate in the formation of age-related nuclear cataract. The model described in this thesis
proposes that phosphorylation of αB increases its molecular chaperone activity, thereby
inducing association with highly deamidated intermediate filament proteins (i.e. filensin) at
fibre cell membranes. This results in the occlusion of membrane pore proteins, including
Cx46 and AQP0, leading to the formation of a physical barrier to diffusion into the nucleus
i.e. the nucleocortical barrier. The presence of this barrier inhibits the transport of GSH into
the nucleus of the lens, leading to low levels of nuclear GSH and the accumulation of
oxidative damage, resulting in the formation of crosslinked HMW complexes involving αB.
The accumulation of non-enzymatic deamidation of αB, together with the loss of soluble,
chaperone-active αB, is then suggested to lead to the insolubilisation of HMW complexes,
resulting in cataract formation.
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Appendix 1

Phosphorylation sites identified in human lens αA-crystallin.
Site

Reference

S20

Wang et al., 2013; Wang et al., 2014

S45

Wang et al., 2013; MacCoss et al., 2002

S51

Wang et al., 2013

S59

Wang et al., 2013; Wang et al., 2014

S62

Wang et al., 2013; Wang et al., 2014

S66

Huang et al., 2011; Wang et al., 2013

S81

Huang et al., 2011 ; Wang et al., 2013

S122

Wilmarth et al., 2013; Wang et al., 2013; Searle et al., 2004; MacCoss et al., 2002;
Miesbauer et al., 1994

S127

Wang et al., 2013

S130

Wang et al., 2013

S134*

Previously unreported

S162

Wang et al., 2013; Wang et al., 2014

S172

Wang et al., 2013

S173

Wang et al., 2013

T13

MacCoss et al., 2002; Wang et al., 2013; Wang et al., 2014

T43

Wang et al., 2013

T55

Wang et al., 2013

T86

Wang et al., 2013

T140

MacCoss et al., 2002

T148

Huang et al., 2011; Wang et al., 2013; Wang et al., 201

T168/S169

Wang et al., 2013

T153

Huang et al., 2011; Wang et al., 2013

Y47

Wang et al., 2013

Y118

Wang et al., 2013
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Phosphorylation sites identified in human lens αB-crystallin.
S19

Wang et al., 2013; Wilmarth et al., 2006; Huang et al., 2011; MacCoss et al., 2002;
Miesbauer et al., 1994

S21

Huang et al., 2011; Wang et al., 2013; MacCoss et al., 2002

S43

Wang et al., 2013; MacCoss et al., 2002

S45

MacCoss et al., 2002; Miesbauer et al., 1994; Wang et al., 2013

S53

Wang et al., 2013; Wang et al., 2014; MacCoss et al., 2002

S59

Wilmarth et al., 2006; Huang et al., 2011; Wang et al., 2013; Wang et al., 2014;
Searle et al., 2004; MacCoss et al., 2002; Kamei et al., 2000; Miesbauer et al.,
1994

S66

Wang et al., 2013

S76

Wilmarth et al., 2006; Huang et al., 2011; Wang et al., 2013; MacCoss et al., 2002

S85

Wang et al., 2013

S136

Wang et al., 2013

S138

Wang et al., 2013; Wang et al., 2014

S139

Huang et al., 2011; Wang et al., 2013; Wang et al., 2014

S153

Wang et al., 2013

T63

Wang et al., 2013

T170

Wang et al., 2014

T132

Wang et al., 2013

T134

Wang et al., 2013

T158

Wang et al., 2013
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Deamidation sites identified in human lens αA and αB-crystallin.
Subunit

Site

Reference

αA

Q6

Lund et al., 1996; Hanson et al.,
2000; Searle et al., 2005; Wilmarth
et al., 2006

Q50

Lund et al., 1996; Wilmarth et al.,
2006

Q90

Lund et al., 1996; Hanson et al.,
2000; Searle et al., 2005; Hains
and Truscott, 2010

Q104

Hanson et al., 2000; Hains and
Truscott, 2010

Q126

Wilmarth et al., 2006 ; Hains and
Truscott, 2010

Q147

Lund et al., 1996; Hanson et al.,
2000; Searle et al., 2005; Hains
and Truscott, 2010

N101

Lund et al., 1996; Wilmarth et al.,
2006

N123

Searle et al., 2005; Wilmarth et al.,
2006; Hains and Truscott, 2010

αB

Q26

Wilmarth et al., 2006; Hains and
Truscott, 2010

Q108

Lund et al., 1996; Hanson et al.,
2000; Srivastava and Srivastava,
2003; Hains and Truscott, 2010

N78

Hanson et al., 2000; Hains and
Truscott, 2010

N146

Searle et al., 2005; Wilmarth et al.,
2006; Asomugha et al., 2010;
Hains and Truscott, 2010
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Appendix 2
Buffers:
PBS: 137 mM NaCl, 2.7 mM KCl, 12.5 mM Na2HPO4, 1 mM KH2PO4, pH 7.4
Sucrose buffer: 10 mM Tris-base, 2 mM EDTA, 2 mM BME, adjusted to pH 8.0 with 10 M
HCl
SSS buffer: 8 M Urea, 100 mM DTT, 4% w/v CHAPS, 0.8% v/v 100x BioLyte® 3/10
Carrier Ampholyte, 100 mM Tris-base
2 times loading buffer: 125 mM Tris-HCl, 0.03% w/v bromophenol blue, 33% glycerol, 3.3%
w/v SDS. Prior to use, 1 M DTT in 10 mM sodium acetate (pH 5.2) was added at the ratio
1:4, for a final DTT concentration of 200 mM.
Coomassie stain: 40% v/v methanol, 10% v/v acetic acid, 0.2% w/v coomassie blue R in
milli-Q water
Coomassie destain: 40% v/v methanol, 10% v/v acetic acid in milli-Q water
HBSS buffer: 137 mM NaCl, 5.4 mM KCl, 250 mM Na2HPO4, 0.01% w/v glucose, 440 µM
KH2PO4, 1.3 mM CaCl2, 1 mM MgSO4, 4.2 mM NaHCO3, pH 7.3
TBST: 20 mM Tris-base, 150 mM NaCl, 0.17% Tween-20, adjusted to pH 7.5 with 10 M
HCl
TBS: 20 mM Tris-base, 150 mM NaCl, adjusted to pH 7.5 with 10 M HCl
DAB working solution: one DAB tablet was solubilised in TBS, with 12 µL of 30%
hydrogen peroxide added prior to use.
Equilibration buffer: 6 M Urea, 0.1% w/v SDS, 300 mM Tris-HCl, 20% v/v Glycerol, 0.1%
w/v DTT, 2.5% v/v acrylamide, pH 8.8
Colloidal coomassie stain: 1.3 M ammonium sulphate, 3% v/v phosphoric acid, 0.1% w/v
coomassie G, 34% v/v methanol in milli-Q water. N.B. Coomassie G was solubilised in
ammonium sulphate solution before adding phosphoric acid and methanol to reach final
concentrations.
Colloidal destain: 1% v/v acetic acid in milli-Q water
PFA: PFA was added to PBS to a final concentration of 0.75% w/v. A few drops of 10 M
NaOH were added and the solution was heated at 80°C until fully solubilised, before the pH
was adjusted to 7.4.
Wash buffer A: 0.01 M Tris-base, 0.15 M NaCl, 0.05% v/v Tween-20, adjusted to pH 7.4
with 10 M HCl
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Wash buffer B: 0.2 M Tris-base, 0.1M NaCl, adjusted to pH 7.5 with 10 M HCl
0.01x wash buffer B: 100x dilution of wash buffer B
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Appendix 3

Heat induced aggregation of WTαB and αB containing single, double or triple
mutations that mimic phosphorylation. WT, 1P, 2P or 3P αB was incubated in PBS (pH
7.4) at 40°C at a concentration of either (A) 0.5 µM or (B) 0.25 µM, and the change in light
scatter at 360 nm was measured over time.

Heat induced aggregation of WTαB and αB containing mutations that mimic
phosphorylation at Ser19, Ser45 or Ser59. WT, S19D, S45D or S59D αB was incubated in
PBS (pH 7.4) at 40°C at a concentration of either (A) 0.5 µM or (B) 0.125 µM, and the
change in light scatter at 360 nm was measured over time.
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Results of ANOVA of CPK aggregation assays. Test performed on experimental end-point
values from data presented in Figures 3.3.1 and 3.3.2 for relative amount of CPK aggregation
following incubation with αB (at molar ratios of 1cpk:1αB, 1cpk:2αB or 1cpk:1αB) with multiple
or single aspartate substitutions. N=3
P
-11
Multiple 1cpk:1αB
6.26
(data in Figure 3.3.1A)
-11
Multiple 1cpk:2αB
1.36
(data in Figure 3.3.1B)
-7
Single 1cpk:1αB
3.67
(data in Figure 3.3.2A)
-4
Single 1cpk:4αB
1.54
(data in Figure 3.3.2B)

F

Fcrit

52.8 2.5
63.1 2.5
18.3 2.5
7.8

2.5

Tukey’s test of aggregation assay performed on data presented in Figure 3.1A: Test
performed on experimental end-point values for relative amount of CPK aggregation
following incubation with αB (at molar ratios of 1cpk:1αB) with single (1P), double (2P) or
triple (3P) aspartate substitutions. Statistical significance at P<0.05 shaded in dark green,
P<0.01 shaded in light green. N=3.
CPK
CPK
WT/CPK
1P/CPK
2P/CPK
3P/CPK
WT
1P
2P
3P

WT/CPK 1P/CPK 2P/CPK 3P/CPK WT
1P
2P
3P
0.001
0.9 0.195 0.009 0.003 0.003 0.005 0.007
0.001
0.001 0.001 0.001 0.001 0.001 0.001 0.001
0.9
0.001
0.049 0.002 0.001 0.001 0.001 0.001
0.195
0.001 0.049
0.769 0.497 0.515 0.631 0.693
0.009
0.001 0.002 0.769
0.9
0.9
0.9
0.9
0.003
0.001 0.001 0.497
0.9
0.9
0.9
0.9
0.003
0.001 0.001 0.515
0.9
0.9
0.9
0.9
0.005
0.001 0.001 0.631
0.9
0.9
0.9
0.9
0.007
0.001 0.001 0.693
0.9
0.9
0.9
0.9

Tukey’s test of aggregation assay performed on data presented in Figure 3.1B: Test
performed on experimental end-point values for relative amount of CPK aggregation
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following incubation with αB (at molar ratios of 1cpk:2αB) with single (1P), double (2P) or
triple (3P) aspartate substitutions. Statistical significance at P<0.05 shaded in dark green,
P<0.01 shaded in light green. N=3.
CPK

WT/CPK 1P/CPK 2P/CPK 3P/CPK WT
1P
0.9 0.134 0.001 0.001 0.001
0.9
0.392 0.001 0.001 0.001
0.134
0.392
0.049 0.001 0.001
0.001
0.001 0.049
0.001 0.001
0.001
0.001 0.001 0.001
0.9
0.001
0.001 0.001 0.001
0.9
0.001
0.001 0.001 0.001
0.9
0.9
0.001
0.001 0.001 0.001
0.9
0.9
0.001
0.001 0.001 0.008 0.513
0.43

CPK
WT/CPK
1P/CPK
2P/CPK
3P/CPK
WT
1P
2P
3P

2P
0.001
0.001
0.001
0.001
0.9
0.9
0.9
0.579

3P
0.001
0.001
0.001
0.001
0.9
0.9
0.9

0.001
0.001
0.001
0.008
0.513
0.43
0.579
0.62

0.62

Tukey’s test of aggregation assay performed on data presented in Figure 3.2A: Test
performed on experimental end-point values for relative amount of CPK aggregation
following incubation with αB (at molar ratios of 1cpk:1αB) with single aspartate substitutions
at Ser19 (S19D), Ser45 (S45D) or Ser59 (S59D). Statistical significance at P<0.05 shaded in
dark green, P<0.01 shaded in light green. N=3.
CPK
CPK
WTαB/CPK
S19D/CPK
S45D/CPK
S59D/CPK
WTαB
S19D
S45D
S59D

WTαB/CPK S19D/CPK S45D/CPK S59D/CPK WTαB S19D
S45D
S59D
0.001
0.9
0.9
0.9
0.031
0.025
0.022
0.02
0.001
0.001
0.001
0.001
0.001
0.001
0.001 0.001
0.9
0.001
0.9
0.9
0.044
0.035
0.031 0.028
0.9
0.001
0.9
0.9
0.049
0.04
0.035 0.031
0.9
0.001
0.9
0.9
0.177
0.148
0.131
0.12
0.031
0.001
0.044
0.049
0.177
0.9
0.9
0.9
0.025
0.001
0.035
0.04
0.148
0.9
0.9
0.9
0.022
0.001
0.031
0.035
0.131
0.9
0.9
0.9
0.02
0.001
0.028
0.031
0.12
0.9
0.9
0.9
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Tukey’s test of aggregation assay performed on data presented in Figure 3.2B: Test
performed on experimental end-point values for relative amount of CPK aggregation
following incubation with αB (at molar ratios of 1cpk:4αB) with single aspartate substitutions
at Ser19 (S19D), Ser45 (S45D) or Ser59 (S59D). Statistical significance at P<0.05 shaded in
dark green, P<0.01 shaded in light green. N=3.
CPK
CPK
WTαB/CPK
S19D/CPK
S45D/CPK
S59D/CPK
WTαB
S19D
S45D
S59D

WTαB/CPK S19D/CPK S45D/CPK S59D/CPK WTαB S19D
S45D
S59D
0.1
0.9
0.9
0.9
0.116
0.166
0.138
0.307
0.1
0.017
0.024
0.008
0.001
0.001
0.001
0.001
0.9
0.017
0.9
0.9
0.476
0.585
0.529
0.79
0.9
0.024
0.9
0.9
0.39
0.5
0.443
0.705
0.9
0.008
0.9
0.9
0.684
0.792
0.736
0.9
0.116
0.001
0.476
0.39
0.684
0.9
0.9
0.9
0.166
0.001
0.585
0.5
0.792
0.9
0.9
0.9
0.138
0.001
0.529
0.443
0.736
0.9
0.9
0.9
0.307
0.001
0.79
0.705
0.9
0.9
0.9
0.9
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Peptides detected from HMW1-10: peptides were detected using MS/MS (APAF) and
identified by comparison with a peptide database. Modified residues in peptide sequences are
highlighted red.
Protein

Mass

Residues

Sequence

Complex 1
Filensin

Peptide
Mass
(Da)

74499

797.54
1014.54
1098.64
1131.6
1182.67
1279.66
1306.63
1310.68
1371.69
1486.83
1554.78
1555.76
1618.81
1634.87
1635.86
1671.9
1725.94
1726.92
1788.93
1979
2060
2252.1
2457.22
2722.33

399-405
484-492
294-303
621-630
352-362
147-157
457-467
78-90
380-392
399-411
470-483
470-483
454-467
144-157
144-157
240-254
294-308
294-308
158-173
223-239
158-175
418-439
631-652
24-50

2831.47
3338.79

320-347
179-208

3724.97

179-211

1265.62
1359.79
1878.98
2081
2179.1
979.57
1036.53
1174.62
3363.64
1728.89
1896.98
1622.78
1638.77
1168.71
1532.84
1538.9

201-211
77-89
122-137
174-191
221-239
71-78
13-21
55-65
22-49
159-174
132-146
233-245
233-245
130-139
223-235
130-143

K.LVQVVLK.E
R.FYVSSITAK.G
R.QLAVAQQTLK.N
K.TVEVVESIEK.I
R.ALQDITAAKPR.Q
K.EADEALLHNLR.L
K.EPETPTELYTK.E
R.LGELAGPEDALAR.Q
K.DKTDGALEDAPLK.G
K.LVQVVLKEESESK.F
R.HVLVTGDANYVDPR.F
R.HVLVTGDADYVDPR.F
R.SPKEPETPTELYTK.E
R.LNKEADEALLHNLR.L
R.LDKEADEALLHNLR.L
R.VELQAQTTTLEQAIK.S
R.QLAVAQQTLKNELDR.Y
R.QLAVAQQTLKDELDR.Y
R.LQLEAQFLQDDISAAK.D
R.SQLEEGREVLSHLQAQR.V
R.LQLEAQFLQDDISAAKDR.H
K.EVSPLTQEGAPEDVPDGGQISK.G
K.ISTESIQTYEETAVIVETMIGK.T
R.AAEPERPADEGWAGATSLAALQGLGER.
V
R.LTSAFIETPIPLFTQSHGVSLSTGSGGK.D
K.NLLEVQTYISILQQIIHTTPPASIVTSGMR.
E
K.NLLEVQTYISILQQIIHTTPPASIVTSGMRE
EK.L
K.AAEEEINSLYK.V
R.ALGISSVFLQGLR.S
K.VHALEQVSQELETQLR.M
R.LMLQTETIQAGADDFKER.Y
K.MDLESQIESLKEELGSLSR.N
K.FVIFLDVK.H
R.TLGPFYPSR.L
R.TVLDSGISEVR.S
R.LFDQFFGEGLFEYDLLPFLSSTISPYYR.Q
R.KPIDWGAASPAVQSFR.R
K.VLEGVWIFYELPNYR.G
K.DVFLGMFLYEYAR.R
K.DVFLGMFLYEYAR.R
K.ILLAELEQLK.G
R.KVESLQEEIAFLK.K
K.ILLAELEQLKGQGK.S

942.51
1098.64
1182.67
1279.65
1280.64
1310.68
1371.69
1486.82
1634.87
1635.86
1635.86
1671.9
1725.94

312-319
294-303
352-362
147-157
147-157
78-90
380-392
399-411
144-157
144-157
144-157
240-254
294-308

R.IIEIEGNR.L
R.QLAVAQQTLK.N
R.ALQDITAAKPR.Q
K.EADEALLHNLR.L
K.EADEALLHDLR.L
R.LGELAGPEDALAR.Q
K.DKTDGALEDAPLK.G
K.LVQVVLKEESESK.F
R.LNKEADEALLHNLR.L
R.LNKEADEALLHDLR.L
R.LDKEADEALLHNLR.L
R.VELQAQTTTLEQAIK.S
R.QLAVAQQTLKNELDR.Y

Phakinin

45851

αA-Crystrallin

19897

γS-Crystallin

20993

Serum Albumin

69321

Vimentin

53619

Complex 2
Filensin

74499

Modification

Mod.
Site

Deamidation

N383

Deamidation

N478

Deamidation

N145

Deamidation

N304

Oxidation

M649

Oxidation

M207

Oxidation

M207

Oxidation
Oxidation

M175
M221

Oxidation

M238

Deamidation

N155

Deamidation

N383

Deamidation
Deamidation

N155
N145
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Phakinin

45851

βB1-Crystallin

28006

Retinal
Dehydrogenase 1

54827

1726.92
1771.88
1788.93
1840.87

294-308
382-398
158-173
125-138

R.QLAVAQQTLKDELDR.Y
K.TDGALEDAPLKGLEDTK.L
R.LQLEAQFLQDDISAAK.D
R.SKYENECECQLLLK.E

1979.02
2060.05
2639.18
2722.33

223-239
158-175
255-275
24-50

2767.28
2768.26

255-276
255-276

R.SQLEEGREVLSHLQAQR.V
R.LQLEAQFLQDDISAAKDR.H
K.SAHECYDDEIQLYNEQIETLR.K
R.AAEPERPADEGWAGATSLAALQGLGER.
V
K.SAHECYDDEIQLYNEQIETLRK.E
K.SAHECYDDEIQLYDEQIETLRK.E

2831.47
3338.79

320-347
179-208

1265.61
1353.72
1359.79
1801.92
1878.98
2081.01
2442.18
1124.59
1449.76
1456.7
1718.82
2007.04
1188.6

201-211
90-103
77-89
6-22
122-137
174-191
319-339
151-160
61-72
203-214
188-202
93-110
69-78

R.LTSAFIETPIPLFTQSHGVSLSTGSGGK.D
K.NLLEVQTYISILQQIIHTTPPASIVTSGMR.
E
K.AAEEEINSLYK.V
R.SSGLATVPAPGLER.D
R.ALGISSVFLQGLR.S
R.VVVDLPTSASSSMPLQR.R
K.VHALEQVSQELETQLR.M
R.LMLQTETIQAGADDFKER.Y
R.VELHNTSCQVQSLQAETESLR.A
K.ISLFEGANFK.G
R.LVVFELENFQGR.R
R.GYQYLLEPGDFR.H
K.VSSGTWVGYQYPGYR.G
R.SIIVSAGPWVAFEQSNFR.G
R.QAFQIGSPWR.T

1396.66

101-113

R.LLLATMESMDGGK.L

144-156
421-435
309-321
396-410
93-103
73-82
12-22
57-69
124-149
71-78
13-21
55-65
12-21
89-99
109-120
173-188
169-188
8-19
159-174
132-146
438-452
26-34

R.TIPIDGNFFTYTR.H
R.ANDTFYGLSAGVFTK.D
R.IFVEESIYDEFVR.R
R.IAKEEIFGPVQQIMK.F
K.VLGDVIEVHGK.H
K.DRFSVNLDVK.H
R.RPFFPFHSPSR.L
R.APSWFDTGLSEMR.L
R.IPADVDPLTITSSLSSDGVLTVNGPR.K
K.FVIFLDVK.H
R.TLGPFYPSR.L
R.TVLDSGISEVR.S
K.RTLGPFYPSR.L
K.VQDDFVEIHGK.H
K.IILYENPNFTGK.K
K.DSSDFGAPHPQVQSVR.R
K.GDYKDSSDFGAPHPQVQSVR.R
K.ITFYEDKNFQGR.R
R.KPIDWGAASPAVQSFR.R
K.VLEGVWIFYELPNYR.G
K.KVPQVSTPTLVEVSR.N
R.ALAEGVLLR.T

αA-Crystallin

19897

βB2-Crystallin

23365

γS-Crystallin

20993

Serum Albumin
Glutathione
Synthetase
βA3-Crystallin
Tubulin α-1A
γD-Crystallin
γC-Crystallin
Tubulin β-4A
Complex 3
Brain Acid
Soluble Protein 1

69321
52352

1543.77
1589.77
1644.8
1745.94
1164.65
1191.62
1373.67
1511.67
2623.37
979.57
1036.53
1174.62
1192.63
1285.63
1407.74
1725.8
2189.01
1516.73
1728.89
1896.98
1638.93
940.57

25134
50104
20725
20865
49554

1454.7
1084.61
1270.6
1364.72
1038.59

33-44
78-86
143-152
143-152
310-318

K.ITIYDQENFQGK.R
K.EIIDLVLDR.I
R.QYLLMPGDYR.R
R.QYLLRPQEYR.R
R.YLTVAAVFR.G

22680

1774.85

103-121

K.APEQEQAAPGPAAGGEAPK.A

2297.13
2635.23

98-121
122-149

2763.36

199-226

1014.54
1131.6
1279.65

484-492
621-630
147-157

K.AEPPKAPEQEQAAPGPAAGGEAPK.A
K.AAEAAAAPAESAAPAAGEEPSKEEGEPK.
K
K.AQGPAASAEEPKPVEAPAADSDQTVTVK.
E
R.FYVSSITAK.G
K.TVEVVESIEK.I
K.EADEALLHNLR.L

αB-Crystallin

Filensin

20146

74499

Deamidation
Deamidation

N304
N383

2 Propionamide

C131,
C133

Propionamide

C259

Propionamide
Propionamide,
Deamidation

C259
C259,
N268

Oxidation

M207

Oxidation

M18

Oxidation
Propionamide

M175
C326

2 Oxidation,
Deamidation

M106,
M109,
N110

Deamidation

N423

Oxidation

M409

Oxidation

M68

Oxidation

M147

Deamidation

N218
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Phakinin

45851

Serum Albumin

69321

αA-Crystallin

19897

βB1-Crystallin
αB-Crystallin

28006
20146

Complex 4
Filensin

74499

βB1-Crystallin

28006

αB-Crystallin

20146

αA-Crystallin

βB2-Crystallin

23365

γS-Crystallin

20993

Phakinin
Niban-like
Protein 2

45851
77364

1310.68
1671.9
1788.93
2457.22
1265.61
1359.79
2081.01
2179.07
1622.78
1638.77
1036.53
1174.62
1449.76
920.5
1164.65

78-90
240-254
158-173
631-652
201-211
77-89
174-191
221-239
233-245
233-245
13-21
55-65
61-72
75-82
93-103

R.LGELAGPEDALAR.Q
R.VELQAQTTTLEQAIK.S
R.LQLEAQFLQDDISAAK.D
K.ISTESIQTYEETAVIVETMIGK.T
K.AAEEEINSLYK.V
R.ALGISSVFLQGLR.S
R.LMLQTETIQAGADDFKER.Y
K.MDLESQIESLKEELGSLSR.N
K.DVFLGMFLYEYAR.R
K.DVFLGMFLYEYAR.R
R.TLGPFYPSR.L
R.TVLDSGISEVR.S
R.LVVFELENFQGR.R
R.FSVNLDVK.H
K.VLGDVIEVHGK.H

942.51
1098.64
1182.67
1279.65
1280.64
1310.68
1373.7
1634.87
1635.86
1635.86
1671.9
1725.94
1726.92
1788.93
1979.03
2060.05
2639.18
2722.33

312-319
294-303
352-362
147-157
147-157
78-90
277-287
144-157
144-157
144-157
240-254
294-308
294-308
158-173
223-239
158-175
255-275
24-50

2767.28
2768.26

255-276
255-276

R.IIEIEGNR.L
R.QLAVAQQTLK.N
R.ALQDITAAKPR.Q
K.EADEALLHNLR.L
K.EADEALLHDLR.L
R.LGELAGPEDALAR.Q
K.EIEETERVLEK.S
R.LNKEADEALLHNLR.L
R.LNKEADEALLHDLR.L
R.LDKEADEALLHNLR.L
R.VELQAQTTTLEQAIK.S
R.QLAVAQQTLKNELDR.Y
R.QLAVAQQTLKDELDR.Y
R.LQLEAQFLQDDISAAK.D
R.SQLEEGREVLSHLQAQR.V
R.LQLEAQFLQDDISAAKDR.H
K.SAHECYDDEIQLYNEQIETLR.K
R.AAEPERPADEGWAGATSLAALQGLGER.
V
K.SAHECYDDEIQLYNEQIETLRK.E
K.SAHECYDDEIQLYDEQIETLRK.E

2831.47
3051.55
3316.73

320-347
147-173
320-351

3338.79

179-208

3466.89

178-208

3724.97

179-211

3755.97

312-347

1124.59
1449.77
1456.7
2007.02
2439.13
1164.65
1373.7
2623.37
2624.35
979.57
1036.53
1174.62
1285.63
3363.64
1407.74
1759.83
2189.01
1516.73
1896.98
1359.79
2663.21

151-160
61-72
203-214
93-110
161-182
93-103
12-22
124-149
124-149
71-78
13-21
55-65
88-98
22-49
109-120
146-160
169-188
8-19
132-146
77-89
641-663

R.LTSAFIETPIPLFTQSHGVSLSTGSGGK.D
K.EADEALLHDLRLQLEAQFLQDDISAAK.D
R.LTSAFIETPIPLFTQSHGVSLSTGSGGKDL
TR.A
K.NLLEVQTYISILQQIIHTTPPASIVTSGMR.
E
K.KNLLEVQTYISILQQIIHTTPPASIVTSGMR
.E
K.NLLEVQTYISILQQIIHTTPPASIVTSGMRE
EK.L
R.IIEIEGNRLTSAFIETPIPLFTQSHGVSLSTG
SGGK.D
K.ISLFEGANFK.G
R.LVVFELENFQGR.R
R.GYQYLLEPGDFR.H
R.SIIVSAGPWVAFEQSNFR.G
K.GNTIEIQGDDAPSLWVYGFSDR.V
K.VLGDVIEVHGK.H
R.RPFFPFHSPSR.L
R.IPADVDPLTITSSLSSDGVLTVNGPR.K
R.IPADVDPLTITSSLSSDGVLTVDGPR.K
K.FVIFLDVK.H
R.TLGPFYPSR.L
R.TVLDSGISEVR.S
K.VQDDFVEIHGK.H
R.LFDQFFGEGLFEYDLLPFLSSTISPYYR.Q
K.IILYENPNFTGK.K
R.VQSGTWVGYQYPGYR.G
K.GDYKDSSDFGAPHPQVQSVR.R
K.ITFYEDKNFQGR.R
K.VLEGVWIFYELPNYR.G
R.ALGISSVFLQGLR.S
K.SSANWILAASLLSCSCFRSGFHR.D

Oxidation

M649

Oxidation
Oxidation

M175
M221

Oxidation

M238

Deamidation

N155

Deamidation
Deamidation

N155
N145

Deamidation

N304

Propionamide

C259

Propionamide
Propionamide,
Deamidation

C259
C259
N268

Deamidation

N155

Oxidation

M207

Oxidation

M207

Oxidation

M207

Deamidation

N146

Phosphorylation
, Propionamide

S655,
C656
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Complex 5
Filensin

74499

βB1-Crystallin

28006

αA-Crystallin

19897

αB-Crystallin

20146

Serum Albumin

69321

γS-Crystallin

20993

Phakinin
βB2-Crystallin
Niban-like
Protein 2
Complex 6
Filensin

45851
23365
77364
74499

942.51
1182.67
1279.65
1280.64
1310.68
1634.87
1635.86
1635.86
1671.9
1725.94
1726.92
1788.93
1840.87

312-319
352-362
147-157
147-157
78-90
144-157
144-157
144-157
240-254
294-308
294-308
158-173
125-138

R.IIEIEGNR.L
R.ALQDITAAKPR.Q
K.EADEALLHNLR.L
K.EADEALLHDLR.L
R.LGELAGPEDALAR.Q
R.LNKEADEALLHNLR.L
R.LNKEADEALLHDLR.L
R.LDKEADEALLHNLR.L
R.VELQAQTTTLEQAIK.S
R.QLAVAQQTLKNELDR.Y
R.QLAVAQQTLKDELDR.Y
R.LQLEAQFLQDDISAAK.D
R.SKYENECECQLLLK.E

1979.02
2060.05
2639.18
2722.33

223-239
158-175
255-275
24-50

2767.28
2831.47
3316.73

255-276
320-247
320-351

3338.79

179-208

3466.89

178-208

3724.97

179-211

1124.59
1449.76
1456.7
2007.02
979.57
1036.53
1174.62
1285.63
920.5
1164.65
1373.7
4003.02

151-160
61-72
203-214
93-110
71-78
13-21
55-65
89-99
75-82
93-103
12-22
23-56

1622.78
1638.77
1516.73
1896.98
1359.79
1407.74
2663.21

233-245
233-245
8-19
132-146
77-89
109-120
641-663

R.SQLEEGREVLSHLQAQR.V
R.LQLEAQFLQDDISAAKDR.H
K.SAHECYDDEIQLYNEQIETLR.K
R.AAEPERPADEGWAGATSLAALQGLGER.
V
K.SAHECYDDEIQLYNEQIETLRK.E
R.LTSAFIETPIPLFTQSHGVSLSTGSGGK.D
R.LTSAFIETPIPLFTQSHGVSLSTGSGGKDL
TR.A
K.NLLEVQTYISILQQIIHTTPPASIVTSGMR.
E
K.KNLLEVQTYISILQQIIHTTPPASIVTSGMR
.E
K.NLLEVQTYISILQQIIHTTPPASIVTSGMRE
EK.L
K.ISLFEGANFK.G
R.LVVFELENFQGR.R
R.GYQYLLEPGDFR.H
R.SIIVSAGPWVAFEQSNFR.G
K.FVIFLDVK.H
R.TLGPFYPSR.L
R.TVLDSGISEVR.S
K.VQDDFVEIHGK.H
R.FSVNLDVK.H
K.VLGDVIEVHGK.H
R.RPFFPFHSPSR.L
R.LFDQFFGEHLLESDLFPTSTSLSPFYLRPPS
FLR.A
K.DVFLGMFLYEYAR.R
K.DVFLGMFLYEYAR.R
K.ITFYEDKNFQGR.R
K.VLEGVWIFYELPNYR.G
R.ALGISSVFLQGLR.S
K.IILYENPNFTGK.K
K.SSANWILAASLLSCSCFRSGFHR.D

1182.67
1279.65
1280.64
1310.68
1634.87
1635.86
1635.86
1671.9
1725.94
1726.92
1788.93
1979.02
2060.05
2722.33

353-362
147-157
147-157
78-90
144-157
144-157
144-157
240-254
294-308
294-308
158-173
223-239
158-176
24-50

2831.47
3316.73

320-347
320-351

3338.79

179-208

R.LQDITAAKPR.Q
K.EADEALLHNLR.L
K.EADEALLHDLR.L
R.LGELAGPEDALAR.Q
R.LNKEADEALLHNLR.L
R.LNKEADEALLHDLR.L
R.LDKEADEALLHNLR.L
R.VELQAQTTTLEQAIK.S
R.QLAVAQQTLKNELDR.Y
R.QLAVAQQTLKDELDR.Y
R.LQLEAQFLQDDISAAK.D
R.SQLEEGREVLSHLQAQR.V
R.LQLEAQFLQDDISAAKDR.H
R.AAEPERPADEGWAGATSLAALQGLGER.
V
R.LTSAFIETPIPLFTQSHGVSLSTGSGGK.D
R.LTSAFIETPIPLFTQSHGVSLSTGSGGKDL
TR.A
K.NLLEVQTYISILQQIIHTTPPASIVTSGMR.
E

Deamidation

N155

Deamidation
Deamidation

N155
N145

Deamidation

N304

2 Propionamide

C131
C133

Propionamide

C259

Propionamide

C259

Oxidation

M207

Oxidation

M207

Oxidation

M207

Oxidation

M238

Phosphorylation
, Propionamide

S655
C656

Deamidation

N155

Deamidation
Deamidation

N155
N145

Deamidation

N304

Oxidation

M207
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αB-Crystallin

20146

βB1-Crystallin

28006

Serum Albumin

69321

αA-Crystallin

19897

γS-Crystallin
Phakinin
βB2-Crystallin
LIM Domain and
Actin-binding
Protein 1
Complex 7
Filensin

20993
45851
23365

74499

αB-Crystallin

20146

βB1-Crystallin

28006

Serum Albumin

69321

αA-Crystallin

19897

Phakinin

45851

βB2-Crystallin
γS-Crystallin
Complex 8

23365
20993

3466.89

178-208

3756.96

312-347

920.5
1164.65
1191.62
1373.7
2623.37
2624.35
2943.52
1124.59
1449.76
1456.7
2007.02
1622.78
1638.77
979.57
1036.53
1174.62
1285.63
1896.98
1359.79
1407.74
1174.58

75-82
93-103
73-82
12-22
124-149
124-149
122-149
151-160
61-72
203-214
93-110
233-245
233-245
71-78
13-21
55-65
89-99
132-146
77-89
109-120
165-175

K.KNLLEVQTYISILQQIIHTTPPASIVTSGMR
.E
R.IIEIEGNRLTSAFIETPIPLFTQSHGVSLSTG
SGGK.D
R.FSVNLDVK.H
K.VLGDVIEVHGK.H
K.DRFSVNLDVK.H
R.RPFFPFHSPSR.L
R.IPADVDPLTITSSLSSDGVLTVNGPR.K
R.IPADVDPLTITSSLSSDGVLTVDGPR.K
K.YRIPADVDPLTITSSLSSDGVLTVDGPR.K
K.ISLFEGANFK.G
R.LVVFELENFQGR.R
R.GYQYLLEPGDFR.H
R.SIIVSAGPWVAFEQSNFR.G
K.DVFLGMFLYEYAR.R
K.DVFLGMFLYEYAR.R
K.FVIFLDVK.H
R.TLGPFYPSR.L
R.TVLDSGISEVR.S
K.VQDDFVEIHGK.H
K.VLEGVWIFYELPNYR.G
R.ALGISSVFLQGLR.S
K.IILYENPNFTGK.K
K.ISADEDSLAVR.S

1182.67
1279.65
1280.64
1310.68
1634.87
1635.86
1635.86
1671.9
1725.94
1726.92
1788.93
1840.87

352-362
147-157
147-157
78-90
144-157
144-157
144-157
240-254
294-308
294-308
158-173
125-138

R.ALQDITAAKPR.Q
K.EADEALLHNLR.L
K.EADEALLHDLR.L
R.LGELAGPEDALAR.Q
R.LNKEADEALLHNLR.L
R.LNKEADEALLHDLR.L
R.LDKEADEALLHNLR.L
R.VELQAQTTTLEQAIK.S
R.QLAVAQQTLKNELDR.Y
R.QLAVAQQTLKDELDR.Y
R.LQLEAQFLQDDISAAK.D
R.SKYENECECQLLLK.E

1979.02
2060.05
2639.18
2722.33

223-239
158-175
255-275
24-50

2767.28
2831.47
3316.73

255-276
320-347
320-351

3338.79

179-208

3466.89

178-208

920.5
1164.65
1373.7
2623.37
2624.35
1124.59
1449.76
1456.7
1622.78
1638.77
1036.53
1171.59
1174.62
1359.79
1878.98
1407.74
1516.73

75-82
93-103
12-22
124-149
124-149
151-160
61-72
203-214
233-245
233-245
13-21
79-88
55-65
77-89
122-137
109-120
8-19

R.SQLEEGREVLSHLQAQR.V
R.LQLEAQFLQDDISAAKDR.H
K.SAHECYDDEIQLYNEQIETLR.K
R.AAEPERPADEGWAGATSLAALQGLGER.
V
K.SAHECYDDEIQLYNEQIETLRK.E
R.LTSAFIETPIPLFTQSHGVSLSTGSGGK.D
R.LTSAFIETPIPLFTQSHGVSLSTGSGGKDL
TR.A
K.NLLEVQTYISILQQIIHTTPPASIVTSGMR.
E
K.KNLLEVQTYISILQQIIHTTPPASIVTSGMR
.E
R.FSVNLDVK.H
K.VLGDVIEVHGK.H
R.RPFFPFHSPSR.L
R.IPADVDPLTITSSLSSDGVLTVNGPR.K
R.IPADVDPLTITSSLSSDGVLTVNGPR.K
K.ISLFEGANFK.G
R.LVVFELENFQGR.R
R.GYQYLLEPGDFR.H
K.DVFLGMFLYEYAR.R
K.DVFLGMFLYEYAR.R
R.TLGPFYPSR.L
K.HFSPEDLTVK.V
R.TVLDSGISEVR.S
R.ALGISSVFLQGLR.S
K.VHALEQVSQELETQLR.M
K.IILYENPNFTGK.K
K.ITFYEDKNFQGR.R

Oxidation

M207

Deamidation

N318

Deamidation
Deamidation

N146
N146

Oxidation

M238

2 Deamidation

N168
N170

Deamidation

N155

Deamidation
Deamidation

N155
N145

Deamidation

N304

2 Propionamide

C131
C133

Propionamide

C259

Propionamide

C259

Oxidation

M207

Oxidation

M207

Deamidation

N146

Oxidation

M238
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Filensin

αB-Crystallin

74499

20146

βB1-Crystallin

28006

αA-Crystallin

19897

Phakinin
γS-Crystallin
βB2-Crystallin
Complex 9
Filensin

45851
20993
23365

βB1-Crystallin

74499

28006

1182.67
1279.65
1280.64
1310.68
1634.87
1635.86
1635.86
1671.9
1725.94
1726.92
1788.93
1979.02
2060.05
2722.33

352-362
147-157
147-157
78-90
144-157
144-157
144-157
240-254
294-308
294-308
158-173
223-239
158-175
24-50

2767.28
2831.47
3316.73

255-276
320-347
320-351

3338.79

179-208

3466.89

178-208

3756.96

312-347

920.5
1164.65
1191.62
1373.7
2623.37
2624.35
2943.52
1124.59
1449.76
1456.7
2007.02
979.57
1036.53
1174.62
1285.63
3363.64
1359.79
1896.98
1407.74

75-82
93-103
73-82
12-22
124-149
124-149
122-149
151-160
61-72
203-214
93-110
71-78
13-21
55-65
89-99
22-49
77-89
132-146
109-120

R.ALQDITAAKPR.Q
K.EADEALLHNLR.L
K.EADEALLHDLR.L
R.LGELAGPEDALAR.Q
R.LNKEADEALLHNLR.L
R.LNKEADEALLHDLR.L
R.LDKEADEALLHNLR.L
R.VELQAQTTTLEQAIK.S
R.QLAVAQQTLKNELDR.Y
R.QLAVAQQTLKDELDR.Y
R.LQLEAQFLQDDISAAK.D
R.SQLEEGREVLSHLQAQR.V
R.LQLEAQFLQDDISAAKDR.H
R.AAEPERPADEGWAGATSLAALQGLGER.
V
K.SAHECYDDEIQLYNEQIETLRK.E
R.LTSAFIETPIPLFTQSHGVSLSTGSGGK.D
R.LTSAFIETPIPLFTQSHGVSLSTGSGGKDL
TR.A
K.NLLEVQTYISILQQIIHTTPPASIVTSGMR.
E
K.KNLLEVQTYISILQQIIHTTPPASIVTSGMR
.E
R.IIEIEGDRLTSAFIETPIPLFTQSHGVSLSTG
SGGK.D
R.FSVNLDVK.H
K.VLGDVIEVHGK.H
K.DRFSVNLDVK.H
R.RPFFPFHSPSR.L
R.IPADVDPLTITSSLSSDGVLTVNGPR.K
R.IPADVDPLTITSSLSSDGVLTVDGPR.K
K.YRIPADVDPLTITSSLSSDGVLTVNGPR.K
K.ISLFEGANFK.G
R.LVVFELENFQGR.R
R.GYQYLLEPGDFR.H
R.SIIVSAGPWVAFEQSNFR.G
K.FVIFLDVK.H
R.TLGPFYPSR.L
R.TVLDSGISEVR.S
K.VQDDFVEIHGK.H
R.LFDQFFGEGLFEYDLLPFLSSTISPYYR.Q
R.ALGISSVFLQGLR.S
K.VLEGVWIFYELPNYR.G
K.IILYENPNFTGK.K

1182.67
1279.65
1280.64
1310.68
1555.76
1634.87
1635.86
1635.86
1671.9
1725.94
1726.92
1788.93
1840.87

352-362
147-157
147-157
78-90
470-483
144-157
144-157
144-157
240-254
294-308
294-308
158-173
125-138

R.ALQDITAAKPR.Q
K.EADEALLHNLR.L
K.EADEALLHDLR.L
R.LGELAGPEDALAR.Q
R.HVLVTGDADYVDPR.F
R.LNKEADEALLHNLR.L
R.LNKEADEALLHDLR.L
R.LDKEADEALLHNLR.L
R.VELQAQTTTLEQAIK.S
R.QLAVAQQTLKNELDR.Y
R.QLAVAQQTLKDELDR.Y
R.LQLEAQFLQDDISAAK.D
R.SKYENECECQLLLK.E

1979.02
2060.05
2639.18
2722.33

223-239
158-175
255-275
24-50

2767.28
2768.26

255-276
255-276

R.SQLEEGREVLSHLQAQR.V
R.LQLEAQFLQDDISAAKDR.H
K.SAHECYDDEIQLYNEQIETLR.K
R.AAEPERPADEGWAGATSLAALQGLGER.
V
K.SAHECYDDEIQLYNEQIETLRK.E
K.SAHECYDDEIQLYDEQIETLRK.E

2831.47
3316.73

320-347
320-351

1124.59
1185.52

151-160
124-132

R.LTSAFIETPIPLFTQSHGVSLSTGSGGK.D
R.LTSAFIETPIPLFTQSHGVSLSTGSGGKDL
TR.A
K.ISLFEGANFK.G
R.WNTWSSSYR.S

Deamidation

N155

Deamidation
Deamidation

N155
N145

Deamidation

N304

Propionamide

C259

Oxidation

M207

Oxidation

M207

Deamidation

N318

Deamidation

N146

Deamidation

N155

Deamidation

N478

Deamidation
Deamidation

N155
N145

Deamidation

N304

2 Propionamide

C131
C133

Propionamide

C259

Propionamide
Deamidation,
Propionamide

C259
N268
C259
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αA-Crystallin

19897

Phakinin

45851

γS-Crystallin

20993

βB2-Crystallin

23365

βA3-Crystallin

25134

γD-Crystallin
Phosphoglycerate
Kinase 1
βA4-Crystallin
Complex 10
Filensin

20715
44586

1449.76
1456.7
1718.8
1934.99
2007.02
2439.13
920.5
921.48
1164.65
1191.62
1373.7
1511.67
1715.9
1881.9
2624.35
979.57
1036.53
1171.59
1174.62
1192.63
1285.63
3363.64
1353.72
1359.79
1878.98
2081.01
1516.73
1728.89
1896.98
1407.74
1725.81
1759.83
2189.01
1454.70
1499.74
1690.75
1270.6
2022.03

22360

1741.85

74499

1014.54
1094.5
1131.6
1279.65
1280.64
1306.63
1310.68
1386.6
1554.78
1555.76
1618.81
1634.87
1671.9
1698.77
1726.92
1725.9
1796.84
1840.91
1265.61
1266.6
1268.72
1269.7
1307.63
1353.72
1359.79
1393.71
1394.69
1660.77
1795.87
1872.95

αB-Crystallin

Phakinin

20146

45851

61-72
203-214
188-202
236-252
93-110
161-182
75-82
75-82
93-103
73-82
12-22
57-69
93-107
57-72
124-149
71-78
13-21
79-88
55-65
12-21
89-99
22-49
90-103
77-89
122-137
174-191
8-19
159-174
132-146
109-120
173-188
146-160
169-188
33-44
126-137
96-109
143-152
280-297

R.LVVFELENFQGR.R
R.GYQYLLEPGDFR.H
K.VSSGTWVGYQYPGYR.G
K.QWHLEGSFPVLATEPPK.R.SIIVSAGPWVAFEQSNFR.G
K.GNTIEIQGDDAPSLWVYGFSDR.V
R.FSVNLDVK.H
R.FSVDLDVK.H
K.VLGDVIEVHGK.H
K.DRFSVNLDVK.H
R.RPFFPFHSPSR.L
R.APSWFDTGLSEMR.L
K.VLGDVIEVHGKHEER.Q
R.APSWFDTGLSEMRLEK.D
R.IPADVDPLTITSSLSSDGVLTVDGPR.K
K.FVIFLDVK.H
R.TLGPFYPSR.L
K.HFSPEDLTVK.V
R.TVLDSGISEVR.S
K.RTLGPFYPSR.L
K.VQDDFVEIHGK.H
R.LFDQFFGEGLFEYDLLPFLSSTISPYYR.Q
R.SSGLATVPAPGLER.D
R.ALGISSVFLQGLR.S
K.VHALEQVSQELETQLR.M
R.LMLQTETIQAGADDFKER.Y
K.ITFYEDKNFQGR.R
R.KPIDWGAASPAVQSFR.R
K.VLEGVWIFYELPNYR.G
K.IILYENPNFTGK.K
K.DSSDFGAPHPQVQSVR.R
R.VQSGTWVGYQYPGYR.G
K.GDYKDSSDFGAPHPQVQSVR.R
K.ITIYDQENFQGK.R
K.MTIFEKENFIGURER.Q
R.WDAWSGSNAYHIER.L
R.QYLLMPGDYR.R
K.ITLPVDFVTADKFDENAK.T

Deamidation

N78

Oxidation

M68

Oxidation
Deamidation

M68
N146

Oxidation

M175

Oxidation

M126

Oxidation

M147

Phosphorylation

S488

Deamidation

N155

Phosphorylation

T460

Deamidation

N478

Phosphorylation
Deamidation

T460
N304

Deamidation

N478

Deamidation

N207

Deamidation
Oxidation

N286
M221

Deamidation

N207

Oxidation
Propionamide

M175
C65

R.EWGSHAPTFQVQSIR.R
484-492
484-492
621-630
147-157
147-157
457-467
78-90
457-467
470-483
470-483
454-467
144-157
240-254
454-467
294-308
294-308
545-560
468-483
201-211
201-211
286-297
286-297
221-231
90-103
77-89
200-211
200-211
401-415
174-189
53-72

R.FYVSSITAK.G
R.FYVSSITAK.G
K.TVEVVESIEK.I
K.EADEALLHNLR.L
K.EADEALLHDLR.L
K.EPETPTELYTK.E
R.LGELAGPEDALAR.Q
K.EPETPTELYTK.E
R.HVLVTGDANYVDPR.F
R.HVLVTGDADYVDPR.F
R.SPKEPETPTELYTK.E
R.LNKEADEALLHNLR.L
R.VELQAQTTTLEQAIK.S
R.SPKEPETPTELYTK.E
R.QLAVAQQTLKDELDR.Y
R.QLAVAQQTLKNELDR.Y
K.EIEPDGAELEGPEEKR.E
K.ERHVLVTGDADYVDPR.F
K.AAEEEINSLYK.V
K.AAEEEIDSLYK.V
K.NRVEAGALLQAK.Q
K.DRVEAGALLQAK.Q
K.MDLESQIESLK.E
R.SSGLATVPAPGLER.D
R.ALGISSVFLQGLR.S
R.KAAEEEINSLYK.V
R.KAAEEEIDSLYK.V
K.DVASYHALLDREESG.R.LMLQTETIQAGADDFK.E
R.APGVYVGTAPSGCIGGLGAR.V
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2075.97
2081.01
1176.61

155-173
174-191
316-326

R.ASWASSCQQVGEAVLENAR.L
R.LMLQTETIQAGADDFKER.Y
K.EITALAPSTMK.I

1197.7
1515.69
1789.88
1953.06
2230.06
1036.53
1174.62
1192.63
1285.63
1168.71
1322.61
940.57

29-39
360-372
239-254
96-113
292-312
13-21
55-65
12-21
89-99
130-139
197-207
26-34

R.AVFPSIVGRPR.H
K.QEYDESGPSIVHR.K
K.SYELPDGQVITIGNER.F
R.VAPEEHPVLLTEAPLNPK.A
K.DLYANTVLSGGTTMYPGIADR.M
R.TLGPFYPSR.L
R.TVLDSGISEVR.S
K.RTLGPFYPSR.L
K.VQDDFVEIHGK.H
K.ILLAELEQLK.G
R.EEAENTLQSFR.Q
R.ALAEGVLLR.T

1027.57
1085.64
989.53

222-230
42-51
251-259

R.AIENELLAR.N
R.VLSSTTLLPR.Q
K.LFGAAEVQR.F

1084.62
1396.66

286-295
101-113

R.DLASVQALLR.K
R.LLLATMESMDGGK.L

1407.74
1124.59
920.5
1164.65
2297.13
2635.22

109-120
151-160
75-82
93-103
98-121
122-149

Actin,
cytoplasmic 1

41719

αA-Crystallin

19897

Vimentin

53619

Glutathione
Synthetase

52352

Paralemmin-1
Spectrin α chain

42050
28436
4

Retinal
Dehydrogenase 1

54827

βB2-Crystallin
βB1-Crystallin
αB-Crystallin

23365
28006
20146

BASP 1

22680

Lactase-like
Protein
NCAM

65047

1097.64

93-101

K.IILYENPNFTGK.K
K.ISLFEGANFK.G
R.FSVNLDVK.H
K.VLGDVIEVHGK.H
K.AEPPKAPEQEQAAPGPAAGGEAPK.A
K.AAEAAAAPAESAAPAAGEEPSKEEGEPK.
K
K.VQEDIILLR.E

14380
0
25134

1244.62

706-715

K.LSPYVNYSFR.V

1454.7
926.49

33-44
12-18

K.ITIYDQENFQGK.R
K.YLYEIAR.R

βA3-Crystallin
Serum Albumin

Propionamide
Oxidation
Oxidation

C161
M175
M325

Oxidation

M305

Deamidation, 2
Oxidation

N110
M106
M109
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Appendix 4
Tukey’s test of percentage of deamidation for P7: Test performed using data presented in
Table 5.5. Statistical significance at P≤0.01 shaded in light green, P≤0.05 shaded in dark
green.
P7 (Q151)
ABC + heat
PBS
PBS + heat
Urea + heat

ABC + heat

PBS
0.19

PBS + heat
0.002
0.03

Urea + heat
0.12
0.98
0.04

Tukey’s test of percentage of deamidation for P8: Test performed using data presented in
Table 5.5. Statistical significance at P≤0.01 shaded in light green, P≤0.05 shaded in dark
green.
P8 (N146)
ABC + heat
PBS
PBS + heat
Urea + heat

ABC + heat

PBS
0

PBS + heat
0.01
0.25

Urea + heat
0.2
0.02
0.65
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